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SUMMARY
In the ra t renal a l lo g ra f t  model, pre-operative administration of 
donor s tra in  blood is s u f f ic ie n t  to produce long-term renal a l lo g ra f t  
survival even in the absence o f adjunctive immunosuppression. The 
precise mechanisms underlying th is  enhancing e ffec t are unclear but 
possible mechanisms include e lim ination or clonal deletion of 
a l lo reac t ive  lymphocytes, removal of passenger leucocytes, blocking of 
e ffe c to r  ce l ls  by antibody or antigen and the induction of 
a lloan tigen-spec if ic  suppressor c e l ls .
Rejecting ra t renal a l log ra f ts  are characterised by a heterogeneous 
mononuclear ce ll and i t  was therefore important to determine whether 
pre-operative blood transfusion affected the in f i l t r a t i o n  of 
a l lo g ra f ts .  A detailed analysis was made of the pattern and phenotype 
o f mononuclear ce lls  in f i l t r a t i n g  re jec ting  DA s tra in  a l log ra fts  in 
unmodified PVG recip ients and non-rejecting DA a llo g ra f ts  from PVG 
recip ients which had been active ly  enhanced by in jec t io n  of 1 ml of 
DA blood intravenously 7 days before transplanta tion. Excised grafts 
were stained with a range of monoclonal antibodies to ra t ce ll surface 
antigens on day 1, 3, 5 and 7 post transp lanta tion. Paradoxically
pre-operative blood transfusion caused accelerated c e l lu la r  
i n f i l t r a t i o n  of the g ra ft  and the rapid disappearance of g ra ft 
i n t e r s t i t i a l  dendrit ic  ce l ls .  The phenotype of ce l ls  found w ith in  both 
enhanced and re jec ting  grafts  was s im ila r except fo r  a reduced number 
o f CD8+ce lls  and IL-2 receptor posit ive ce lls  in the enhanced compared 
with re jec ting  gra fts  at day 5 a fte r  transp lanta tion. However,there 
was no concomitant decrease in levels of in v i t ro  c y to to x ic i ty ,  since
18
g ra f t  i n f i l t r a t i n g  ce lls  and splenocytes from transfused animals had 
comparable levels of both specific  and non-specific cy to to x ic i ty  to 
those found in re jecting  animals.
Class I and class I I  MHC antigen expression w ith in  enhanced and 
re jec ting  g ra fts  was studied since the d is t r ib u t io n  and density of MHC 
expression may influence the v u ln e ra b i l i ty  o f the g ra ft  to host
e f fe c to r  responses. Unexpectedly i t  was found that enhanced grafts 
underwent an accelerated and extensive induction of both donor class
I and class I I  MHC antigens. This suggested that pre-operative blood
transfusion i n i t i a l l y  causes sensitisa tion  of the rec ip ien t resulting 
in an accelerated immunological response to the a l lo g ra f t ,  but that 
th is  is  rap id ly  and e ffe c t ive ly  suppressed by immunoregulatory 
mechanisms.
The p o s s ib i l i ty  that humoral factors may play a ro le in the 
benefic ia l e ffec t of blood transfusion on g ra f t  survival was then 
investigated. Because of reports suggesting an association between
serum Fc blocking a c t iv i ty  and renal a l lo g ra f t  su rv iva l, Fc blocking 
a c t iv i t y  was measured in the serum of unmodified and transfused PVG 
rec ip ients  o f a DA renal a l lo g ra f t .  Serum harvested on day 5 from 
a c t ive ly  enhanced PVG recip ients of a DA renal a l lo g ra f t  was shown to 
s p e c if ic a l ly  in h ib i t  erythrocyte-anti body (EA) rosette formation with 
donor s tra in , but not th ird -p a rty  s tra in , splenocytes, while the 
leve ls  o f EA rosette in h ib it io n  in day 5 serum from re jec ting  rats was 
markedly lower. This FcR-blocking a c t iv i ty  was present in enhanced 
serum frac tions , prepared by discontinuous density gradient 
cen tr ifuga tion , which corresponded to the 7S peak. Purif ied IgG 
prepared from enhanced serum was also found to in h ib i t  EA rosette
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formation with donor splenocytes, and absorption of the IgG 
preparations with donor-strain erythrocytes fa i le d  to abrogate EA 
rosette in h ib i t io n .  Further experiments, in which absorbed IgG from 
enhanced animals was tested fo r  FcR-blocking a c t iv i ty  against 
splenocytes o f defined major h is tocom patib il i ty  complex (MHC) 
subregion s p e c i f ic i t ie s ,  established that FcR blocking a c t iv i ty  was 
mediated by IgG alloantibodies directed against donor MHC class I I  
antigens.
This find ing suggested that there might be important differences in 
the nature and timing of the alloantibody response to a renal 
a l lo g ra f t  in re jecting  and enhanced rec ip ients . A sequential analysis 
was therefore made of the antibody response to donor class I and class 
I I  MHC antigens in unmodified PVG rats bearing a re jec ting  g ra ft and 
transfused PVG recip ients bearing an ac tive ly  enhanced g ra f t .  There 
was a dichotomy in the antibody response to class I and class I I  MHC 
antigens. Enhanced recip ients had barely detectable post 
transplantation levels of an ti-c lass I antibody while unmodified 
rec ip ients  made a substantial an ti-c lass I response which increased 
stead ily  a fte r  transplantation . On the other hand, enhanced animals 
had high levels of anti-c lass I I  antibody in th e ir  serum in the f i r s t  
7 days a f te r  transplantation and the re jec ting  animals did not produce 
comparable levels of anti-c lass I I  u n t i l  day 10 a fte r  transplantation. 
Cytotoxic antibody levels in re jecting  animals were directed mainly at 
class I MHC antigens and rose steadily  a fte r  transplantation. 
Conversely,cytotoxic antibodies in enhanced animals were directed at 
class I I  antigens and were present at low levels in the f i r s t  10
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days a f te r  transplantation. Therefore in th is  s tra in  combination 
enhancement correlated with high levels o f an ti-c lass I I  and low 
leve ls of anti-c lass I MHC antibodies.
The a b i l i t y  of serum from transfused and unmodified PVG re c ip ie n ts ,5 
days a f te r  transplantation with a DA kidney to in h ib i t  the DA to PVG 
MLR was tested. Serum and pu r if ied  IgG from enhanced animals showed 
greater in h ib i t io n  of the MLR than re jec ting  serum or IgG.However 
there was also considerable in h ib it io n  of the th ird -p a r ty  MLR. Since 
the p ro l i fe ra t iv e  response in the MLR is generally held to be a 
response to class I I  MHC antigens i t  seems l ik e ly  that the greater 
in h ib i t io n  of the MLR in enhanced animals is due to anti-c lass I I  
antibodies.
The find ing that blood transfusion primes the rec ip ien t to develop a 
high an ti-c lass I I  alloantibody response to a subsequent renal 
a l lo g ra f t  raises the p o s s ib i l i ty  that the an ti-c lass I I  antibody may 
contribute to the beneficial e ffec t on g ra f t  surv iva l. The a b i l i t y  of 
serum from active ly  enhanced rats during the early 
post-transplantation period to in h ib i t  the MLR is in keeping with th is  
suggestion, but in vivo adoptive transfe r studies w i l l  be necessary to 
fu r th e r substantiate th is  hypothesis.
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ABBREVIATIONS
ADCC - Antibody dependent c e l lu la r  c y to to x ic i ty
ARCO - Antigen reactive ce ll opsonisation
BSA - Bovine serum albumin
ConA - Concanavalin A
CyA - Cyclosporin A
DAB - Dulbeccos A and B
DST - Donor specific  transfusion
DTH - Delayed type hypersensitiv ity
EA - Erythrocyte antibody
FcR - Fc receptor
FCS - Foetal c a l f  serum
GvH - Graft versus host
HLA - Human leucocyte antigen
IgG - Immunoglobulin G
IL -1 - In terleuk in  1
IL - 2 - In terleuk in  2
LNC - Lymph node cell
MLR - Mixed lymphocyte reaction
NK - Natural k i l l e r
RES - Reticuloendothelial system
RT - Room temperature
TcR - T ce ll receptor
TDL - Thoracic duct lymphocyte
PLN - Popliteal lymph node
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CHAPTER 1
INTRODUCTION AND REVIEW OF THE LITERATURE
1.1.0 The development and current status of renal transplantation
Renal transplantation is the treatment o f choice fo r  patients 
su ffe ring  from end-stage renal fa i lu re .  I t  is  not only cost e ffec tive  
in comparison to haemodialysis, but more importantly provides a much 
improved qua lity  of l i f e .  However, successful c l in ic a l  renal 
transplantation is a re la t iv e ly  recent phenomenon and has only been 
widely achieved over the las t two decades.
In 1951 David Hume in Boston embarked on a series of cadaver 
kidney transplants. Although these operations were considered to be 
techn ica lly  successful, unfortunately nearly a l l  g ra fts  were rapidly 
re jected. Another Bostonian, Dr. Joseph Murray, avoided the 
immunological problems associated with transplants between 
genetica lly  d i f fe re n t individuals by successfully transplanting 
kidneys between identical twins. This success heralded the f i r s t  of 
many subsequent transplants between identica l twins, but the problems 
of immunological re jection between non-identical ind iv iduals remained.
Hope fo r  the seemingly in tractab le problem of g ra ft  re jection 
came with the discovery by Schwartz and Dameshek (1959) that a purine 
analogue, (6-MP) could e ffe c t ive ly  suppress the immune response of 
rabbits  to human serum albumin. This exciting find ing was followed up 
by Caine in Great B r ita in  (1960) and Zukoski,Lee & Hume in the United 
States (1960) who independently found that 6-mercaptopurine would 
prolong the survival of renal a l log ra fts  in dogs. In 1961 
azathioprine, a derivative of 6-MP was synthesised and was found to
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be a less tox ic , but equally e ffec t ive  immunosuppressant. (Caine, 
Alexandre and Murray, 1962). C lin ica l t r i a ls  o f azathioprine began and 
in 1963 the f i r s t  drug-treated rec ip ien t of a cadaver kidney to 
survive fo r  one year was reported (Murray, M e r r i l l ,Harrison et a l , 
1963). For the next twelve years azathioprine in combination with 
cort icostero ids was the accepted immunosuppressive therapy in most 
renal transplant un its . In the 1970's the optimism which had pervaded 
the transplant world in the previous decade began to fade with the 
re a lisa t ion  that the immunosuppressive therapy available could not 
guarantee successful transplantation between unrelated ind iv iduals. 
One year cadaveric g ra ft  survival rates quoted in 1974 were s t i l l  of 
the order o f 50%, l i t t l e  better than several years previously (Opelz, 
Mickey and Terasaki, 1974). Tissue matching of the donor and 
rec ip ien t fo r  h is tocom patib il ity  antigens improved g ra f t  surv iva l,bu t 
even well-matched grafts  were sometimes rejected.
The next important advance was the discovery by Sandoz Ltd. of 
a new drug cyclosporin A (CyA) which was found to have remarkable 
immunosuppressive properties (Borel, 1976). Again, i t  was Caine who 
was the f i r s t  to demonstrate the effectiveness o f th is  new drug as 
an immunosuppressive agent in renal transplantation. (Caine, White, 
Thiru et a l , 1978). The introduction of CyA has heralded a new era
in c l in ic a l  transplantation with 1 year cadaveric renal a l lo g ra f t  
survival rates o f around 80% being widely reported (Morris, 1988). 
CyA e ithe r alone or in combination with steroids and/or azathioprine 
is  now the standard immunosuppressive therapy in nearly a l l  transplant 
un its . Recently a novel fungal metabolite FK-506 was discovered 
(Kino,Hatanaka,Hashimoto et a l ,1987) and found to be a more potent
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immunosuppressive agent than CyA . I t  has been found to in h ib i t  T 
ce l l  activa tion  and lymphokine production in v i t ro ,  and to suppress 
re je c t ion  of skin and heart grafts  in rats and kidney grafts  in dogs 
(Kino, Hatanka, Miyata et al,1987; Thomson,Stephen,Woo et
a l (1989); Inamura,Nakahara, Kino et a l ,1988; Ochiai,Nagata, Nakajima 
et a l ,1987). However there are no published data to date on the use of 
FK-506 on human renal transplant patients. Despite the advances in 
immunosuppression, immunological re jection remains a major problem. 
Furthermore, the non-specific immunosuppression currently  used 
resu lts  in an increased susce p tib i l i ty  to v ira l and other types of
in fe c t ion  as well as an increased incidence o f some types of 
malignancy . Moreover in the case of CyA, nephrotoxicity may be a
serious side e ffec t.
An important empirical observation in c l in ic a l  renal 
transp lanta tion was that transfusion with random donor blood p r io r  to 
transp lanta tion s ig n if ica n t ly  improved g ra ft survival (Opelz, Sengar, 
Mickey et al 1973). This in i t i a l  observation was subsequently
confirmed in several transplant centres and has led to the ubiquitous 
use o f pretransplant transfusion fo r recip ients of cadaver kidneys. 
Following on from this,Sal vatierra(1980)introduced donor specific  
transfusion in an attempt to achieve better g ra ft  survival in 
one-haplotype matched l iv in g  related recip ients . The mechanism of the 
benefic ia l e ffec t of blood transfusion on a l lo g ra f t  survival remains 
unclear despite intensive study in th is  f ie ld .  I t  is clear, however, 
tha t a be tter understanding of th is  important c l in ic a l  observation 
may provide an insight into methods of fu r the r improving renal 
a l lo g ra f t  surv iva l.
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The overall aim of th is  thesis is to examine the 
mechanism of prolonged a l lo g ra f t  survival fo llowing donor specific 
blood transfusion using a ra t renal a l lo g ra f t  model. The ra t model 
allows the immune response to defined h is tocom patib i l i ty  differences 
to be examined, using inbred stra ins of ra ts . Furthermore the rat 
unlike the mouse has s u f f ic ie n t ly  large vessels such that anastamosis 
o f the renal vessels may be performed with the aid of a dissecting 
microscope. While one must exercise caution in extrapolating the 
find ings in an animal model, to the c l in ic a l  s itua tion  one can 
hopefully gain information about, and a greater understanding of the 
"transfusion e f fe c t" .  This in turn may allow the development of 
stra teg ies fo r  inducing specific  unresponsiveness in transplant 
rec ip ien ts .
1.2 .0 . The blood transfusion effect in c lin ical transplantation
The beneficial e ffec t of blood transfusion on renal 
a l lo g ra f t  survival was not reported un t i l  1973 (Opelz et a l , 1973). 
Interestingly,however, Medawar, whils t preforming skin gra ft ing  
experiments in rabbits, found that rabbits which had received massive 
transfusions of homologous blood did not re jec t th e ir  
grafts(Medawar,1946). Subsequently Kearns and Reid (1949) reported the 
success o f a father to son skin g ra ft in which p r io r  transfusion had 
occurred. The f i r s t  report of a "donor spec if ic " transfusion e ffec t 
came from Halasz, O r lo ff  and Hirose (1964) who showed in a canine 
renal a l lo g ra f t  model that the subcutaneous in jec t ion  of donor blood 
10 and 5 days p r io r  to transplantation prolonged g ra ft  survival . In
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1967 Dossetor, MacKinnon, Gault et al reported the f i r s t  case of a 
successful renal transplant in man following donor-recipient cross 
c irc u la t io n .  However, when Opelz et al (1973) compared kidney
g ra f t  survival between patients who had received blood transfusions 
(from blood group compatible but otherwise random donors) p r io r  to 
transp lanta tion,w ith  those who had not, they found that transfusion 
had a beneficial e ffect on surviva l. Furthermore, the same authors 
(1974) suggested that patients who had received whole blood or packed 
red ce l ls  (but not frozen ce lls ) had improved g ra f t  survival and th is  
benefic ia l e ffec t correlated with the amount of blood received. In a 
study o f over 1300 cadaver transplants, g ra ft  survival at one year was 
42% fo r  recip ients who had never been transfused and 71% fo r  those who 
had received more than 20 units of blood (Opelz and Terasaki, 1978). 
The general find ing that blood transfusion had a benefic ia l e ffec t on
renal a l lo g ra f t  survival was confirmed by other renal transplant
centres, although there was disagreement over the amount and type of
transfusion which gave the maximum benefit fo r  g ra f t  survival along 
with the minimum r is k  of sensitisation (the development of cytotoxic 
antibodies to the g ra ft donor). In a retrospective and prospective 
study o f patients receiving only one transfusion p r io r  to 
transp lanta tion , 1 year g ra ft survival rates were 73% and 70% 
respective ly compared with only 26% in the non-transfused group 
(Pers ijn , D'Amaro and van Rood,1984). Other groups favoured the 
administration of between two and f ive  transfusions and noted that 
maximum benefit was obtained i f  transplantation was carried out w ith in 
three months of the transfusion protocol (Hourmant,Soulillou, 
Bui-Quang,1979; Werner-Favre, Jeannet, Harder et a l ,1979).
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1.2.1 Blood components required for a transfusion effect
The demonstration that blood transfusion improved a l lo g ra f t  
surviva l led to many investigations aimed at determining which of the 
c e l lu la r  or other components of blood were responsible fo r the 
benefic ia l e ffec t. A number of experiments have addressed th is  
question in man, but th is  has been most extensively studied in animal 
models (see section 1.9.2 ).
Some studies t r ie d  to achieve a transfusion e ffec t with pu rif ied  
p la te le ts  which in man carry class I ,bu t not class I I  major 
h is tocom pa tib il i ty  antigens. I t  had previously been shown in monkeys 
tha t p la te le t  transfusion improved renal a l lo g ra f t  survival without 
inducing cytotoxic antibodies (Borle ffs , Neuhaus, van Rood et a l , 
1982). The three major studies carried out in man have produced 
c o n f l ic t in g  resu lts . Chapman, Fisher, Ting et a l ,1985 together with 
Pallardo, Montoro, Moll et a l ,1985 did not f ind  any benefic ia l e ffect 
o f p la te le t  transfusion on g ra ft outcome, but noted a s ign if ica n t 
degree o f sensitisa tion . On the other hand,Betuel, Cantarovich, 
Robert et al (1985), noted a beneficial e ffec t on g ra ft  survival and a 
minimum degree of sensitisation . Such contradictory findings may 
re f le c t  differences in the purity  of the p la te le t populations used. 
Other studies have looked at the role of leucocytes in the beneficial 
e f fe c t  o f blood transfusion. Freeze thawing of blood, which decreases 
the number of viable leucocytes was found to decrease the transfusion
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e ffe c t :  one year survival fo r patients receiving packed ce lls  or whole 
blood was 53% compared with only 20% fo r  patients receiving frozen 
c e l ls  (Opelz and Terasaki, 1974).
1*2.2. Donor specific transfusion
The e a r l ie r  animal work on donor spec if ic  transfusion (DST) 
suggested that such a protocol in l iv in g  related transplants might 
increase g ra ft  surviva l. While th is  was not considered necessary in 
HLA-identical or one-haplotype matched pairs with low re a c t iv i ty  in 
mixed lymphocyte culture (MLC), i t  was thought that i t  might be 
benefic ia l fo r  pairs in which there was high MLC re a c t iv i ty .  Cochrum, 
Sa lva tie rra  and Belzer (1974) had previously shown that the la t te r  
group had a poorer renal a l log ra f t  prognosis. This led Salvatierra 
et al (1980) to administer a course of donor spec if ic  transfusion in 
an attempt to achieve better g ra ft survival in one-haplotype matched 
l iv in g  related recip ients with high MLC re a c t iv i ty .  The main problem 
with th is  approach was sensitisation and 13 of the 45 potentia l l iv in g  
re lated recip ients developing either a T ce ll or a warm B ce ll 
crossmatch (discussed la te r ) .  However, g ra ft survival was excellent 
in the 30 patients who were transplanted: 95% had functioning grafts
at one year and a low incidence of re jection episodes (Salvatierra , 
Iwaki, Vincenti et a l , 1981a). Furthermore the transfusion e ffec t was
found to pers is t fo r at least four years a fte r  transplantation with 
82% g ra f t  surv iva l, which was comparable to that achieved with 
HLA-identical l iv in g  related transplant recip ients (Salvatierra ,
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Melzer, Potter et a l , 1988). I t  is unclear at present whether DST
confers any advantage over cyclosporin in one-haplotype matched 
l iv in g  related transplants and th is  w i l l  depend on the results of a 
prospective study of these two groups(Salvatierra,Melzer,Vincenti et 
a l ,1987).
Before discussing the animal models which have been studied 
to address the p o s s ib i l i ty  of developing strategies of specific 
immunosuppression, i t  is f i r s t  necessary to look at the tissue 
antigens responsible fo r g ra ft re jection and the mechanisms which are 
thought to bring about g ra ft destruction.
1.3 .0 . The Major Histocompatibility Complex (MHC)
1.3 .1 . Discovery of the human MHC
The Major H istocompatibility Complex (MHC) is a complex of 
genes which encode cell surface glycoproteins which are the major 
transplantation antigens. Incom patib ility  between ind iv iduals fo r  MHC 
antigens is the major barrie r to successful transplantation. Moreover 
MHC antigens are also v i ta l  recognition molecules of the immune 
system and some description of th e ir  structure and function is 
necessary to understand th e ir  role in re jec tion . A ll vertebrates and 
some invertebrates possess an MHC and there is a high degree of 
homology with respect to immunogenetics and biochemistry.
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Studies of the h istocompatib ility  antigens of man began with the 
discovery by Jean Dausset in 1958 of antibodies to white blood ce lls  
in the sera of burned and m ult ip ly  transfused patients (Dausset, 
1958). Using such antisera he detected the f i r s t  leucocyte antigen 
named 'Mac' on a panel of leucocyte donors. In 1958 van Rood and Payne 
independently discovered that cytotoxic antibodies to foetal 
leucocytes were present in the sera of multiparous women (van Rood, 
Eernisees and van Leeuwen, 1958; Payne and Rolfs, 1958). Using a 
leuco-agglutination test to define antigenic s p e c i f ic i t ie s  two a l le l i c  
systems were described: Group 4 (van Rood and van Leeuwen, 1963) and
'LA' (Payne,Tripp,Weigle et a l , 1964). In 1968, Kissmeyer-Nielsen,
Svejgaard and Hauge, described two a l le l i c  series of antigens coded 
by two d is t in c t  loc i Human Leucocyte Antigen-A (HLA-A) (equivalent to 
LA) and HLA-B (equivalent to group 4). A th ird  locus HLA-C was not 
established u n t i l  1972 (Svejgaard,Nielsen,Ryder et al 1972).
The HLA-D locus was designated when i t  was found that
lymphocytes from d iffe ren t individuals p ro life ra ted  when cultured 
together (Bach and Hirschkorn, 1964) even when HLA iden tica l.  The
locus determining the mixed leucocyte reaction (MLR) was mapped
outside the known HLA regions and designated HLA-D (Thorsby and
Piazza, 1975). Later i t  was shown that D-region antigens could also 
be detected sero log ica lly , each being associated with an HLA-D 
determinant and hence termed HLA-DR (D-related) (Bodmer and Bodmer, 
1978).
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Expression o f the HLA genes is co-dominant so that each cell 
expresses on i t s  surface two sets of antigens, one inherited from each 
parent. HLA genes are usually inherited en bloc by the offspring from 
each parent, each set of genes being termed the haplotype.
1 .3 .2 . The Genetic Map of HLA
I w i l l  describe in b r ie f  the maps of man, mouse and ra t in the 
fo llow ing section since many of the experiments to be described are in 
animal models. In pa rt icu la r, a description of the ra t MHC is given 
since the work in th is  thesis has been carried out in the ra t renal 
a l lo g ra f t  model.
The MHC of man is located on the short arm of chromosome six. 
The class I antigens of man are encoded by the B,C and A loc i Which 
are located on the opposite end of the chromosome from the centromere. 
Telomeric to HLA is the TCA (T cell system A) region which codes fo r
the antigens equivalent to mouse Qa or Tla which have been found on a
subset o f human T lymphocytes.
The class I I  antigens are encoded by three main subregions, 
namely DP, DQ and DR, though two other regions DN and DO have been 
described recently. The DP region codes fo r the oCl and B1 genes of the
DP class I I  molecule as well as two pseudogenes A2 and B2. DP is
thought to be analagous to the H region of the ra t ,  but has no 
homologue in mouse.
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The DQ subregion has two sets of alpha (Al and A2) and 2 sets of 
beta (B1 and B2) genes. The 1 and B1 genes are expressed but the 2 
and 32 genes are not. The HLA-DR chain is encoded by a single locus 
(0(1) while the 3 chain is coded fo r  by 2 genes 31 and 32, both of 
which are usually expressed.
The class I I I  genes map between HLA-DR and HLA-B and code for 
C2, Factor B, C4, 21 OH and TNF0( and 3. The genetic map of HLA can be 
seen in Fig 1.1
1.3.3 Discovery of the mouse MHC
In 1936 Peter Gorer showed that a rabbit anti-mouse serum 
reacted with red ce lls  from some but not other mouse stra ins (Gorer, 
1936). The determinant detected by th is  antibody was termed antigen 
I I  and was found to be controlled by an autosomal dominant locus 
which was termed histocompatib ility-2 or "H-2"(Gorer,1937). He 
hypothesised that tumour grafts exchanged between mice e l ic i te d  an 
immune response in the host due to an incom patib i l i ty  between the 
host and donor fo r antigen II(G ore r,1938). The establishment of 
congenic stra ins of mice by Snell (1948) , allowed Gorer to show that
tumour g ra fts  exchanged between mice d i f fe r in g  at H-2 were rejected 
and the locus was termed the major h is tocom patib il i ty  complex 
(MHC), (Gorer,Lyman and S ne ll,1948).
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1.3 .4 . The genetic map of H-2
The MHC of the mouse was mapped to chromosome 17 (Gorer et 
a l ,1948). The H-2K,H-2D and H-2L genes encode the class I antigens 
which were o r ig in a l ly  defined serologically (Bach, Widmer, Bach et a l , 
1972). The K and D/L regions which defined the H-2 complex are located 
at opposite ends of the H-2 region. These genes are highly 
polymorphic with more than 60 class I genes iden tif ied  in the wild 
population (Duncan, Wakeland and Klein, 1979). The T1 and Qa loc i map 
telomeric to the D/L region and code for the thymic leukemia antigen 
(TL antigen) found on thymocytes and the Qa antigens found on 
subpopulations of lymphocytes.
The immune response to certain synthetic polypeptides was found 
to map to a region between H-2K and H-2D (McDevitt and Tyan, 
1968;McDevitt and Benaceraff 1972), and the genes encoded by the 
region termed immune response genes ( I r  genes). I t  was also found that 
MLR a c t iv i t y  mapped to th is  region which became known as the I region 
(K le in ,1975). This region codes for the class I I  antigens which have 
been detected by both ce llu la r and serological means. The I region can 
be subdivided into I-Q and I-E which code fo r two d if fe ren t class I I  
antigens. The I-E antigen is encoded by two genes E<* and EB: EB is 
coded fo r  by the I-A subregions while Ed( is coded by I-E. The I-A 
subregions coded fo r the pCand B chains of the I-A antigen. The nature 
o f AB2 and EB2 is unknown while AB3 has been shown to be a pseudogene 
(Widera and F lave ll, 1985).
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The class I I I  genes are located between the I-E and D/L loc i and 
code fo r  serum complement components C2, factor B and C4. The genetic 
map o f the H-2 complex can be seen in figure 1.2.
1.3 .5 . The genetic map of RT1
The genetics of the MHC are less well defined fo r the ra t than 
man and mouse. The rat MHC was designated RT-1 in 1978 (Gil 1 ,Kunz & 
Misra,1987) and has provisionally been placed on ra t chromosome 14 
(Oikawa,Yoshida,Saitoh et al 1983). A number of loc i have been 
id e n t i f ie d ,  though the ir  position re la tive to the centromere is s t i l l
unknown. The class I antigens are coded for by the RT1.A and E loci
which are thought to be analagous to the H-2K and H-2D loci 
respective ly. Several other class I antigens have been defined 
se ro log ica l ly  and mapped to the RT1.A region namely FI and Pa.
Antigens encoded by the G and C regions have properties s im ilar 
to the TL and Qa antigens of the mouse (G ill et a l , 1987). The class
I I  lo c i ,  RT1.B and RT1.D are homologous to the I-A and I-E regions of 
the mouse (Blankenhorn and Cramer, 1985). Polymorphism arises in the 
RT1.B and D B chains (Natori,Ohashi, Inomata et al 1983) rather than 
the c<chains which are highly conserved (Wallis and McMaster, 1984). A 
th i r d  class I I  locus, RT1.H has been iden tif ied  to the RT1.A side of 
RT1.B and may be the ra t equivalent of HLA-DP (Walters,Locker,Kunz et
al 1987a).
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So fa r  the only class I I I  genes to have been i te n t i f ie d  are 
those encoding factor B (Wurst, Rothermel and Gunther 1988) and C4 
(Walters,Locker, Kunz et al 1987b). The genetic map of the ra t MHC can 
be seen in Figure 1.3.
1.4 .0 . Histocompatibility Antigens
1 .4 .1 . Structure of MHC antigens
The antigens encoded by the MHC have been subdivided on the 
basis o f structure and function into class I, class I I  and class I I I  
antigens (K le in ,1975). The class I and class I I  antigens of mouse and 
man have the same basic structure (Nathenson, Uehera,Ewenstein et 
a l , 1981; Kauffman, Auffray, Korman et al,1984). The structure of a rat 
class I antigen has only just been described and appears to be sim ilar 
to man and mouse(Radojcic,Stranick, Locker et a l ,1989) but a complete 
sequence fo r  a class I I  gene has yet to be described.
Class I antigens are cell surface glycoproteins comprised of two 
chains: the Kchain (approx 45 kd) is highly polymorphic and associated 
non-covalently with a non-variable l ig h t  chain (32 microglobulin) 
which is  not encoded by the MHC( Nathenson et a l , 1981). The heavy 
chain is composed of three extracellu lar domains ( oC 1, P^ 2, P^3), a 
transmembrane part and an intracytoplasmic t a i l .  Such molecules are 
said to be expressed on a ll nucleated ce lls , but have been d i f f i c u l t  
to detect on normal cells such as hepatocytes, corneal endothelium and 
sy n c it ia l  trophoblasts (Daar, Fuggle & Fabre 1984; Lew,Lillehoj,Cowan 
et al 1986; Lala, Chatterjee-Hasrouni,Kearns et al 1983).
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Class I I  antigens are heterodimetric glycoproteins comprised of 
an chain (33kd) and a B chain (28kd) which forms two extrace llu la r 
domains (pCl,pC2, Bl, B2) both of which are linked to a transmembrane 
region and an in tra ce llu la r  tail(Kaufman et a l , 1984).
Class I I  antigens have a more restric ted tissue d is tr ib u t io n
being expressed constitu tive ly  on B ce lls , monocytes, dendrit ic  ce lls  
and some endothelial cells and being induced on activated T ce lls .
The class I I I  products comprise the serum complement components 
C2, C4 and factor B; the enzyme 21 hydroxylase and tumour necrosis 
fa c to r  o(and B. In the ra t, only C4 and factor B have so fa r  been 
id e n t i f ie d  (G il l  et a l , 1987). These factors unlike those coded by the 
MHC do not function as alloantigens.
1 .4 .2 . The ro le  o f MHC antigens in immune recognition
The class I and class I I  MHC antigens , apart from serving as
transplanta tion antigens, act as res tr ic t ion  elements in the
recognition of foreign antigens thereby allowing the immune system to 
d is t ingu ish  s e lf  from non-self (Schwartz, 1985). T lymphocytes recognise 
fore ign antigens in the context of se lf MHC; CD8+ T ce lls  are 
re s tr ic te d  by class I antigens and w il l  k i l l  virus infected ce lls  only 
i f  the ce ll  is expressing the appropriate 's e l f '  class I antigen
(Zinkernagel and Doherty, 1979). CD4+ cells are res tr ic ted  by class I I  
products (Bach,Bach and Sondel,1976) and function in a number o f ce ll 
in te rac tions  such as T-B cell co-operation (Katz,Graves,Dorf et a l , 
1975) and in the generation of cytotoxic responses (Cantor and Boyse,
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1975a,b).Although CD4+ T cells generally mediate "helper" function 
and CD8 T ce lls  have cytotoxic" function, the correlation between 
phenotype and function is not strict(Meuer,Hussey, Penta et 
a l , 1982,Swain,1983),T ce lls , unlike B cells do not recognise native 
antigens but recognise processed peptides in association with MHC 
antigens (Grey and Chestnut, 1985; Townsend ,Rothbard, Gotch et al 
1986). In the case of CD4+ cells antigen must be presented by class I I  
po s it ive  accessory cells (dendritic cells or macrophages). 
Al 1 orecognition was thought to involve d irect recognition of foreign 
MHC, but recent studies have shown that allorecognition may involve 
recognition of endogenous peptides in the groove of the foreign MHC 
molecule(reviewed by Lechler, Lombardi, Batchelor et a l ,1990). This 
would explain the unusually high precursor frequency of a lloreactive 
c e l ls  f i r s t  described by Skinner and Marbrook (1976) since each 
peptide MHC combination could stimulate a separate T cell population.
1.4 .3. Minor h istocompatibility (mH) antigen
Minor histocompatibility antigens are coded fo r by a region 
outwith the MHC . The observation that grafts exchanged between HLA 
ide n tica l individuals are rejected, a lbeit somewhat slower than in 
HLA mismatched individuals,has been taken as evidence o f a weaker or 
minor h is tocom patib il ity  system. However the fact that skin grafts 
between MHC identical mouse strains can be rejected almost as rapidly 
as those between MHC incompatible strains argues that these minor 
antigens are not necessarily weak transplantation antigens. (Loveland
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and Simpson, 1986). The precise nature of minor histocompatib ility  
antigens (mH) is enigmatic but over fo rty  loci encoding a l le l ic  forms 
o f mH antigens have been found throughout the genome in mice (Bailey, 
1975). They do not appear to evoke antibody responses and so cannot be 
defined sero log ica lly . However they have been found to e l i c i t  T cell 
responses in v i t ro  and such recognition is MHC restr ic ted (Loveland 
and Simpson, 1986). The best defined mH antigens are the H-Y antigens 
which are expressed by male but not female mice, as detected by 
re je c t io n  of male skin grafts by female mice.
The only evidence that mH antigens are on the cell surface is 
tha t target ce lls  are k il led  in cy to tox ic ity  assays and 
p ro l i fe ra t iv e  responses are restricted by class I or class I I  
antigens. The immunogenicity of mH antigens is l ik e ly  to depend on a 
number o f factors including the host's immune response genes, and the 
number o f antigens similar to se lf (the response to which would most 
l i k e l y  be suppressed), the immunogenicity of the donor tissue and any 
t issue spec if ic  antigens (Loveland and Simpson, 1986).
1 .4 .4. Tissue specific  antigens
Relatively l i t t l e  is known about the possible ro le that 
t issue  spec if ic  antigens may play in g ra ft re jection. An antigen 
system has been described on vascular endothelial ce lls  (VEC) and 78% 
o f  rec ip ien ts  o f HLA identical, l iv ing  related renal a llog ra fts  who 
ir re v e rs ib ly  re ject the ir allografts develop antibody to th e ir  
donors' vascular endothelial cell specific antigens (C e r i l l i  and
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Brasi1 e, 1988). Vascular endothelial cell antigens are found in high
concentrations throughout the renal vasculature particu la rly  the 
p e r itub u la r  cap il la r ies  and veins. There is evidence from pedigree
studies that vascular endothelial cell antigens segregate in
association with parental HLA haplotypes and th is supports the
vascular endothelial cell antigen system being a part of or closely 
linked to the major histocompatibility complex. Eluates from
re je c t in g  renal a llografts  have been analysed fo r cytotoxic 
antibodies. Sera were found after absorption with T and B lymphocytes 
to react with renal cells supporting the existance of unique renal 
ce l l  antigens and a possible role in rejection (C e r i l l i  and Brasile, 
1988).
1 .5 .0 . Normal distribution of Class I and Class I I  antigens in organ 
grafts
The d is tr ib u t io n  of class I and class I I  MHC antigens varies 
between organs and species studied.Most species have strong class I 
expression on vascular endothelial cells (which may be important 
ta rgets  o f the rejection response). Renal parenchymal ce lls  such as 
the renal tubules have been shown to be weakly positive fo r class I 
antigens in both rats and humans(Hart and Fabre, 1981a; Daar, Fuggle , 
Fabre et a l , 1984). The myocardial ce lls  of the heart have
cons is ten t ly  been shown to be class I negative, while the 
i n t e r s t i t i a l  ce lls  are positive in both the rat and human (Daar et 
a l ,  1984, Milton and Fabre, 1 9 8 5 ). The in te rs t i t ia l  dendritic  cells
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found in a l l  grafts except those of nervous tissue are strongly class 
I I  pos it ive  and are thought to be important in sensitising the host to 
donor antigens (see section 1.6.1). In the human and other species the 
vascular endothelial cells of the kidney are normally class I I  
p o s it ive  but in the rodent have been found to be class I I  negative. In 
the ra t  the ep ithe lia l cells of the proximal convoluted tubules are 
class I I  positive (Hart and Fabre, 1981b) while in humans tubular 
expression of class I I  is variable (Fuggle,Errasti, Daar et al 1983) 
and in the mouse is negative (Benson, Colvin and Russell, 1985).
1.5.1 Induction of class I and class I I  antigens in organ grafts
MHC expression is influenced by the presence of various 
lymphokines. In particu lar the and B interferons produced by a number 
o f ce l l  types have been found to induce class I antigens only 
(Fellous, Nir,Wallach et a l , 1982; Wong, Clark-Lewis, Harris et a l ,
1984). Gamma interferon , produced by activated T ce lls ,s trong ly  
induces both class I and class I I  antigens (Wong et a l , 1984; Basham, 
Smith, Lanier et a l , 1984). During graft rejection, in f i l t r a t in g  ce lls  
release MHC inducing lymphokines which upregulate class I and class I I  
MHC antigens on donor tissue. This MHC induction is l ik e ly  to have a 
major e f fe c t  on the development and amplification of the re jection
response.
A fte r  gra ft ing , an increase in class I expression has been found
in the parenchyma a n d  v a s c u l a r  endothelium of the kidney (Milton,
Spencer and Fabre, 1986a), on the myocardial ce lls  o f the heart 
(M ilton and Fabre, 1985) exocrine cells of the pancreas (Steimger et
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a l,  1985) and hepatocytes in the l iv e r  (Settaf,Milton, Spencer et a l ,
1988) during re jection. Induction of class I is more rapid in the
kidney than in the heart, beginning at day 1 and being maximal at day
3, when ten to twenty fold increases in expression have been shown
(M ilton et a l , 1986a).
In the ra t kidney both cortical and medullary tubules and 
a r te r io la r  vascular endothelium have been shown to become strongly 
class I I  positive during rejection. The glomerulus, however, remains 
class I I  negative possibly because of the fewer in f i l t r a t in g  
leucocytes and/or the washing away of lymphokines by the glomerular 
f i l t r a t e  (Milton et al 1986). Widespread class I I  induction is also a 
feature o f re jecting kidney grafts in humans (Hall, Duggin, P h il l ips  
et a l , 1984) while in the mouse only the proximal convoluted tubules
become posit ive  (Benson et a l , 1985). Surprisingly, however, i t  has
been found that there is also a marked induction of class I and class 
I I  antigens in ra t renal allografts in which graft re jection has been 
prevented by pre-operative donor-specific blood transfusion 
(Wood, Hopley,Dal 1 man et al ,1988) .A recent report has confirmed th is  
f in d in g , but found that in passively enhanced animals, class I I  
induction was delayed until 7 days after transplantation ( Priestley 
and Fabre, 1989).
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1 .6 .0 . The rejection response
At the same time that early work on histocompatibility antigens 
was evolving, Dr. Peter Medawar was carrying out experiments which 
underlined the immunological nature of the rejection phenomenon. In
1943, Medawar along with Mr. Thomas Gibson, observed the fate of skin 
g ra f ts  in a burns patient in the Burns Unit of Glasgow Royal Infirmary 
(Gibson and Medawar, 1943). They found that a second g ra ft from the 
same donor was rejected more rapidly than the f i r s t  g ra ft ,  the so 
ca lled  "second set phenomenon", which implied that there was some 
form o f immunological memory. That rejection was a specific phenomenon 
was emphasised by further experiments in rabbits in which i t  was 
shown tha t accelerated rejection only occurred when the second set of 
skin came from the same donor as the f i r s t  skin g ra ft (Medawar,
1944, 1945). Despite many advances in our understanding of the 
re je c t io n  response since these early observations the mechanisms 
underlying re jection are s t i l l  incompletely defined. The re jection 
response can fo r  ease of description be divided into the afferent 
1 imb in which host sensitisation to graft antigens occurs and the 
e ffe re n t limb in which the effector cells mediate g ra ft damage.
43
1 .6 .1 . Host sensitisation
Donor dendrit ic  ce lls , which constitu tive ly  express class I and 
class I I  antigens , are found as "passenger leucocytes" in a l l  organ 
g ra f ts  . Dendritic cells are c r i t ic a l ly  important in the afferent 
phase o f g ra f t  re jection and are known to be potent stimulators of in 
v i t r o  immune responses (Steinman and Witmer, 1978; Mason, Pugh and 
Webb, 1981). Their importance in host sensitisation is underlined by 
experiments in which removal of "passenger leucocytes" from thyroid 
or skin g ra fts  by in v itro  culture or irrad ia tion results in 
prolonged g ra f t  survival (Lafferty,Bootes,Dart et al 1976; Emma and 
Jacobs, 1981). Lechler and Batchelor (1982) have suggested that 
se n s it isa t io n  may occur by two routes. One suggested route is d irect 
presentation o f donor antigen by donor ce lls . The second and 
possib ly less e f f ic ie n t  route is presentation of donor antigen by host 
antigen presenting ce lls . Evidence for the second route was recently 
provided by Sherwood , Brent & Rayfield (1986) who found that adherent 
peritoneal ce l ls  isolated from allosensitised mice and depleted of T 
c e l ls  could cause accelerated rejection of skin grafts i f  injected 
in to  naive host stra in mice. I t  should be noted that dendritic  ce lls  
may be more important in sensitisation of the rodent than in man where 
the vascular endothelium expresses class I I  MHC and may therefore be
able to present donor alloantigen.
Cultured human umbilical vein endothelial cells are able to
stimulate unprimed lymphocytes in an MLR and can present soluble 
pro te in  antigen to T c e l l s  ( H i r s c h b e r g . E v e n s o n . H e n r i k s e n  et a l, 1975;
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Hirschberg, Berg and Thorsby, 1980). As described ea r l ie r , induction 
o f class I I  antigens on the vascular endothelium is a feature of 
re je c t in g  organ grafts . The finding by Pober ,Gimbrone,Cotran et al 
(1983) tha t co-culture with allogeneic T cells and gamma interferon 
induces la expression on vascular endothelium emphasises that 
vascular endothelium could present a potent allostimulus to the host 
in v ivo.
The route of sensitisation may depend on the type of g ra ft.  In 
the case o f a primary vascularised graft such as the kidney,
induction of the response may occur within the gra ft ( i .e .
pe r iph e ra lly )  while in a secondarily re-vascularised graft such as the 
skin i t  is  generally thought to occur centrally in the lymphoid
system. This conclusion was drawn on the grounds that in f i l t r a t io n  of 
vascularised organ allografts by host lymphocytes occurs from the time 
o f transp lan t, while in skin revascularisation takes several days and 
so sens it isa t ion  is more l ike ly  to be a result of donor dendritic 
c e l ls  (presumably tangerhans cells) travelling via the lymphatics to 
the central lymphoid organs. However Larsen,Morris & Austyn (1990), 
who followed the fate of donor dendritic cells from cardiac
a l lo g ra f ts  in the mouse found they travelled to the recipient spleen 
where they were seen in the white pulp in close association with CD4 
p o s it ive  c e l ls .  This finding is in accordance with that of Forbes, 
Parfrey and Gomersall (1986) who showed that three to four days a fte r 
cardiac transplant in the rat, localised dendritic cell-lymphoid ce ll 
aggregates could be seen in tissue sections and they proposed that
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th is  was the counterpart of dendritic cell-lymphocyte clustering 
seen in v i t r o  during an MLR (Austyn,Steinman,Weinstein e t a l ,  1983; 
Steinman.Gutchinov, Witmer et al 1983; Green and Jotte, 1985).
1 .6 .2 . Classification of rejection
In c l in ic a l  organ transplantation, there are three main types 
o f re je c t io n  response which have been classified on the basis of the 
tempo in which they occur and the histological appearance of the 
g ra f t .
Hyperacute rejection occurs almost immediately following
completion o f the vascular anastamosis. I t  is due to preformed 
cy to tox ic  alloantibody in the recipient,directed either against ABO 
blood group antigens or donor histocompatibility antigens, the la t te r  
re su lt in g  from previous pregnancy,blood transfusions or renal
transp lan t. In c l in ica l practice hyperacute rejection is avoided by 
screening the patients ' sera for cytotoxic antibody against a panel of 
lymphocytes o f known HLA specific ity.
Acute re jection occurs most frequently in the f i r s t  two months 
a f te r  transplantation and often between two and ten days.
H is to lo g ic a l ly  there is widespread oedema and focal in f i l t r a t io n  by 
leucocytes; endothelial swelling; f ib r ino id  necrosis of small
a r te r ie s ;  p la te le t  aggregates and f ib r in  thrombi in cap illa r ies  and 
foc i o f  tubu lar necrosis. Acute rejection may be the result of a
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humoral response, in which case, glomerular and a r te r ia l changes
predominate or by a ce l lu la r  mechanism where in te r s t i t ia l  changes are 
most often found.
Chronic re jection usually occurs several months or la te r  a fte r 
transp lanta tion  and i t  is thought that antibody may play a role since 
deposits o f immunoglobulin, complement and fibrinogen are found in 
varying patterns and quantities.
Before discussing specific immunosuppression and the
mechanisms thought to mediate various forms of immunosuppression i t  is
f i r s t  necessary to look at the mechanisms responsible fo r g ra ft damage 
during re jec t ion .
1 .6 .3 . The ro le  o f antibody in g ra ft destruction
In 1966 Kissmeyer-Nielsen described the f i r s t  cases of 
hyperacute re jection of renal a llografts . This was found to be due to 
cy to tox ic  antibodies to donor histocompatibility antigens formed as a 
re s u lt  o f previous pregnancies, transfusion or transplants. In order 
to detect such antibodies in the sera of prospective transplant
re c ip ie n ts , the lymphocytotoxicity test was developed (Terasaki,
Mickey and K re is le r, 1971). Patient sera were reacted with a panel of 
leucocytes in the presence of complement and cell k i l l in g  assessed by 
dye exclusion. Although lymphocytotoxic antibodies were i n i t i a l l y  said 
to  be directed against HLA antigens on lymphocytes, i t  was found that 
some were in fac t autoantibodies (Mottironi and Terasaki, 1970). These 
were mostly IgM antibodies and reacted more strongly in the cold or
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at room temperature than at 37C, (C icciarel1i , Chia, Terasaki et 
a l , 1980) and bound more frequently to B ce lls  than T ce lls  (Park, 
Terasaki and Bernocco, 1977). The so called "cold antibodies" which 
react only at 5C are not indicators of sensitisation, while those 
which react at 37C (warm antibodies) are usually directed to HLA 
antigens and therefore harmful. A T cell crossmatch which is 
p o s it ive  at the peak of sensitisation but which is negative at the 
time of transplant does not necessarily preclude transplantation. 
However, transplantation in the presence of a peak positive T cell 
crossmatch due to an anti-HLA antibody may only be successful i f  the 
antibody in the peak serum is of the IgG class(Chapman, Taylor, Ting 
et a l , 1986). The precise role of antibody in acute or chronic
re je c t io n  is  not clear but graft damage could result from complement 
dependent cy to tox ic ity  or antibody dependent ce l lu la r  cy to tox ic ity  
(ADCC). In ADCC, cells bearing Fc receptors (K ce lls ) in teract with 
the Fc portion of IgG which is bound to the target cell and th is  
re su lts  in the release of lysosomal enzymes or other toxins and 
u lt im a te ly  ce ll death. K cells alone do not have ly t i c  a c t iv i ty  and 
the s p e c i f ic i t y  of the response is a result of the sp e c if ic i ty  of the 
antibody (Perlmann and Holm, 1969). I t  has been d i f f i c u l t  to properly 
evaluate the ro le of antibody in graft rejection since techniques of 
e lu t io n  are f a i r l y  crude. However rejecting rat renal a llog ra fts  
show glomerular and tubular necrosis, gross oedema, f ib r in o id  
necrosis o f a r te r ia l walls, thrombosis and deposition of IgG and 
complement in arteries a ll of which could in princip le be the result 
o f antibody mediated damage (Abbas, Corson, Carpenter et a l , 1974a,b). 
Cells mediating ADCC have been isolated from rejecting heart
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a l lo g ra f ts  in the rat (Tilney, Strom, McPherson et al 1975; Strom, 
Tilney,Paradysz et a l , 1977). Complement dependent cytotoxic damage 
o f a l lo g ra f ts  in the rat model is not readily demonstrable and a study 
by French (1969) found that hyperacute rejection of ra t kidneys could 
only be demonstrated when hyperimmune serum was transferred along with 
guinea pig complement.
1 .6 .4 . Delayed type hypersensitivity and specific  cytotoxic T ce lls  
in  re je c t ion
T ce lls  play an essential role in graft re jection and neither 
congen ita lly  athymic nude or T cell depleted mice are able to re ject 
a l lo g ra f ts  (Hall,Dorsch and Roser, 1978; Rolstad and Ford, 1974). 
However the precise mechanism(s) whereby T ce lls  cause g ra ft 
re je c t io n  remains a contentious issue since Brent, Brown and Medawar 
(1962) i n i t i a l l y  suggested a delayed type hypersensitiv ity reaction. 
Subsequently, Hayry and Defendi (1970) proposed that specific  
cy to tox ic  T ce lls  were responsible for graft re jection. They showed 
tha t MHC incompatible lymphocytes pro life ra te  in response to one 
another resu lt ing  in the generation of a llospecific  cytotoxic T ce lls  
and suggested that th is was a complete in v i t ro  model of a l log ra f t  
re je c t io n .  In th is  model optimal cy to tox ic ity  was seen when 
responder and stimulator lymphocytes differed at both class I and 
class I I  regions of the MHC. Less cyto tox ic ity  was generated in the 
response to an isolated class I and least cy to tox ic ity  to an 
iso la ted  class I I  d isparity (Bach et a l , 1976).
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The studies of Mintz and Silvers (1970) of skin g ra ft rejection 
in mice len t weight to the hypothesis that the specific cytotoxic T 
c e l l  was the mediator of rejection. Using a l1ophenic mice( a genetic
mosaic formed by fusing early blastomeres of d if fe ren t MHC
genotypes), they showed that when skin from an allophenic mouse
containing H-2^ and H-2^ antigens was transplanted to e ither H-2^ or
L
H-2 re c ip ie n t , there was focal destruction of melanocytes bearing
the incompatible MHC antigens, while closely adjacent 
histocompatible melanocytes remained viable.
1.6 .5. Studies examining the re la tive roles of CD4+ and CD8+ ce lls  as 
effectors of rejection
The re la tive  contribution of CD4+ and CD8+ T ce lls  to the
re je c t io n  response has been investigated using adoptive transfer of 
p u r i f ie d  populations of T cells into T cell defic ient hosts.
Naive CD4+ cells alone are able to restore skin g ra ft
re je c t io n  in adult thymectomised bone marrow irradiated (ATXBM) hosts 
(Loveland, Hogarth, Ceredig et a l ,1981; Dallman, Mason & Webb,1982). 
S im ila r ly  CD4+ cells alone restore heart a llog ra ft re jection in 
acutely irrad ia ted hosts (Hall,de Saxe and Dorsch,1983) and renal 
a l lo g ra f t  re jection in both acutely irradiated ( Gurley, Lowry, and 
Forbes,1983) and nude hosts( Bolton, Gracie, Briggs et a l ,1989). 
In te rp re ta t ion  of these experiments is complicated, however, by the 
presence o f host derived CD8+ cells which have been found
in f i l t r a t i n g  grafts in ATXBM,acutely irradiated and nude hosts
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respective ly  (Dallman and Mason,1982;Hall et a l ,1983 & Bolton et
al ,1989). Adoptive transfer of naive CD8+ T cells  to T cell de fic ien t
g ra f t  rec ip ients is generally insu ff ic ien t to in i t ia te  a l lo g ra f t  
re je c t io n .
However,sensitised CD8+ T cells have been found to mediate heart 
a l lo g ra f t  re jection in acutely irradiated hosts (Lowry,Gurley & 
Forbes,1983; Herbert and Roser,1987),but not kidney g ra ft re jection in 
nude hosts (Bolton et a l ,1989).
Recent studies in which the T cell requirements fo r grafts 
bearing isolated class I or class I I  MHC d isparit ies suggest that both 
CD4+ and CD8+ T cells may contribute to re jection. Transfer of 
CD4+c e l ls  alone causes rejection of class I I  disparate grafts and CD8+ 
c e l ls  the re jection of class I disparate grafts.(Lowry and 
Gurley,1983; Sprent, Schaefer, Lo et a l , 1986; Rosenberg, Mizuochi & 
Singer, 1986). Therefore the effector cell may depend on the nature of 
the MHC subregion disparity.
The demonstration that cloned CD4+ cells can mediate cy to tox ic ity  
as well as CD8+ cells (Krensky,Reiss,Mier et a l , 1982;
Spits,Borst,Terhorst et a l , 1982; Strassman and Bach, 1984)
underlines the fact that rejection associated with the transfer of 
CD4+ c e l ls  does not necessarily imply a DTH mechanism. Kim,Rosenstein 
,Weil and et al (1983) have demonstrated that skin g ra ft re jection 
could be accelerated in sublethally irradiated mice by a lloreactive , 
non-cytotoxic CD4+ clones. However caution must be applied in 
in te rp re t in g  the results of experiments using cloned ce lls  as th e ir  in 
v i t r o  and in vivo responses do not always correlate 
(Lynch,Weiland,Rosenberg et al, 1987).
51
1.6.6 Histologic and phenotypic analysis of the in filtra te
Early studies before the development of monoclonal antibodies 
to  ce l l  surface antigens showed that rejecting ra t a llog ra fts  were 
in f i l t r a t e d  by a heterogeneous population of mononuclear ce lls  
inc lud ing T ce lls ,  B cells,and macrophages (Strom et a l ,1977; Hayry, 
von Willebrand; Soots et a l ,1979). More recent and detailed analysis 
has shown that most of the lymphocytes in re jecting ra t renal 
a l lo g ra f ts  were T cells of the cytotoxic/suppressor phenotype 
(Renkonen,Soots, von Willebrand et a l ,1983; Christmas and 
McPherson,1982a;1982b). Interestingly, neither passive enhancement 
nor CyA treatment prevents the in f i l t r a t io n  of rat renal a llog ra fts  by 
leucocytes, but there is a predominance of CD8+ ce lls  in re jecting 
compared with passively enhanced rat kidney and heart a llog ra fts  
(Bradley,Mason & Morris,1985; Padberg,Lord, Di Stefano et a l , 1988). A 
preponderance of CD8+ cells was also found in the re jecting grafts 
o f ra ts  which had received autologous blood transfusion compared with 
non-re jecting rats which had received donor-specific transfusion 
(Ruiz, Coffman & Howell, 1988). Interestingly, neither passive 
enhancement nor cyclosporin treatment prevents the in f i l t r a t io n  of 
ra t  renal a llog ra fts  by leucocytes(Bradley et a l ,1985) . S im ilarly
active and passive enhancement regimens did not a lte r  the degree of 
c e l lu la r  in f i l t r a t io n  into cardiac allografts,though low dose 
cyclosporin given concomitantly reduces both the level and degree 
o f ac t iva t ion  of the infiltrate(Padberg et a l , 1988).
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Studies on the nature of the ce llu la r in f i l t r a te  in re jecting 
human renal a llogra fts  have produced variable resu lts . Some have 
shown the in f i l t r a t e  to be composed mainly of T ce lls  (van Es, Meyer 
O lijans et al 1984; Hall, Bishop , Farnsworth et a l (1984), while in 
others macrophages were the major cell type present (Hancock, Thomson 
and Atkins, 1983). The Oxford group has examined biopsies stained 
w ith monoclonal antibodies using morphometric analysis, to provide a 
qu an tita t ive  measure of the area of the section in f i l t r a te d  by ce lls  
o f a p a r t icu la r  phenotype (McWhinnie, Thompson, Taylor et a l , 1985, 
1986). T ce lls  were found in greater numbers in re jection than during 
stable function, comprising 30-35% of the in f i l t r a te ,  with monocytes 
and macrophages accounting for 60% and NK/K ce lls  less than 10%. 
CD4:CD8 ra tios  were similar in both rejecting and stable grafts  with
CD8 c e l ls  always found in greater numbers than CD4 ce l ls .  This
f ind ing  has been confirmed by some (P latt, LeBien and McMichael 1982; 
Hancock et a l ,1983) while others found greater numbers of CD4+ ce lls  
(Tufveson, Forsum , Claesson et a l , 1983; van Es et a l , 1984). Such 
c o n f l ic t in g  results could be due to the d if fe ren t monoclonal 
antibodies used, particu larly  those reacting with the CD4+ ce lls ,
which react weakly in tissue section and label macrophages which
may authentica lly  express CD4.
I t  is d i f f i c u l t  to determine the mechanism of re jection from
such studies since one cannot correlate the presence of ce lls  of a 
p a r t ic u la r  phenotype with functional a c t iv i ty  in vivo. For th is  
reason a number of groups have harvested the ce lls  in f i l t r a t in g  
re je c t ing  grafts  and assayed the ir functional a c t iv i ty  in v i t ro .
53
1 .6 .7 . Functional characteristics of cells in filtra tin g  allografts
In a series of papers, Strom and T ilney's group, using 
mechanical and enzymatic disruption of human renal a llog ra fts  and rat 
cardiac a llog ra fts , have identif ied ce lls  mediating specific  
c y to to x ic i ty  and antibody dependent cell-mediated cytotoxicity(ADCC) 
(T ilney et a l , 1975;Strom et a l , 1977; Tilney,Notis-McConarty & Strom 
et a l , 1978. Roberts and Hayry (1976), using a sponge matrix
a l lo g ra f t  model, identified anti-donor cytotoxic ce lls  in f i l t r a t in g  
the g ra f t ,  a finding confirmed by Ascher's group using the same 
model (Ascher,Ferguson, Hoffman et a l ,1979). Nemlander,Saksela & 
Hayry, (1983) found high levels of both natural k i l l e r  (NK) and 
sp e c if ic  cytotoxic cells in rejecting rat renal a l log ra fts .
Support for the role of the specific cytotoxic ce ll in g ra ft 
re je c t ion  comes from the finding that rats receiving cyclosporin A 
or passively enhanced to prevent rejection do not have any 
demonstrable donor-specific cytotoxic ity but do have high levels of 
NK activity(Mason & Morris,1984, Bradley et a l ,1985). Conversely i t  
has been found that pre-transplant blood transfusion which results in 
prolonged survival of rat renal a llografts  does not prevent the 
appearance of cells in the grafts displaying donor-specific 
cy to tox ic ity (D a l 1 man,Wood and Morris,1987; Ruiz et al ,1988). However, 
one cannot conclude that cytotoxic cells are not important since 
th e i r  a c t iv i ty  may be blocked in vivo by suppressor ce lls  or antibody.
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1.7 .0 . Transplantation tolerance
The f i r s t  description of transplantation tolerance was made by 
Owen (1945) who observed that dizygotic twin ca tt le ,  which shared the 
same placental c ircu la t ion  at b ir th  were to lerant to one another's red 
c e l ls  and other haemopoietic ce lls . These ca tt le  twins were shown to 
accept skin grafts  from each other but not from unrelated ca tt le .
These find ings led Burnet and Fenner (1949) to propose that lymphoid 
c e l ls  learned se lf  tolerance during ontogeny and that antigens which 
reached the lymphoid tissues during the immunologically immature 
period would be regarded as 's e l f ' ,  thereby providing a means of 
d is t ingu ish ing 's e l f '  from 'non -se lf ' .  This prediction was confirmed 
by Billingham, Brent and Medawar (1953) when they induced specific 
tolerance to an allogeneic skin g ra ft in adult mice by in jec t ing  the 
foetus with donor stra in bone marrow ce lls .  Such findings engendered 
hope that some form of antigen pretreatment could be devised which 
would lead to subsequent tolerance of a histoincompatible g ra ft .
Two forms of specific immunosuppression have been extensively
studied in animal models of transplantation;
a) Antigen induced suppression (ACTIVE ENHANCEMENT ) where specific
immunosuppression is induced by treatment of the recip ients with 
preparations containing donor h is tocom patib il ity  antigens, 
b) Antibody induced suppression (PASSIVE ENHANCEMENT) where specific 
immunosuppression is induced by the administration to the rec ip ient of 
antibodies directed against donor h is tocom patib il ity  antigens.
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Administration of donor blood is an example of the former 
and before describing th is  in detail I would f i r s t  l ik e  to discuss 
b r ie f ly  passive enhancement since part of th is  thesis discusses the 
possible ro le of transfusion-induced antibody in the mechanism of 
active enhancement and there may be pa ra lle ls  between the two models.
1 .8 .0 . Passive Enhancement
1.8 .1 . Early observations
The term passive enhancement was coined by Kaliss and Molomut 
in 1952 when they showed that passively administered donor-specific 
alloantibody enhanced the growth of allogeneic tumours in the mouse. 
In te rest in the phenomenon waned due to the in a b i l i t y  to prolong skin 
g ra f t  survival by passive transfer of antibody. However with the 
advent o f microsurgical techniques and the a b i l i t y  to perform
vascularised organ a llog ra fts  in inbred stra ins o f ra ts , in terest in 
passive enhancement was renewed. Stuart,Saitoh & Fitch (1968) were the 
f i r s t  to report successful enhancement of renal a l lo g ra f t  survival in 
inbred rats when they injected donor s tra in  spleen ce lls  intravenously 
1 day before gra ft ing  followed by 1.0 ml of hyperimmune serum two 
hours before and one hour a fte r g ra ft ing . French and Batchelor (1969) 
then demonstrated convincingly that the protective e ffec t could be 
induced by alloantiserum alone. The advantage o f th is  type of 
protocol over active enhancement,if i t  could be extrapolated to man,
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would be that antiserum or combined antigen/antibody could be 
administered around the time of transplant, rather than several days 
before.
1.8 .2 . Factors influencing the induction of passive enhancement
In the ra t renal a l lo g ra f t  model, anti serum has a beneficial 
e f fe c t  on g ra ft  surviva l, i f  given the day before transplant or up to 
two days a fte r  transplant(Morris, 1980). Dose response studies show 
tha t passive enhancement in the (DA x LEW)FI to DA model can be 
achieved with as l i t t l e  as 10 ul of DA anti-Lewis antiserum while in
the stronger (DA x LEW) FI to LEW model 50ul may be necessary to
prolong survival (Fabre & Morris,1972a;1973). Clearly there is a 
va r ia t ion  in e ffec t due to stra in combination and the ease of inducing 
enhancement is consistently greater in the heterozygous FI to parental 
strains(Fabre & Morris, 1974). D ifferent types of tissue a llog ra fts  
may also vary in th e ir  su sce p tib i l i ty  to passive enhancement: the 
order o f ease of enhancement of a llog ra fts  being, kidney > cardiac >
skin (Morris, 1980). The reasons fo r these differences are not f u l ly
understood but may pa rt ly  re f le c t  tissue antigen 
d is t r ib u t io n ,p a r t ic u la r ly  class I I  antigens and whether or not the 
g ra f t  is  p r im arily  or secondarily revascularised.
57
1.8 .3 . Class and specificity of enhancing antibody
The donor specific  anti sera used to produce enhancement are 
usually generated by repeated immunisation o f the rec ip ient with
donor lymphoid ce lls  . Enhancing antibody is generally considered to 
be o f the IgG class (Mullen, Raison & Hildemann,1977) although there 
is  one report of enhancing a c t iv i ty  associated with the IgA class 
(Voisin,Kinsky,Jansey et a l ,1969). Both non-complement f ix in g  IgGl 
and complement f ix in g  IgG2 have been shown to mediate enhancement of 
ra t  renal a llog ra fts  (Mullen et a l , 1977). The Fc portion of IgG is
important since preparations of F(ab') 2 > are at least 100 fo ld less 
e ffe c t ive  than whole IgG (Winnearls,Fabre,Millard et a l , 1979).
I n i t i a l l y  the bulk of evidence favoured anti-c lass I I  MHC 
antibody as the mediator of enhancement(Davies and Staines,1976).
Davies and Alkins (1974) showed that enhancement of heterotopic 
cardiac a l log ra f ts  in the ra t can be achieved by antisera absorbed 
with erythrocytes (which express only class I but not class I I  MHC 
antigens). These findings were substantiated by Staines ,Guy &
Davies(1975) and McKenzie and Hemming (1977) using skin a llog ra fts  
between congenic mice and by Soulillou,Carpenter, d'Apice et a l ,(1975) 
in a ra t renal a l lo g ra f t  model. However there is contradictory
evidence showing that anti-c lass I antibody may enhance skin g ra ft
survival in the mouse (Staines,Gray,Fish et a l ,1977) as well as 
cardiac and renal a l log ra f t  survival in the ra t (Jeekel,van 
Dongen,Majoor et a l»1977; Gallico,Butcher & Howard,1979). Monoclonal 
antibodies to both class I and class I I  antigens have been found to
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enhance survival of rat renal a llog ra fts  (Stuart,McKearn & Fitch, 
1979; Gallico et al 1979; Hart and Fabre, 1981c). Overall, however,the 
enhancing a c t iv i ty  of hyperimmune serum is probably due to the 
an ti-c lass  I I  a c t iv i ty ,  since the immunisation protocol appears to 
favour the production of anti-class I I  antibody (Gallico and Mason, 
1978; McKenzie,Fabre & Morris, 1980).
1.8.4 Mechanisms of passive enhancement
A number of a lternative mechanisms have been proposed to 
explain passive enhancement namely: masking of g ra f t  antigens or
opsonisation of g ra ft dendrit ic  ce lls  by injected antibody; blocking 
o f e ffec to r ce lls ;  clonal deletion; a n t i - id io ty p ic  antibody; 
antigen-reactive cell opsonisation and suppressor ce l ls .  Similar 
mechanisms have also been proposed to explain active enhancement and 
jthere may be para lle ls  between the two models.
The suggestion that injected alloantibody acts by masking g ra ft 
alloantigens has been dismissed on the basis that the very small 
amounts o f antiserum which induce enhancement would be in s u ff ic ie n t 
to mask a l l  of the g ra ft alloantigens. In addition, i t  has been shown 
tha t 125I -1abel1ed anti-donor antibody i n i t i a l l y  binds to the 
g ra f t ,b u t  then is los t within 48 hrs a fte r  transplantation(French and 
Batchelor, 1972). Another p o s s ib i l i ty  is that small amounts of 
in jected antibody label and then lead to opsonisation of donor class 
I I  pos it ive  dendrit ic  ce lls  in the g ra f t .  Dendritic ce lls  are 
important fo r  host sensitisation and long surviving kidney a llog ra fts  
obtained from passively enhanced recip ients are not rejected when
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retransplanted to unmodified recipients of the same genotype as the 
f i r s t  recip ient(Lechler and Batchelor,1982). In jection of recipients 
w ith donor dendrit ic  ce lls  restores re jection in th is  model. On the 
other hand,there is also evidence, that donor s tra in  dendrit ic  ce lls  
w ith in  a g ra ft  may be necessary fo r passive enhancement to be 
established (Hart & Fabre,1982).
Hutchinson (1980) proposed that when antigen reactive ce lls  bind 
antigen in the presence of specific  antibody reactive with other 
determinants, complexes are formed which are then removed by 
in te rac tion  of the Fc region of immunoglobulin with the Fc receptors 
on macrophages. This was termed Antigen-Reactive Cell Opsonisation 
(ARCO) and was based on the finding that when ce lls  coated with 
antibody directed at a cell surface antigen are injected
intravenously into a normal animal, the antibody coated ce lls  are 
ra p id ly  sequestered by Fc bearing macrophages in the 
re t icu lendo the lia l system (RES) (Hutchinson, 1980). This mechanism has 
been found to be operative in rats bearing passively enhanced kidney 
a l lo g ra f ts  (Hutchinson and Zola, 1977) and mice bearing enhanced 
tumour or skin a llog ra fts  (Hutchinson and Brent, 1982).
The variable,antigen-combining regions of both antibody 
molecules and T cell receptors (TcR), can because of th e ir  unique
conformation fo r specific antigen act as antigenic determinants
(id io types). Antibody produced to the idiotypes o f both antibody and
TcR is  known as an ti- id io type antibody and Jerne (1974) proposed that 
the immune system is regulated (both help and suppression) by 
id io type -an t i- id io type  interactions. A fter administration of spleen 
c e l ls  and alloantibody, Stuart, Scollard, McKearn et al (1976)
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described an anti- id io type response which peaked at day 10 a fte r 
transplanta tion. They found that g ra ft survival was enhanced i f  
transplant was delayed un til the peak of the an ti- id io type  response. 
More recently Stuart, Fitch and McKearn (1982) showed some 
prolongation of renal a l log ra f t  survival a fte r  immunising rats with 
an a n t i- id io ty p ic  antiserum generated by immunising rats with an 
an ti-c lass  I monoclonal antibody. Presumably such an ti- id io type 
antibodies act by blocking antigen receptors on B and T ce lls  fo r 
donor a lloantigen, thereby preventing activation or by causing 
opsonisation of ce lls  as envisaged in the ARCO mechanism.
A lte rnative ly , passively administered antibody alone or 
in the form ofimmune complexes could block the e ffec to r arm of the 
immune response. There is l i t t l e  evidence fo r  the presence of serum 
blocking factors since most groups have been unable to prolong 
survival in an unmodified host following the passive administration of 
serum from an enhanced ra t (Morris, 1980). One exception to th is  rule 
is  the f ind ing by Tilney and Bell (1974) that passive transfer of 
serum from long surviving kidney a l lo g ra f t  recip ients to naive hosts 
prolonged kidney a l log ra f t  survival. The reason fo r  th is  discrepancy 
is  not c lear but prolonged survival may have been due to the absence 
o f cyto tox ic  antibody at the time of transfer.
There is no convincing evidence that clonal deletion of 
a l lo reac t ive  ce l ls  plays a role in passive enhancement. Animals with 
long term surviving grafts have a normal g ra f t  versus host (GvH) 
response in the popliteal lymph node assay and show cytotoxic
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a c t iv i t y  in v i t ro  , though th is  a c t iv i ty  has been found to be delayed 
compared with re jecting rats (Biesecker, Fitch, Rowley et a l ,1973; 
Strom, Carpenter, Garaway,et a l , 1975).
Suppressor ce lls  have been found in passively enhanced rats by a 
number o f groups. Batchelor, P h il l ips  and Grennan (1984) looked fo r 
suppressor ce lls  in the spleens of long term surviving rats 
bearing AS x AUG kidneys following passive enhancement. Previous 
attempts to adoptively transfer suppression from passively enhanced 
ra ts  had fa i le d  (Batchelor, Brent and Kilshaw, 1977). I t  was therefore 
decided that an adoptive transfer system into rats bearing kidneys 
which were taken from an enhanced ra t and were therefore depleted of 
passsenger ce lls  would be more akin to the s itua tion  in the long term 
surv iv ing ra t .  They found that spleen ce lls  transferred s ign if ica n t 
suppression of re jection . Barber, Hutchinson and Morris (1984) used a 
s im ila r  protocol to transfer splenocytes or T ce l ls  from rats 
receiving a combined active and passive regimen into secondary hosts 
given passenger ce ll depleted kidney g ra fts . The la t te r  were rejected 
in 15 days in the absence of "suppressor" ce ll transfe r but survived 
fo r  > 100 days i f  splenocytes or T ce lls  from enhanced rats were
administered using adoptive transfer into sub letha lly irrad iated 
hosts. Hall (1985) demonstrated specific  suppressor ce lls  in the 
spleens o f rats bearing passively enhanced ra t cardiac a l log ra f ts . 
Whole spleen ce lls  were more e ffec tive  that T ce lls  alone at 
suppressing the a b i l i t y  of normal DA LNC to restore re jection , 
however, LNC and rec ircu la ting  T ce lls  from enhanced rats restored 
re je c t io n .
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A number of factors appear to be involved in the induction 
and maintenance of passive enhancement. However, attempts to 
passively enhance higher species such as dogs and monkeys have been 
la rg e ly  unsuccessful, which has precluded the use of such a regimen in 
man, where the r is k  of hyperacute re jection is considered too great 
(Morris, 1980).
1.9 .0 . Active Enhancement
1.9.1 Early observations
I w i l l  review mainly the findings of experiments which have 
attempted to elucidate the mechanism of the blood transfusion effect 
in animal models with particu la r reference to the ra t renal a l log ra f t  
model which is the subject of th is  thesis.
Earl ie r experiments on active enhancement were not necessarily 
concerned with blood components since the transfusion e ffec t had not 
yet been described. One of the ea r l ies t descriptions was by Ockner, 
Guttman and Linquist (1970a) who showed that certain doses of bone 
marrow ce l ls  given at an optimum time p r io r  to transplant could cause 
prolonged survival of ra t renal a l log ra fts . The f i r s t  group to show 
tha t donor blood given pr io r to transplantation could enhance 
survival o f both renal and cardiac a l log ra f ts  in rats was 
Marquet, Heystek & Tinbergen(1971). This was confirmed by Jenkins and 
Woodruff (1971) in the ra t cardiac model and by Fabre and Morris
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(1972b) in the ra t renal a l log ra f t model. As with passive enhancement
there were a number of factors influencing the induction o f active
enhancement.
1 .9 .2 . Factors influencing the induction of active enhancement
Fabre and Morris (1972b) found that several pre-operative 
in jec t ions  of donor-specific blood led to long term survival o f rat 
renal a l lo g ra f ts .  However, i f  only a single transfusion of whole blood 
was given the timing was c r i t i c a l .  For example, blood given one day 
before g ra ft ing  fa iled  to produce active enhancement, while blood 
given one to two weeks before grafting led to prolonged surv iva l.
As with passive enhancement the a b i l i t y  to induce active 
enhancement is s tra in dependent (Fabre and Morris, 1972b). The immune 
response to an a l log ra f t  is under the influence o f immune response 
( I r )  genes (Butcher and Howard, 1982) and since these control the
strength o f the re jection response i t  is l ik e ly  that they are one of
the important factors which influence the ease with which enhancement 
may be induced.
1.9.3 Blood components required for a "transfusion effect"
Several studies have attempted to elucidate which of the 
components o f blood were responsible fo r the "transfusion e ffec t , 
w ith much of the evidence leading to co n f l ic t in g  conclusions 
(Table A . l ) .  Martin, Hewitt, Osborne et al (1982) found that while 
whole blood had the most potent enhancing a c t iv i ty ,  s ign if ica n t
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enhancement could also be produced with purif ied  populations of bone 
marrow mononuclear ce lls  (BMM); thymocytes; red blood ce lls  or 
p la te le ts ,  but not with macrophages, plasma or blood lysate. El-Maiik, 
Maiik,Varghese et al (1984) found that red ce lls  and B ce lls  were more 
e f fe c t iv e  than whole blood in increasing g ra ft survival in the LEW to 
DA ra t  renal a l lo g ra f t  model. Jeekel, et al (1977) were able to
produce enhancement of cardiac a l log ra ft  survival in recip ients by 
p r io r  immunisation with donor erythrocytes (which carry class I but 
not class I I  MHC antigens). More recently Wood, Evins and Morris 
(1985) have convincingly shown that in jection of highly pu rif ied  donor 
erythrocytes can cause donor-specific prolongation of kidney g ra ft 
su rv iva l.  Furthermore, purif ied plasma membrane and endoplasmic 
reticulum expressing class I can also prolong survival of ra t renal 
a l lo g ra f ts  (Foster, Wood and Morris , 1987). However pretreatment
with water soluble class I MHC molecules , which do not e l i c i t  an 
antibody response,fail to prolong ra t renal a l lo g ra f t  survival 
(Priestley,Dalchau, Sawyer et a l ,1989). The majority of evidence seems 
to favour a ro le fo r erythrocytes in the transfusion e ffec t but there 
are a few who have been unable to show th is  (Lauchart, Alkins and 
Davies, 1980; Hibberd and Scott, 1983). P late le ts, which l ike  
erythrocytes only express class I,  have also been shown by a number of 
groups to prolong g ra ft survival in animal models (Batchelor, Welsh 
and Burgos, 1977; Hibberd and Scott 1983; Martin et a l , 1982; El-Malik 
et a l ,  1984).
Both B and T ce lls  have been found to prolong surv iva l, however 
Lauchart et al (1980) was unable to produce an e ffec t with T ce lls  and 
E l-Malik et al (1984) could do so only at low doses. Cranston,
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Wood, Carter et al (1987) prepared purif ied populations o f Lewis B and 
T c e l ls  by a rosette depletion method and found that both could 
enhance the survival of a Lewis kidney in a DA rec ip ient. They 
extended these findings to show that lxlO6 B ce l ls ,  T ce lls  and T 
helper ce l ls  (CD4+) prepared by flow cytometry could mediate 
enhancement, but the same number of CD8+ (Tc/s) ce lls  could not. Dose 
response studies were not carried out , so i t  is not clear whether 
a la rger number of 0X8 positive could cause enhancement.This study is 
more conclusive in implicating both B and T ce lls  in the enhancing 
e f fe c t  o f blood since the methods used to prepare the sub-populations 
and to confirm th e ir  phenotype were more re lia b le  than those used in 
e a r l ie r  experiments. However, differences in dose and stra in
combinations may also have contributed to the contradictory findings. 
Donor dendrit ic  ce lls  which are strongly class I and class I I  
pos it ive  do not seem to be good mediators of enhancement. El-Malik et 
al (1984) could find an effect only at very low doses and Peugh, 
Austyn, Carter et al (1987) using highly pu r if ied  populations of
d e n d r i t ic  ce l ls  were unable to enhance mouse cardiac a l log ra fts .
1.9 .4 The role of class I and class I I  MHC antigens in the transfusion 
effect
The re la t ive  roles of class I and class I I  MHC products in 
the in i t ia t io n  of the blood transfusion e ffec t have been examined 
using congenic ra t stra ins. I t  has been shown in recip ients of heart 
or kidney a l log ra f ts  pretreated with donor blood sharing class
I,c la ss  I I ,  or both with the g ra ft donor, that class I I  antigens have
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a strong immunosuppressive e ffect. While sharing of class I antigens 
between blood and g ra ft donor led to prolonged g ra ft surviva l, sharing 
o f  class I and class I I  together , had the greatest enhancing effect 
on both heart and kidney g ra ft survival (Soul illou,Blandin,Gunter et 
a l , 1984,Soul i l l o u , B1andin & Gunter,1985; Hutchinson and Morris,
1986). However, an appropriate recombinant expressing only a class 
I I  gene product is not available to assess whether class I I  alone is 
enhancing. Furthermore, Hutchinson and Morris (1986) have found that 
they could enhance recipients against grafts bearing minor antigen 
differences by pretreatment with minor antigen plus th ird  party class 
I I  products. The authors conclude that class I I  antigens alone induce 
unresponsiveness and are required to provide help to e l i c i t  
unresponsiveness directed at class I and minor alloantigens. The role 
o f class I and class I I  MHC antigens has been investigated further by 
p re treating  murine recipients of cardiac a llog ra fts  with mouse L ce lls  
transfected with class I and class I I  MHC genes of the donor 
(Superina,Wood & Morris, 1985;1987; Madsen, Superina, Wood et a l ,1988) 
They showed that pretreatment with e ither donor class I or class I I  
antigens prolonged survival of cardiac a llog ra fts  and was dependent 
on both the immunogenicity and the dose of MHC antigen.
1.9.5 Avoiding the sensitising effects of blood transfusion
In order to decrease the sensitis ing e ffec t of donor 
antigen pretreatment, while s t i l l  maintaining the enhancing e ffec t, 
attempts have been made to a lte r  the antigen or to administer antigen 
together with immunosuppressive drugs. A number o f workers have
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investigated the effect of CyA administered concomitantly with blood 
transfusion. I t  has been shown that a b r ie f  pre-transplant course of
CyA combined with DST enhances the transfusion e ffec t in a rat
cardiac and renal a llog ra ft model (M il le r , M a rt in e ll i ,  Racelis et 
a l , 1982; M a rt in e ll i ,  R a c i l l i ,  Giannone et a l , 1983; Yasamura and
Kahan, 1983). Attempts have been made to a lte r  antigens by various 
treatments in order to decrease sensitisation while maintaining an
enhancing e ffe c t.  Cranston, Wood and Morris (1986) found that Lewis 
splenocytes which would normally enhance kidney g ra ft  survival in the 
Lewis to DA stra in  combination were ine ffective a fte r heat treatment 
or i r ra d ia t io n .  Another group, using a d if fe re n t heat treatment 
protoco l, found that administration of donor heat treated blood unlike 
fresh blood, did not induce a humoral cytotoxic response but s t i l l  led 
to prolongation of cardiac a llog ra ft survival in the ACI to Lewis 
s tra in  combination (M art ine ll i,  Horowitz, Chiang et a l , 1987). The 
benefic ia l e ffec t of th is  protocol on g ra ft survival was even greater 
when CyA was administered to recipients a fte r transplantation.
Lenhard, Renner, Hansen et al (1985) looked at the e ffec t of
m u lt ip le  Lewis blood transfusions on alloantibody levels in BN rats 
and found that cytotoxic antibody t i t r e s  reached a maximum level a fte r 
the second donor-specific blood transfusion. Therafter, administration 
o f  fu r th e r  blood transfusions resulted in a decline in antibody
leve ls . This finding has important implications fo r  donor-specific 
transfusion in the c l in ica l setting where idea lly  one would l ik e  to 
maintain the maximum beneficial e ffect of transfusion but to minimise 
the degree o f sensitisation. The influence of repeated transfusions 
alone or in combination with CyA on secondary alloantibody responses
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was studied by Jones,Power,Cunningham et a l ,(1988). Lewis rats were 
f i r s t  sensitised with DA splenocytes and then were given e ither no 
treatment,CyA alone,or weekly DA blood transfusions with or without 
CyA. CyA did not affect the spontaneous decline in alloantibody 
t i t e r s  against class I antigens but did reduce s ig n if ic a n t ly  the 
response to class I I  antigens. I t  also prevented the maintenance of 
high an ti-c lass  I levels in rats repeatedly transfused. This suggests 
tha t transfusion given concomitantly with CyA could prevent the 
development of po ten tia l ly  harmful cytotoxic antibodies but i t  is
not c lear whether removal of these antibodies may diminish the 
benefic ia l e ffec t of blood transfusion.
1.10.0. Mechanisms of the blood transfusion effect
Several d if fe ren t immunological mechanisms have been proposed 
to explain the beneficial e ffect of blood transfusion on a l lo g ra f t  
su rv iva l.  These include clonal deletion, the development of serum 
blocking factors ; Fc receptor blocking antibodies; a n t i- id io ty p ic  
antibodies and suppressor ce lls . The evidence favouring a particu la r 
mechanism is discussed in the next section.
1.10.1. Clonal deletion
Terasaki (1984),proposes that transfusion results in 
immunisation o f the recipients such that upon transplantation, a 
vigorous anamnestic response occurs resulting in the rapid 
p ro l i fe ra t io n  of alloreactive clones. The introduction of high dose
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immunosuppression at the time of transplantation then k i l l s  or 
inactiva tes clones of reactive cells (clonal deletion). This model may 
play some ro le in the transfusion effect in the c l in ic a l s ituation but 
does not explain the prolonged survival in the ra t model where 
exogenous immunosuppression is not required. Furthermore, Quigley, 
Wood and Morris (1988) have examined both lymphocyte p ro l i fe ra t io n  and 
the generation o f donor-specific cytotoxic ce lls  in rats enhanced by 
donor-specific  blood transfusion. S ignificant depression of the MLC 
response was found with LNC and thoracic duct lymphocytes (TDL) but 
not splenocytes harvested from enhanced rats. Specific cy to tox ic ity  
generated by in v i t ro  MLC stimulation , however was augmented in the 
LNCs and TDLs, but not splenic lymphocytes compared with controls. 
Furthermore cytotoxic cells specific fo r donor alloantigen have been 
found in g ra f t  in f i l t r a t in g  cells harvested from rats receiving 
donor-specific  transfusion (Dallman et a l ,1987;Ruiz et a l ,1988). The 
fa c t  tha t there are ce lls  capable of responding to donor alloantigen 
in transfused animals suggests that an active immunoregulatory 
mechanism is responsible for the absence of re jection in transfused 
animals and argues against the theory that alloantigen reactive ce lls  
are c lo n a l ly  deleted .
1.10.2 Serum blocking factors
In the early studies of active enhancement consideration 
was given to the p o ss ib i l i ty  that serum factors were generated which 
blocked the e ffec to r response . However Jenkins and Woodruff (1971) 
fa i le d  to suppress cardiac a llog ra ft re jection by in jec t ing  serum
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from ra ts  given a donor-specific blood transfusion 14 days previously. 
S im ila r ly ,  Hendry,Tilney, Baldwin, et al (1979) fa iled  to prolong 
surv iva l o f cardiac allografts  by the transfer of serum from rats 
which had received a combined protocol of active and passive 
enhancement at the time of cardiac transplant. Fabre and
Morris, (1972c) were able to prolong survival of (DA X LEW)FI to DA 
kidney by transfer of serum from (FI to DA) active ly enhanced long
term surviving rats in 3 out of 4 animals,but in view of the small
numbers o f animals tested no firm conclusion could be drawn. 
S im ila r ly ,  Nagata ,Ochiai,Asano et a l (1984) found that serum but not 
spleen ce l ls  from rats transfused with donor blood 10 days previously 
prolonged cardiac a llog ra ft survival in sublethally irrad iated hosts. 
They suggest that serum factors are important in the induction of the 
transfusion e ffec t.  The re la t ive ly  small number of studies that have 
addressed th is  p o ss ib i l i ty  do not rule out a role fo r serum factors 
in the enhancement of rat renal allografts.Furthermore, i t  is 
in te re s t in g  that serum from long surviving recipients of orthotopic
l i v e r  transplants (OLT serum) which are spontaneously accepted without 
pretreatment, can transfer enhancement to secondary hosts (Kamada 
Shinomiya, Tamaki et a l , 1986). The same author has shown in an
adoptive transfe r assay with irradiated recipients that ce lls  which 
would normally restore rejection are unable to i f  pretreated with OLT 
serum (Kamada, Sumimoto, Baguerizo, 1988).
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1.10.3 Fc receptor blocking antibodies
In a series of studies MacLeod and her colleagues have 
shown tha t non-cytotoxic antibodies which in h ib i t  EA rosetting with B 
lymphocytes (Fc blocking) develop following blood transfusion and 
co rre la te  with g ra ft survival (MacLeod, Mason, Stewart et a l , 1982; 
MacLeod, Power, Mason et a l, 1982). They have also found evidence
tha t such antibodies are a lio  rather than auto-antibodies (MacLeod, 
Mason, Power et a l , 1985; MacLeod, Stewart, Urbaniak et a l , 1988). 
Forwell, Cocker, Peel et al (1987) also found Fc receptor(FcR)
blocking antibodies in a proportion of sera obtained from transfused 
uraemic patients but could find no correlation with subsequent
a l lo g ra f t  surv iva l. However, serum fractionation studies did reveal a 
s t r ik in g  corre la tion between graft survival and FcR blocking, 
mediated by a serum factor with a sedimentation coe ff ic ien t of > 19S. 
I t  is  not c lear how such FcR blocking antibodies operate to induce a 
suppressive e ffec t.  I f  they do bind to, or near to, alloantigens then 
they could prevent allorecognition or could form complexes which are 
removed by macrophages by an ARCO mechanism.
1.10.4 Anti-idiotypic antibodies
Several groups have suggested that a n t i- id io ty p ic  
antibody may mediate enhancement by binding to the antigen binding 
s i te  o f T c e l ls .  An ti- id io typ ic  antibodies have been described both 
c l i n i c a l l y  and in animal models a fte r blood transfusion. Fagn il l i  and 
Singal (1982) showed that sera from 17 m ult ip ly  transfused uraemic
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patients  which had been depleted of lymphocytotoxic antibodies, bound 
to a higher percentage of T cells than untransfused controls as 
measured by ind irec t immunofluorescence. Singal, Joseph and Szewczuk 
(1982) found a correlation between graft survival and inh ib it ion  of 
MLC between donor and recipient. However, both studies involved very 
small numbers of patients and indirect evidence fo r a n t i- id io typ ic  
in te ra c t io n . Barkley, Sakai, Ettenger et al (1987) studied sera from 
post blood transfusion patients for the presence of a n t i- id io typ ic  
antibodies to anti-HLA class I IgG. Such antibodies were assayed by 
th e i r  a b i l i t y  to in h ib it  an enzyme immunoassay fo r anti-HLA 
antibodies. Of the 16 patients studied, ha lf showed in h ib it io n  which 
was spe c if ic  fo r  anti-HLA antibodies since no in h ib it io n  of other 
antigen antibody systems was found. I t  has been suggested that 
a n t i - id io ty p ic  antibodies might modulate the appearance of anti-HLA 
antibodies following donor-specific blood transfusion and thus exert 
a favourable e ffec t on graft outcome (Pohanka, Manfro, Oto et a l ,1989; 
H i l l  is ,  MacLeod ,A1-Muzairai et a l , 1989).
Another study looked at the induction of a n t i- id io typ ic  
antibodies following blood transfusion in mice (Singal, Ludwin, Joseph 
et a l ,  1986). Balb/c mice were given three blood transfusions from C3H 
mice. The Balb/c mice were bled a week la te r  and the serum absorbed 
w ith C3H lymphocytes. IgG was prepared from th is  serum and normal 
mouse serum, and used to immunoprecipitate molecules on alloantigen 
activated (Balb/c anti-C3H) lymphocytes which had been labelled with 
35S methionine. They were able to precip ita te serum molecules from 
donor-specific  lymphoblasts but not th ird  party or syngeneic 
lymphocytes. The authors suggested that a n t i- id io typ ic  antibody was
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binding and precip ita ting alloantigen-specific receptors on the 
re c ip ie n t 's  T ce l ls ,  but as they have not iden tif ied  the molecules 
th is  is  s t i l l  speculative. Overall, therefore, the above studies 
provide good evidence that blood transfusion induces the development 
o f a n t i - id io typ ic  antibodies but whether they play a role in 
enhancement has not been established.
1.10.5. Suppressor cells
Recent studies on the mechanism of enhancement have focussed 
on the possible role of suppressor T ce lls . Donor-specific suppressor 
c e l ls  have been found during both the induction and maintenance phase 
o f active enhancement and are detected by adoptive transfer of 
lymphoid ce l ls  from enhanced recipients into naive hosts which are 
then challenged with an a llog ra ft. However, the naive hosts have to 
be l i g h t l y  irrad ia ted "to make space" fo r the adoptively transferred 
c e l ls  which makes interpretation of such experiments d i f f i c u l t .  
T ilney, Graves and Strom (1978) found suppressor ce lls  in the thymus 
and spleen o f rats conditioned by active and passive immunisation as 
early  as one week after heart transplantation. The presence of an 
in ta c t  thymus is necessary for the induction of unresponsiveness 
since Hendry et a l (1979) found that i f  rats bearing well functioning 
enhanced cardiac a llografts  were thymectomised between six and ten 
days post transplant th is led to acute re jection. Spleen ce lls  and 
thymocytes obtained from transfused rats bearing a cardiac a l lo g ra f t ,  
are able, when adoptively transferred into sublethally irradiated
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rec ip ien ts  bearing a heart g ra ft,  to prolong surviva l. This 
suppressive e ffec t was not apparent when peripheral blood lymphocytes 
or lymph node ce lls  were transferred (Marquet & Heystek,1981). 
Fractionation o f suppressor spleen cells into T and B enriched 
populations and macrophages, showed that suppression was mediated by T 
c e l ls .  As discussed previously, alloantibody t i t r e s  wane following 
successive donor-specific blood transfusions and th is  suppression can 
be adoptively transferred by splenocytes from m ult ip ly  transfused 
rats(Lenhard et a l , 1985). Nagata et al (1984) who found a role fo r 
serum factors in the induction of the transfusion e ffec t, conversely 
found tha t spleen ce lls  but not serum harvested during the maintenance 
phase (30 days post transplant), were able to prolong survival of 
cardiac a l lo g ra f ts .  S imilarly Singh,Marquet, de Bruin et al found that 
0X8+ c e l ls  isolated from transfused rats 30 days a fte r receiving a 
heart transplant could prolong survival of skin grafts  when 
transfe rred to naive hosts. Hutchinson (1986) has found donor-specific 
suppressor ce lls  in the spleens of long term surviving ra t renal 
a l lo g ra f ts  fo llowing blood transfusion using an adoptive transfer 
assay. Furthermore he has shown that CD8+ ce lls  from long term 
surv iv ing (LTS) kidney grafted rats prevent kidney but not heart 
g ra f t  re je c t ion .
Recently, Quigley, Wood & Morris (1989a) examined the role of 
suppressor ce l ls  in the induction of the transfusion e ffec t. Lymphoid 
c e l ls  were harvested from transfused and untreated rats and
transfe rred e ithe r to l ig h t ly  irradiated syngeneic hosts which were
subsequently challenged with a kidney a l lo g ra ft  or t i t ra te d  as
regu la to r ce l ls  into a naive unidirectional MLC. They found dose
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dependent suppression of rejection by the adoptive transfer of 
tho rac ic  duct lymph (TDL) or lymph done (LN) ce lls  but not splenocytes 
from ra ts  transfused 7 days previously. S im ilarly LN and TDL regulator 
c e l ls  transferred in v i t ro  led to s ign if ican t depression of a 
un id irec t iona l donor/recipient MLC. These results correlated with the 
paper discussed e a r l ie r  in which the same group showed that LN and TDL 
c e l ls  have reduced responsiveness to donor alloantigens in MLC, while 
splenocytes show increased pro life ra tion  (Quigley, Wood and Morris, 
1988). Why the suppressive effect should be so dose dependent is not 
adequately explained, except to say that a fine balance must exist 
between suppressor and other effector ce lls . The same group found 
tha t the phenotype of these putative suppressor ce lls  was CD4+ and 
tha t they were found only transiently in the spleen and then in the 
TDL(Quigley,Wood & Morris, 1989b, 1989c). Shelby, Wakely and Corry 
(1984) also found suppressor cells in mice one week a fte r donor 
sp e c if ic  blood transfusion, but they found them in the spleens. I t  is 
not c lear from these studies why there is a discrepancy between the 
presence o f suppressor cells in d iffe ren t lymphoid compartments in the 
various models. The phenotype of the suppressor T cell remains elusive 
but i t  appears that ce lls  bearing either the CD4 or CD8 marker may be
suppressive in d if fe ren t systems.
Recently,a hypothesis to explain both the s p e c if ic i ty  of the 
suppressive e ffec t and the fact that both CD4+ and CD8 ce lls  can 
mediate suppression has been advanced (Batchelor,1989,Lechler, 
Lombardi,Batchelor et al (1990). I t  has been shown that rats with long 
surv iv ing kidney a llografts  possess T ce lls  which p ro l i fe ra te  in 
response to autologous T cells specific fo r  the kidney donor
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alloantigen (Lancaster, Chui and Batchelor, 1985). Furthermore 
a n t i - id io ty p ic  T ce lls  can be generated in culture (Damle and
Engelman, 1983; Mohagheghpour, Damle, Takada et a l , 1986). These 
workers have grown CD8+ T cell clones which p ro life ra te  spec if ica lly  
when stimulated with autologous CD4+ cells harvested from specific but 
not th i r d  party MLRs and do not respond themselves to alloantigenic 
s t im u la to r c e l ls .  Such CD8+ cells are not demonstrably cytotoxic, but 
can in h ib i t  CD4+ T cells from pro life ra t ing  in response to
a lloan tigen . Recent evidence indicates that alloreactive T ce lls  do
not recognise a l io  MHC alone, but recognise a lio  MHC plus a peptide
fragment (Marrack and Kappler, 1988). Lechler et a l (1990) propose that 
CD4+ and CD8+ T ce lls  bind to a complex of MHC plus peptide which 
would consist o f an amino acid sequence derived from the id io typ ic  
variab le  regions of the TCR of the alloreactive clones.
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1.11 Aims of this study
I t  is  c lear from th is  survey of the l i te ra tu re  that the precise 
mechanism of active enhancement has not been fu l ly  elucidated. I t  
appears tha t both ce l lu la r  and humoral factors may play a role in the 
benefic ia l e ffec t of blood transfusion on renal a l log ra f t  survival. 
The overa ll aim of th is  thesis is to examine the mechanism of 
prolonged a l lo g ra f t  survival following donor specific  blood 
transfusion using a ra t renal a llograft model. Much of the previous 
work has focussed on mechanisms maintaining the state of 
donor-specific  unresponsiveness and so the intention in th is  study is 
to look more closely at possible mechanisms of induction of the 
enhanced state, both at the ce llu la r and humoral leve l.
The ra t model allows the immune response to defined 
h is to com p a tib i l i ty  differences to be examined, using inbred strains 
o f ra ts .  Furthermore the rat unlike the mouse has s u f f ic ie n t ly  large 
vessels such that anastamosis of the renal vessels may be performed 
with the aid o f a dissecting microscope. While one must exercise 
caution in extrapolating the findings in an animal model, to the 
c l in ic a l  s itua tion  one can hopefully gain information about, and a 
greater understanding of the "transfusion effect . This in turn may 
allow the development of strategies fo r inducing specific
unresponsiveness in transplant recipients.
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CHAPTER 2 
MATERIALS AND METHODS
2.1 ANIHALS
Inbred male rats of the following strains were obtained from 
Harlan Olac Ltd, Bicester, Oxon: DA(RTla), PVG(RT1C), Lewis(RT'), 
Brown Norway (RTln) , (DAXPVG)F1 hybrids and PVG congenics PVGRTlr l 
(RTl.AaBcCcDc) and PVG.RTlav l(RTl.AaBcCcDc) . Animals were kept in the 
animal f a c i l i t y  of the University Department of Surgery, Western 
In f irm ary  Glasgow and maintained on standard rat d ie t and water. Rats 
were transplanted when 8-16 weeks old.
2.2 SURGICAL PROCEDURES
2.2.1 Renal transplantation
Kidney donors and recipients were anaesthetised with e ither a 
mixture o f 5% Halothane in oxygen, or with diethylether, followed by 
an in traperitonea l in jection of 0.7-1.2 ml of 7.5% chloral hydrate 
(BDH, Ltd). The dose of chloral hydrate required differed between ra t 
s tra in s .  Renal transplantation was carried out essentially as
described by Fabre and Morris [1975].
The donor ra t was prepared f i r s t .  The abdomen was opened through a 
m idline inc is ion and the intestines displaced and kept moist with a 
gauze swab soaked in saline. The le f t  kidney, renal vessels and ureter
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were then mobilised. This procedure was repeated in the recip ient ra t 
and a fte r  placing c lips  across the renal artery and vein, the renal 
vessels and ureter were cut to enable removal of the kidney.
The donor kidney was then transplanted into the le f t  orthotopic s ite  
o f the re c ip ie n t ra t with end-to-end anastamosis of the renal artery, 
vein and ureter using a 10/0 s te r ile  polyamide interrupted suture 
(Ethicon L td ). Cold ischaemia times were 25-35 minutes and during th is  
period the kidney was kept cold by frequent application of small 
volumes o f ice cold saline. F inally the intestines were replaced and 
the abdomen closed in two layers with a continuous 3/0 cat gut suture 
(Ethicon L td ). Microsurgery was carried out with the aid of a Leitz 
Wild M650 microscope.
2.2 .2 Contralateral nephrectomy
For g ra ft survival experiments,contralateral nephrectomy was 
performed at the time of transplant by mobilising the r ig h t kidney, 
then pos ition ing  a 4/0 s ilk  suture [Ethicon Ltd] around the rig h t 
renal a rte ry , vein and ureter followed by excision of the kidney.
2.3 Transfusion
Active enhancement of rat renal allografts was produced by the 
intravenous administration of 1.0ml of fresh heparinised donor strain 
blood, 7 days prior to transplantation.
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2.4 HISTOLOGY
2.4.1 Antibodies
A range o f mouse monoclonal antibodies [Mab] were used to label 
d if fe re n t ra t leucocyte populations and MHC antigens as shown in Table
1.1. 0X21, a monoclonal antibody against the human C3b inactiva tor
(Hsiung, Brandon, Barclay et a l,1982) was used as a negative control 
in  a l l  s ta in ing  procedures. Peroxidase-conjugated rabbit anti-mouse 
Ig [Dako Ltd, High Wycombe] was used to detect primary monoclonal 
antibod ies.
2.4 .2 Preparation of cryostat sections
Tissue samples were embedded in OCT compound [Tissue-Tek, BDH Ltd], 
snap frozen in liq u id  nitrogen and 5n sections cut with a Slee 
c ryos ta t at -20°C and transferred to multispot slides [C.A.Hendley, 
Essex] which had been gelatinised prio r to use.
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Table 1.1.
Mouse monoclonal antibodies to ra t leucocyte antigens 
Antibody S pe c ific ity  Reference
MRC 0X1 Common leucocyte antigen
MRC 0X8 CD8+ cytotoxic suppressor 
T ce lls , majority of NK 
Cells
W3/25 CD4+ helper T ce lls , 
some macrophages
MRC 0X19 Peripheral T ce lls
MRC 0X39 IL-2 receptor
W3/13 T ce lls , neutrophils 
and plasma ce lls
MRC 0X18 MHC class I antigen
MRC 0X6 MHC class I I  I/A like  
antigen
MN4-91-6 Polymorphic determinant 
o f MHC class I.  DA (RTla 
pos itive ), PVG (RT1 
negative)
F17-23-2 Polymorphic determinant 
o f MHC class I I ,  DA 
(RTla positive), PVG 
(RT1C negative)
Sunderland et al (1979)
Gilman et al (1982) 
Dallman et al (1982) 
Cantrell et al (1982)
Brideau et al (1980) 
Barclay et al (1981)
Dallman et al (1982)
Patterson et al (1987)
Williams et al (1977) 
Fukomoto et al (1982)
McMaster et al (1979)
Milton & Fabre (1985)
Hart & Fabre (1981) 
Milton & Fabre (1985)
2.4 .3 Immunoperoxidase staining
Sections were fixed in acetone [BDH, Ltd] at room temperature [RT] 
fo r  10 min, wrapped in aluminium fo i l  and stored at -70C u n til use. 
A fte r rehydration in Dulbeccos A+B [DAB] fo r 5 mins. excess moisture 
was removed from around the section before adding 50ul of primary 
monoclonal antibody (appropriately d iluted) to each section. Slides 
were incubated fo r 45 minutes in a humidified chamber and then washed 
three times in DAB. A 1:20 d ilu tion  of peroxidase-conjugated rabbit 
anti-mouse Ig [Dako Ltd], with 10% rat serum [to  absorb out any 
cross-reacting  a c t iv ity ] ,  was added and the slides were incubated for 
a fu r th e r 30 min at RT. A fter washing, the peroxidase substrate 
[0.6mg/ml 3,3-diaminobenzidine te tra  hydrochloride, Sigma Chemical Co, 
plus 0.01% hydrogen peroxide] was added to each slide u n til there was 
a noticeable colour change. The substrate was then removed and the 
s lides  washed. F ina lly  the slides were counterstained l ig h t ly  with 
H a rr is 's  haematoxylin [BDH, Ltd] then dehydrated in alcohols and 
xylene before being mounted in DPX [BDH, Ltd].
2.4 .4  Morphometric analysis of in filtra te
In order to assess the area of each immunoperoxidase-labelled 
tissue  section in f i l t ra te d  by ce lls  of a pa rticu la r phenotype, 
morphometric analysis was used employing the point counting technique 
(Aherne andD unn ill, 1982; McWhinnie et a l, 1 9 8 6 ). Sections were 
examined on a Le itz  Dialux microscope at a magnification of 400 in the
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presence o f an eyepiece g ra ticu le , which had a square grid  with e ither 
121 in te rsections [1mm apart] or 745 intersections [0.5mm apart]. For 
each high power f ie ld ,  the number o f po s itive ly  stained ce lls  
superimposed by an in tersection was counted and the area of the f ie ld  
occupied by c e lls  o f a p a rticu la r phenotype was calculated as:
% area of in f i l t r a te  = 
number o f +ve arid  intersections xlQO 
to ta l number of grid  intersections
The 745 point g ra ticu le  was used fo r most sections except fo r those 
in which there was a heavy in f i l t r a te  in which case the 121 point 
g ra tic u le  was u til is e d . Ten consecutive f ie ld s  were counted fo r each 
section, so tha t fo r a ll sections the to ta l number o f points observed 
was well in excess of that required to maintain the accuracy of the 
po in t counting technique (Aherne and D unnill, 1982). Slides were 
assessed independently by two observers (the author and Dr. E. Bolton) 
who had no p r io r  knowledge of the time point or the group from which 
the kidney had been harvested. Each observer counted 10 adjacent high 
power f ie ld s  o f the kidney cortex and the resu lts  are expressed as the 
mean o f the two observers.
83
2.5 MEDIA
2.5.1 Washing medium
Hanks buffered sa lt solution (HBSS) + 10mM Hepes + 5% heat 
inactiva ted  fe ta l c a lf  serum was used as a washing medium.
P en ic illin /S trep tom ycin  were added during the preparation o f s te r ile  
c e ll suspensions [Gibco,Ltd, Paisley, Scotland].
2.5.2 Complete medium
RPMI 1640 + sodium bicarbonate + lOmM Hepes + 10% FCS + 2mM 
glutamine + pen ic illin /s trep tom ycin  was used as a complete medium fo r 
c e ll cu ltu re  [A ll from Gibco Ltd, Paisley, Scotland].
2.6 CELLS
2.6 .1 . Splenocytes
Spleens were placed in a pe tri dish with washing medium and gently 
teased apart w ith s te r ile  p las tic  forceps. The ce ll suspension was 
then transfe rred to a p las tic  tes t tube and the debris allowed to 
s e tt le  out. The remaining ce ll suspension was transferred to another 
tube and washed at 200g fo r 10 minutes. The ce ll p e lle t was gently 
resuspended and the red ce lls  lysed by addition o f 3.0ml o f d is t i l le d  
H20 followed by 3.0ml of 2 X NaCl. Cells were washed twice, counted in 
trypan blue and resuspended at the appropriate ce ll concentration in 
complete medium.
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2.6 .2 Kidney graft in filtra tin g  cells
In in i t i a l  experiments fresh ly excised kidney gra fts  were placed in 
ice cold DAB/0.2% BSA and chopped up fin e ly  w ith a scalpel blade. The 
DAB was pipetted o f f  and the kidney fragments transferred to another 
p e tr i dish containing collagenase and hyaluronidase [Sigma Chemical 
Co, Poole, Dorset] at l.Omg/ml in RPMI + lOmM Hepes. A fte r 30 min 
incubation at 37°C the pieces were passed gently through a stainless 
steel mesh in ice cold DAB/0.2% BSA. The resu lting  ce ll suspension 
was f i l te r e d  through cotton gauze to remove debris, washed X 2 in ice 
cold DAB/0.2%BSA and f in a l ly  resuspended in complete medium. V ia b ility  
as assessed by trypan blue staining was usually 80% and the cell 
y ie ld /k id ne y  approximately 1- 3 x 10^.
In la te r  experiments an a lte rna tive  method fo r preparing g ra ft 
in f i l t r a t in g  c e lls  was developed which gave better v ia b il i ty  (>90%). 
A fte r d ic ing  the kidney, a ce ll suspension was produced by passage 
through a fin e  stain less steel mesh. This ce ll suspension was washed 
once and the mononuclear ce lls  separated by Percoll cen trifugation . 
Iso-osmolar 90% Percoll [Sigma Chemical Co.] stock solution was 
prepared in Ca2+ and Mg2+ free 10 X concentrated Hanks BSS containing 
lOmM Hepes bu ffe r and th is  was fu rthe r d ilu ted with single strength 
HBSS/lOmM Hepes to give 80% and 35% solutions o f the stock 90% 
P erco ll. The g ra ft in f i l t r a t in g  ce lls  were resuspended in 80% Percoll, 
layered underneath 35% Percoll and centrifuged at 500g fo r 30 min. The
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mononuclear c e lls , free of dead ce ll debris and erythrocytes, were 
then re trieved from the interface and ce ll v ia b i l i ty ,  assessed by 
trypan blue exclusion, was always >90%.
2.6.3 Concanavalin A stimulated lymphoblasts
Splenocytes from donor and th ird  party ra t stra ins were stimulated 
w ith  concanavalin A (conA) to produce lymphoblasts fo r use as targets 
in  51 Chromium (®^Cr) release assays.
Splenocytes at a concentration of 2.0 X 10® cells/m l in complete 
medium containing 2 X 10"5 M 2-Mercaptoethanol were incubated with 5.0 
mg/ml o f con A [Sigma Chemical Co] in 25.0ml tissue culture flasks
[Nunc] fo r  72 hours at 37°C in a humidified CO2  incubator.
2 .6 .4 Cell line s
The ra t myeloma lin e  Y3 (RT1U: Galfre, M ils te in  and Wright, 1979)
which is  sensitive  to natural k i l le r  ce ll mediated cy to to x ic ity  was
used as a ta rge t in cy to to x ic ity  assays.
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2.7 FUNCTIONAL ASSAYS
2.7.1 ^ C r  release assay
G raft in f i l t r a t in g  ce lls  and splenocytes from transfused and 
unmodified PVG recip ients were prepared as described previously and 
were tested fo r a lloantigen-specific  and non-specific cy to to x ic ity  
using a 6hr 51Cr release assay. Donor a lloantigen-specific  
c y to to x ic ity  was assessed using 51Cr-labelled DA con A blasts as 
ta rge ts , while LEW con A blasts were used as th ird  party targets. 
Non-specific c y to to x ic ity  was assessed using the ra t myeloma Y3. 
Target c e lls  were labelled with 5 Mega Becquerels (5MBQ) 51 
Na-chromate a c t iv ity  and incubated at 37°C with occasional ag ita tion 
fo r  90 min. They were then washed X 5 and resuspended at 1.3 X 10^
ce lls /m l in RPMI + lOmM Hepes + 5% FCS.
G raft in f i l t r a t in g  ce lls  and splenocytes were prepared from 
experimental animals as described previously and resuspended at 1.3 X 
107 ce lls /m l in RPMI + lOmM Hepes + 5%FCS. Doubling d ilu tio n s  of 
e ffe c to r c e lls  were prepared to give e ffec to r : target ra tios  of
100 : 1; 50 : 1; 25 : 1; 12.5 : 1; 6 : 1 and 3 : 1 and each set up in
t r ip l ic a te  or quadruplicate. Effector ce lls  (75ul) were added to the 
w ells  o f a 96 well V-bottomed plates [S te r il in ]  followed by 75u.l of 
ta rg e t c e lls .
Target c e lls  were also incubated e ither with medium only (to measure 
spontaneous release) or Triton X [Sigma Chemical Co] to measure 
maximum release.
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Plates were spun b r ie f ly , then incubated at 37°C in a humidified C02 
incubator fo r  6 hours. A fter incubation, 75ifl o f supernatant was 
harvested from each well and released ra d io a c tiv ity  determined with a 
Compugamma counter [LKB Pharmacia, M ilton Keynes, U.K.]
The % sp e c ific  Cr release =
Experimental Release - Spontaneous Release X100 
Maximum Release - Spontaneous Release
2.7.2 P op litea l lymph node assay
G raft in f i l t r a t in g  ce lls  and lymph node ce lls  prepared as 
described in sections 2.6.2 and 2.6.3 respectively were tested fo r 
th e ir  a b i l i t y  to mediate a regional g ra ft versus host reaction (GvHR), 
using the Popliteal Lymph Node Assay of Ford, Burr & Simonsen (1970). 
Test c e lls  were harvested and adjusted to 1x10®, 3X10® and 9x10®
ce lls /m l in 0.1ml o f DAB/2% FCS and the ce ll suspensions injected into 
the hind footpads o f (DAXPVG)Fl ra ts. The animals were k ille d  7 days 
a fte r  in je c tio n  and the poplitea l lymph nodes weighed to an accuracy 
o f 0.1 mg. The log median response o f t r ip lic a te  assays was then 
ca lcu la ted fo r  each dose leve l.
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2.8 Fc RECEPTOR BLOCKING ASSAY
2.8.1 Preparation o f antibody sensitised sheep erythrocytes (EA)
Rat anti-sheep erythrocyte serum was prepared by the method of
Parish and Hayward (1974). B rie fly , 5.0ml o f sheep erythrocytes were
washed 4 times in DAB, then 10  ^ packed erythrocytes in 500ul o f DAB 
were mixed with 500ul o f Freunds Complete Adjuvant. 50ul o f th is  
suspension was then injected into the hind footpads of DA rats. 
Fourteen days la te r  the animals were bled by aortic  puncture and the 
co llec ted  serum was heat inactivated at 56C fo r 30 min, aliquoted and 
stored at -70°C p rio r to use. A known volume of a 5% suspension of 
washed sheep erythrocytes was incubated with an equal volume of a 1 in 
100 d ilu t io n  o f ra t anti-sheep erythrocyte serum fo r 45 mins at 37C, 
then washed twice and adjusted to a 1.25% suspension in Hanks balanced
s a lt so lu tion  (HBSS) plus lOmM Hepes.
2.8 .2 Erythrocyte antibody rosette in h ib itio n  assay (EAI) assay
Lymphocytes were prepared from the spleens of normal DA (kidney 
donor s tra in ) or Lewis (th ird  party) rats in HBSS/Hepes plus 5% FCS. 
1.25xl06 splenocytes were then resuspended in 125ul o f tes t serum or 
serum fra c tion s  or in the appropriate controls (normal ra t serum or 
PBS). Following incubation at 37°C fo r 30min, ce lls  were washed twice 
and resuspended in 175ul HBSS/Hepes and mixed with an equal volume of
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1.25% sheep EA. Tubes were then centrifuged at 200g fo r 5 min to 
encourage rosette formation. Rosettes were gently resuspended and 
fixed  in 250ul o f 3% gluteraldehyde [BDH Ltd] fo r 20 min at room 
temperature (RT). Gluteraldehyde was then removed and the ce lls  were
f in a l ly  resuspended in 125ul trypan blue and inspected under sealed 
cove rs lips . At least 400 lymphocytes per slide were counted (each
s lid e  being read blind on two occasions) and the percentage of
rosetted lymphocytes determined. A rosette was defined as a 
mononuclear ce ll with 3 or more erythrocytes bound to i t  . EA rosette
in h ib it io n  (EAI) was calculated as the percentage in h ib itio n  of
rose tte  formation produced by test serum or IgG compared with 
co n tro ls . Typ ica lly , 20-30% of normal ra t splenocytes formed EA 
rosettes in  the absence of inh ib ito ry  factors.
A m odification of the above procedure was developed in order to 
te s t small volumes of monoclonal antibodies and IgG preparations. 
B r ie f ly ,  2 .5x l05 splenocytes in 25ul HBSS/Hepes were incubated in a 
m ic ro t itre  p la te at 37C fo r 30 min with lOul test IgG at 1 mg/ml. A fter 
washing tw ice, lymphocytes were rosetted with 50ul 2% sheep EA by 
ce n trifu g in g  at 200g fo r 5min and fixed as before.
2 .8 .3  Preparation o f Serum Fractions o f graded molecular weight
Blood was obtained by aortic  puncture and allowed to c lo t. 
Unfractionated sera were heat inactivated fo r 30 min at 56C and 
u ltracen trifug e d  at 105,000g fo r lh r to remove immune complexes p rio r 
to  in ve s tiga tin g  th e ir  a b il i ty  to in h ib it EA rosette formation.
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Serum fractions of graded molecular weight were prepared as 
described previously fo r human serum ,to  y ie ld  six fractions of which 
fra c tio n  2 contained the majority o f serum IgM and fraction 4 
contained the m ajority of serum IgG (Reid, Peel, Jarret et a l , 1983). 
One ml o f each of 4 sucrose solutions (20%, 27%, 33%, 40% sucrose
weight/volume) was layered in a 0.5" X 2" polyallomer-tube. Onto th is  
discontinuous sucrose gradient, 500ul o f serum was layered and then 
u ltrace n trifu g ed  at 105,000g fo r 16 hours at 4°C. This produced six 
serum fra c tio n s  o f graded molecular weight which were collected from 
the bottom o f the gradient.
Fractions were screened by radial immunodiffusion to ascertain which 
contained IgM or IgG using a k it  from Serotec, Oxford (Cat nos: AAR 
08Z & AAR 02Z). B rie fly  5ul of test serum was added to the wells of 
agar p la tes containing anti-IgG or anti-IgM . IgM was found in 
fra c tio n  2 only, while IgG was found in fractions 3, 4, and 5, peaking 
in fra c tio n  4. The fractions were also analysed by SDS polyacrylamide 
gel electrophoresis to confirm the position of other proteins w ithin 
the fra c tio n s  (Fig 1.4).
2 .8 .4  P u rif ic a tio n  o f IgG by n-octanoic acid sedimentation
IgG was prepared according to the method of Steinbuch and Audran 
(1969). Approximately 6.0 i mis of 0.06M sodium acetate buffer(BDH Ltd) 
pH 4.0 was added to 3.0 ml o f serum. A fter gentle mixing, 225ul of 
n-octanoic acid [Sigma Chemical Co] was added to the buffer/serum 
mixture and s tir re d  fo r 30 min at RT. The resu lting  p rec ip ita te  was
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removed by cen trifuga tion  at 2000 g fo r 20 minutes at RT. F ina lly , the 
supernatant was f i lte re d  through Whatman Grade IV f i l t e r  paper and 
dia lysed in  several washes of PBS to remove n-octanoic acid. Small 
a liquo ts  at l.Omg/ml were stored at -70°C to avoid freeze-thawing. The
p u r ity  o f the IgG preparations was confirmed by Sodium Dodecyl
Sulphate Polyacrylamide Gel Electrophoresis [SDS PAGE](Fig 1.5)
2.8 .5 Absorption of IgG with erythrocytes and splenocytes
Fresh-Heparinised DA blood was washed 5 times in DAB with aspiration 
o f the bu ffy  coat and surface layer a fte r each wash. Then, 200 ul of
IgG (a t l.Omg/ml) was absorbed with 200ul of packed DA erythrocytes at
room-temperature fo r one hour. S im ilarly  200 ul of IgG was absorbed 
w ith 107 DA or PVG.RTlr l  splenocytes. A fte r centrifugation at 1500g 
fo r  10 minutes, the supernatant was transferred to a second tube fo r a 
repeat absorption as before.
2.9 ANALYSIS OF SERUM FRACTIONS AND IgG BY GEL ELECTROPHORESIS
2.9.1 Running of gel
Electrophoresis in 8.5% Polyacrylamide gel in the presence o f sodium 
dodecyl sulphate (SDS-PAGE) was performed essentia lly  by the method of 
Laemmli (1970). The following stock solutions were prepared (See
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tab le  A .3 in appendix) and the quantities required to produce the 
appropriate percentage indicated. A ll reagents were purchased from 
Gibco, BRL, Paisley Scotland
Stock Solution JUmninq Gel (8.5%) Stackina Gel i
30% Acrylamide 12.0 (ml) 2.4 (ml)
Tris-HC] running buffer 12.0 -
Tris-HC1 Stacking buffer - 6.0
De-ionised water 24.0 15.6
10%ammonium persulphate 0.20 0.2
TEMED 0.02 0.01
Glass pla tes were washed thoroughly in decon, rinsed, then wiped with 
70% alcohol before clamping together. The appropriate volumes of 
running bu ffe r, acrylamide and deionised water were mixed together. 
Then, 2.0 ml o f the resu lting solution was removed and 200 ul of 
fre s h ly  prepared ammonium persulphate added followed by 20 ul of temed 
and th is  so lu tion  pipetted quickly between the plates to form a seal. 
Once the seal had set, the appropriate volume of ammonium persulphate 
and temed were added to the remaining gel solution and the gel poured 
immediately between glass plates separated by 1.5cm spacers. The gel 
was then overla id  with isobutanol to exclude a ir .  When the gel had 
hardened the isobutanol was removed, stacking gel poured on top and a 
comb inserted between the plates to create sample wells. To reduce
pro te in  samples, 50 ul o f each sample was mixed together with 10 ul of
reducing sample bu ffe r and the mixture boiled in a microcap tube fo r 3
min. Once the stacking gel had set, the combs were removed, the plates
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clamped to  the electrophoretic equipment and upper and lower tanks 
f i l l e d  w ith th e ir  respective buffers. Protein samples were carefu lly 
layered onto the stacking gel and electrophoresis performed at a 
constant current of 40mA un til the dye fron t was w ith in 1 cm of the 
bottom o f the gel. The gel was removed and stained as required.
2.9 .2  Coomassie Blue Staining
Coomassie Blue stain was prepared by dissolving 0.3g of B r il l ia n t  
Blue [Sigma Chemical Co] in 300 ml solution of H2 O, methanol and 
ace tic  acid (6 :3 :1 ). The resulting stain was f i lte re d  through grade 1 
f i l t e r  paper and stored at RT u n til required. Immediately a fte r 
e lectrophoresis, the slab gel was placed in 200ml of Coomassie Blue 
and allowed to sta in (l-16hrs). To destain, the dye was removed and 
replaced w ith approximately 200 ml of 10% acetic acid/10% methanol. 
The so lu tion  was replaced several times u n til the gel background was 
c lea r.
2.10 ALLOANTIBODY ASSAY
Antibodies against class I and class I I  (RTla) antigens were detected 
by a two-stage binding assay, essentia lly  as described by Kamada 
(1986). A n ti-c lass I antibodies were assayed using red ce lls  from 
PVG.RTl® ra ts  and anti-c lass I I  antibodies were assayed on PVG.RTl4 
lymph node c e lls .
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2.10.1 Anti-class I assay
Round bottomed 96 well m icro titre  plates [Scotlab] were treated with 
10% fe ta l c a lf  serum (FCS) in DAB fo r 10 min (to prevent non-specific 
binding o f ra t Ig ), washed with PBS and dried. Quadrupling d ilu tions 
o f sera were prepared in DAB and dispensed into the m ic ro titre  wells 
(50ul per w e ll) .  DAB was added to some of the wells to assess the 
background binding of the second antibody and hyperimmune serum was 
added to  other wells as a standard control. Then 50ul of a 2.0% 
suspension o f PVG.RTla red ce lls  was added to each well and incubated 
fo r  one hour at RT. Red ce lls  were then washed four times and 
resuspended. Radio-iodinated, a f f in ity  pu rified  sheep a n ti-ra t Ig 
F(ab ' ) 2  [Amersham International Ltd] was then dispensed in to each well 
(lOOyMl a t a 1:320 d ilu tio n , giving 50 - 60,000 cpm per w e ll), and 
incubated fo r  a fu rthe r hour. F inally the red ce lls  were washed four 
times in  the wells before transfer to clean RT25 tubes [S te r il in ]  fo r 
counting in  a LKB Compugamma.
2.10.2 Anti-class I I  assay
A n ti-c la ss  I I  antibodies were assayed by lymph node ce ll binding. Rat 
sera were f i r s t  exhaustively absorbed with DA (RTla) red ce lls  to 
remove anti-donor class I a c tiv ity . This involved four successive 
absorptions o f 200ul o f packed DA red ce lls  with 200ul o f serum fo r
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one hour at 4°C. Absorption was confirmed by testing of the serum in 
the class I assay fo r residual a c tiv ity  against RTla red ce lls . The 
assay fo r  an ti-c lass  I I  antibody followed the same procedure as the 
red c e ll binding assay except the targets were 50ul of lymph node 
c e lls  ( at 10^/ml). A ll incubations were carried out at 4°C.
2.10.3 Complement dependent cy to tox ic ity  assay
Serum samples were tested fo r cytotoxic antibody in a complement 
dependent c y to to x ic ity  assay essentia lly as described by 
Winnearls,Fabre, M illa rd  et a l(1979). A fter heat inactiva ting  at 56°C 
fo r  30min,sera were centrifuged b r ie fly  to remove protein aggregates, 
then s e r ia lly  d ilu ted  in RPMI/5%FCS/10mM Hepes.50ul of each d ilu tio n  
was then mixed with 5x10^ ^C r-labe lled  con /\ lymphoblasts prepared 
from donor and th ird  party stra in splenocytes. Following incubation 
fo r  30 min at RT,lOOul of freshly reconstituted guinea pig complement 
[Sera-Lab, Sussex ] d ilu ted 1:5 was added , and the ce lls  were 
incubated fo r  lh r  at RT. F inally lOOul of the supernatant was removed 
and counted in  a gamma counter. Maximum and minimum release were 
measured as fo r  the ce llu la r cy to tox ic ity  assay and the % cy to tox ic ity  
ca lcu la ted as before.
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2.10.4 Measurement o f IgG and IgM component o f the alloantibody 
response
I n i t ia l ly ,  96-well round bottomed plates [Scotlab] were blocked 
w ith 2% BSA/DAB fo r lh r at RT then washed in DAB and dried before 
use. Serum samples to be tested were dilu ted 1:2 in 1% BSA/DAB and 
25ul added in t r ip lic a te  to the plates. DAB controls were added to 
determine the background binding of the second antibodies. To measure 
the IgG and IgM component of the class I response unabsorbed sera were 
incubated w ith 50ul of 1% DA red ce lls  fo r lh r at RT. To measure the 
IgG and IgM component of the class I I  response ,DA red ce ll absorbed 
sera were incubated with 50ul of DA LNC at lxlO^/ml in 0.2% BSA/DAB 
at 4°C. A fte r washing three times with 1% BSA/DAB ,50ul of a 1:50 
d ilu t io n  o f e ith e r b io tinylated a n ti-ra t IgG or a n ti- ra t IgM were 
added and incubated fo r lh r. Cells were washed three times and 50ul of 
a 1:50 d ilu t io n  o f 125I -1abel1ed streptavidin [Amersham International] 
added fo r  30 minutes. A fter four washes in 1% BSA/DAB ce lls  were 
harvested in to  LP3 tubes and the cpm measured in a gamma counter. The 
cpm in  50ul o f a 1:50 d ilu tio n  of 125I-s trep tav id in  was measured and 
the % binding calculated as:
100 X Test - Background
CPM Added - Background
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2.11 MIXED LYMPHOCYTE REACTION
Allogeneic one-way mixed lymphocyte reactions (MLR) were set up to 
assess the in h ib ito ry  a c tiv ity  of serum or IgG from enhanced and 
re je c tin g  ra ts . In i t ia l  experiments indicated that LNC responded 
be tte r in MLR than splenocytes and therefore LNC were used as 
responders in a ll subsequent experiments. LNC were prepared and 
resuspended at a fin a l concentration of 8.0 X 106/ml in complete 
medium containing 2 X 10'5M 13-Mercaptoethanol and 5% normal rat 
serum. Splenocytes of e ither DA (donor-specific) or LEWIS (th ird  
party) ra t stra ins were prepared as described previously and 
irra d ia te d  (2000R) before use as stimulator ce lls . The ce lls  were 
washed a fte r  irra d ia tio n  and resuspended at 8.0 X 106/ml in medium as 
before. In experiments where the inh ib ito ry  a c t iv ity  of serum was 
assessed, the concentration of normal ra t serum added was adjusted so 
tha t the f in a l concentration in each well was always 5%.
Doubling d ilu t io n s  of e ither serum or IgG (50ul per well) were 
prepared in t r ip l ic a te  in 96 well s te r ile  round-bottomed m icro titre  
p lates [NUNC] to which 4.0 X 105 responders and 4.0 X 105 stimulators 
per well were added to give a fina l volume of 200ul in each w ell. 
Control w ells contained medium only or normal IgG. Plates were 
incubated at 37°C in 5% C02 fo r 4 days,pulsed with 3H Thymidine (luCi 
per w e ll)  fo r  16-18 hours,then harvested using a Dynatech Autowash 
automatic c e ll harvester. F ina lly  the discs were placed in Ecosint 
s c in t i l la t io n  f lu id  and counted in a Beta counter (LKB 1209).
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2.12 STATISTICAL ANALYSIS
S ta t is t ic a l analysis of data was performed using the Mann-Whitney 
U te s t .  A p value of 0.05 or less (two ta ile d ) was considered 
s ig n if ic a n t.
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CHAPTER 3
PHENOTYPE AND FUNCTION OF CELLS INFILTRATING REJECTING AND
ENHANCED RAT RENAL ALLOGRAFTS
ACTIVELY
3.1 Introduction
In the ra t,rena l or cardiac a llog ra fts  undergoing unmodified 
re je c tio n  are characterised by a heterogeneous mononuclear cell 
i n f i l t r a t e  which is comprised of T ce lls , B ce lls , macrophages and NK 
c e lls  (von Willebrand et a l ,1979; Renkonen et a l ,1983; and Strom et 
a l , 1977). Associated with th is  in f i l t r a te ,  is a s tr ik in g  increase of
donor class I and class I I  MHC antigen expression (Milton & 
Fabre, 1985; M ilton et a l , 1986a). Analysis of the functional
a c t iv i t ie s  o f ce lls  w ithin rejecting renal and cardiac a llog ra fts  has 
shown th a t c e lls  displaying both specific and non-specific in v itro  
c y to to x ic ity  can be isolated (Tilney et a l , 1975; Strom et a l , 1977; 
Nemlander et a l ,1983).
In te re s tin g ly , although CyA treatment and passive enhancement, 
prolong a llo g ra f t  su rv iva l, they do not prevent leucocyte in f i l t ra t io n  
o f renal allografts.However,they do affect the functional a c tiv it ie s  
o f the g ra ft in f i l t r a t in g  ce lls , since ce lls  isolated from these 
non-re jecting  g ra fts  do not display donor-specific cy to tox ic ity  
(Bradley e t a l ,1985). Furthermore induction of class I and class I I  
MHC antigens is  reduced or absent in CyA treated rats and delayed in 
passively enhanced rats (M ilton, Spencer, Fabre et a l , 1986b;
P rie s tle y  and Fabre,1989).
In view o f these findings i t  was of in te rest to examine the 
phenotype and function of ce lls  in f i l t r a t in g  ra t renal a llog ra fts  
enhanced by preoperative donor blood transfusion and compare the
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re su lts  w ith renal a llog ra fts  undergoing unmodified re jection. The 
pattern and degree of class I and class I I  MHC expression in enhanced 
and re je c tin g  rats was also studied using immunohistological 
techniques.Since there is no s tr ic t  correlation between phenotype 
and func tion ,the  in v itro  cy to tox ic ity  of g ra ft in f i l t r a t in g  cells 
harvested from enhanced and rejecting kidneys was also measured.
Results
3.2 A b ility  of preoperative blood transfusion to prevent allograft 
rejection
Preoperative blood transfusion is known to produce long term renal 
a llo g ra f t  surviva l in some but not a ll ra t stra in combinations ( Fabre 
& Morris ,1972b). In most of the experiments in th is  thesis, the
fu l ly  allogeneic DA into PVG stra in combination was used. This 
s tra in  combination was chosen because active enhancement of a renal 
a llo g ra f t  could be induced readily by preoperative blood transfusion 
and also because monoclonal antibodies were available which
s p e c if ic a lly  label DA (donor) and not PVG (rec ip ien t) MHC thereby 
allow ing unequivocal determination of donor MHC expression.
Confirmation tha t the i .v .  administration of DA donor blood 7 days 
p r io r  to  transplanta tion led to long term g ra ft survival whereas 
unmodified PVG recip ients rapid ly re ject th e ir  g ra fts  is  shown in
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Table 1 .2 .Using th is  p ro toco l.it was possible to make a comparison
between unmodified (re jecting) and transfused (enhanced) rats in 
fu tu re  experiments.
3.3 K ine tics  o f leucocyte in f i l t ra t io n  in to enhanced and rejecting 
ra t renal a llo g ra fts .
An analysis was made of the leucocyte in f i l t ra te s  in rejecting DA 
kidneys from unmodified PVG recipients (re jecting) and non-rejecting 
kidneys from PVG recip ients which had received a DA blood transfusion 
7 days before transplantation (enhanced). Grafts were excised on days
1,3,5 and 7 post transp lan ts  grafts/group/time point) and cryostat 
sections labe lled  with a range of mouse monoclonal antibodies to rat 
leucocyte antigens using the ind irect immunoperoxidase technique . 
Sections were counted by the point counting technique in order to 
give a qu a n tita tive  assessment of the area of each section that was 
occupied by c e lls  o f a pa rticu la r phenotype.
The to ta l leucocyte in f i l t ra t io n  (determined by labe lling  with 
0X1,which binds to the common leucocyte antigen) is shown in Fig 2.1. 
In f i l t r a t io n  occured more rapidly in enhanced than re jecting grafts 
(a t day 3, the % area in f i l t r a te  was 31+/-8 vs 11+/-3) (p<0.0 5 ).(Fig 
2.2a and 2.2b). By day 5 however there was a marked increase in the 
number o f leucocytes in f i l t r a t in g  rejecting g ra fts , which was not 
s ig n if ic a n t ly  greater than that found in enhanced g ra fts ,(p ,0.05). Day 
7 re je c tin g  g ra fts  were too severely damaged to examine 
immunohistologically but levels of 0X1 positive ce lls  in day 7 
enhanced g ra fts  were s im ila r to those at day 5. A ll the results shown
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Table 1.2 Survival times fo r transfused and unmodified PVG 
re c ip ie n ts  o f DA kidneys
Donor-to- Recipient No of Survival MST^)
Recipient pretreatment animals (days) (days)
DA(RTla) to 
PVG(RT1C) None SU) 7,7,7,7,7,8,8,10
DA(RTla) to  
PVG(RT1 )
1.0ml DA whole
5(a)
>100,>100,>100,
blood at day -7 >100,>100
(a) C ontra la tera l nephrectomy performed at day 7.
(b) Median survival time.
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Fig 2.1 Morphometric analysis of 0X1 
in filtra tio n  into DA renal allografts in 
unmodified and transfused PVG recipients
DA gra fts  were removed on d iffe re n t days 
a fte r  transplantation from unmodified(n=5) 
and transfused (n=5) PVG recip ients. 
Cryostat sections were stained by 
immunoperoxidase with MRC 0X1(against the 
leucocyte common antigen), ana the % area 
in f i l t r a te  o f leucocytes was determined by 
morphometric analysis.Normal DA kidneys(n=4) 
were stained as a control.The results are 
expressed as the mean and standard deviation.
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Fig 2.2. MRC 0X1 la b e llin g  o f enhanced and 
re je c ting  DA a llo g ra fts  in PVG recip ients 
(day 3)
Cryostat sections of enhanced and reject ing 
DA a l logra f ts ,  3 days a f te r  transplantat ion, 
were immunoperoxidase label led with MRC 
0X1(common leucocyte antigen).
(a) Enhanced kidney label led with 0X1 (x200)
(b) Rejecting kidney label led with 0X1 (x200)
fo r  the morphometric analysis are expressed as the mean of two
observers ( the author and Dr.E.Bolton ). There was close agreement 
between the two observers fo r 0X1 staining as shown by the high
c o rre la tio n  co e ffic ie n t (r=0.99) (Fig 2 .3 ),and the low mean %
d iffe rence  between the two observers D = 6.7% . No attempt was made 
by the two observers to count the same area o f the tissue section, 
there fore  the close corre la tion  between the observers indicated that 
the area counted was representative o f the whole section. There was 
no apparent d ifference in the anatomical d is tr ib u tio n  o f leucocytes 
w ith in  re je c tin g  and enhanced g ra fts . I n i t ia l ly  t ie  in filtra te  was 
focal and peri vascular, however th is  progressed with tine t® became 
more d iffu s e  w ith leucocytes clustering around t ie  tibiulles ami 
glom eruli , though never w ith in  the glomerulus i t s e l f ,  Om day 3 a fte r 
transp la n ta tion  the re jecting  in f i l t r a te  was focal but in  t ie  ertaimcedl 
g ra fts  had already become more d iffuse(F ig  2.2a and 2.2b).
Fig 2.4 shows the resu lts  o f staining with 0X8 (which labels Tc and 
most NK c e l ls ) .  On day 3 post transplant there were s ig n ifica n tly  
greater numbers o f 0X8 positive ce lls  in the enhanced grafts 
compared w ith re je c ting  g ra fts  (area in f i l t r a te ,6.5% + /- 2% vs 1.9% +/- 
0.9%). Between days 3 and 5 there was a large in flu x  o f 0X8 positive 
c e lls  in to  re je c tin g  g ra fts , so that by day 5 there were s ig n ifica n tly  
greater numbers o f 0XS+ than in enhanced gra fts .(p<0 .01). The pattern 
o f s ta in ing  on day 5 post transplantation is  shown in Fig 2.5a and 
2.5b. Again there was close corre la tion between the two observers when 
counting 0X8 p o s itive  ce lls  (r=0.98,mean % difference D=6.7%).
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Fig 2.3 Correlation curve o f observer A vs 
observer B fo r 0X1
Counts o f observer A were plotted against 
observer B fo r 0X1 labe lling  and the 
co rre la tion  coefficent r  was calculated.
% 
ar
ea
 
in
fil
tr
at
e
MRC 0X 8
25
20
15
10
J Normal 
I  Enh
22 Rei
p<0.01
T
p<0.01
0 1 3  5 7
days after transplantation
Fig 2.4 Morphometric analysis o f 0X8 staining 
o f DA renal a llog ra fts  in unmodified and 
transfused PVG recipients 
DA g ra fts  were removed on d iffe re n t days 
a fte r  transplantation from unmodified (n=5) 
and transfused (n=5) PVG recipients.Cryostat 
sections were stained by immunoperoxidase 
w ith MRC 0X8 (against Tc and NK c e lls ) , and 
the % area in f i l t r a te  of labelled leucocytes 
was determined by morphometric analysis. 
Normal DA kidneys were stained as a 
control.The results are expressed as the mean 
and standard deviation.
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Fig 2.5 MRC 0X8 la b e llin g  o f enhanced and 
re je c tin g  DA a llo g ra fts  in PVG rec ip ien ts  
(day 5)
Cryostat sections of enhanced and reject ing 
DA a l lo g ra f t s ,5 days af ter  transplantat ion 
were immunoperoxidase label led with MRC 
0X8(labels cytotoxic T cel ls  and NK ce l ls )
(a) Enhanced kidney label led with 0X8 (x200)
(b) Rejecting kidney label led with 0X8 (x200)
There was a progressive in f i l t r a t io n  of W3/25 positive ce lls  (Th 
c e lls  and macrophages) into both enhanced and re jecting grafts with no 
s ig n if ic a n t d ifference between the two groups at any of the days 
tested (Fig 2 .6 ). The percentage area in f i l t ra te d  by W3/25 positive 
c e lls  was consistently  less than that in f i l t ra te d  by 0X8 positive 
c e lls  in both groups. Staining with W3/25 was always weaker and 
there fore  more d i f f i c u l t  to count than with 0X8 , re flected in the 
lower co rre la tio n  co e ffic ie n t (r=0.85) and mean % difference( 
D=16% ) between the two observers.
To assess whether in f i l t r a t in g  ce lls  simultaneously expressed the 
W3/25 and 0X8 antigens , sections were labelled with a mixture of the 
two antibodies and counted as before. The results of the morphometric 
analysis are shown in Fig 2.7a. The percent area in f i l t r a te  determined
in these sections was s im ila r to that calculated as the sum of MRC 0X8
p o s itive  and W3/25 positive ce lls  fo r each section (Fig 2.7b),
in d ica ting  tha t few of the in f i l t r a t in g  ce lls  expressed both the W3/25 
and MRC 0X8 antigens simultaneously.
I t  can be seen in Fig 2.8 that the percentage area in f i lt ra te d  by 
0X19 p o s itive  ce lls  (pan T ce ll marker) in both re jecting and 
enhanced g ra fts  is  surpris ing ly  low(maximum in f i l t r a t io n  less than 6%) 
and is  e a s ily  exceeded by the sum of W3/25 positive and 0X8 positive 
c e lls  . This may be due to labe lling  o f NK ce lls  which are
0X8+0X19- or macrophages W3/25+0X19" or a lte rna tive ly  by weak 
la b e llin g  w ith 0X19. Again, enhanced gra fts  were more quickly 
in f i l t r a te d  than re jecting grafts ( mean % area in f i l t ra te d  by 0X19
po s itive  c e lls  o f 2.9% +/- ° -9% vs K6% + / ' ° ' 9% at day 3>P<0-05’ 
(Fig 2.9a and 2.9b). By day 5 the numbers of 0X19 positive ce lls  had
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Fig 2.6 Morphometric analysis o f  IB/25 
s ta in ing  o f DA renal a llo g ra fts  in  unmodified! 
and transfused PVG recip ients 
DA g ra fts  were removed on d iffe re n t days 
a fte r  transplantation from unmodified ( 1 =$) 
and transfused (n=5) PVG rec ip ien ts . Cryostat 
sections were stained by iimitfnoperoxidase 
w ith W3/25 (against Th and macrophages), and 
the % area in f i l t r a te  o f labelled leucocytes 
was determined by morphometric analysis. 
Normal DA kidneys were stained as a con tro l. 
The resu lts  are expressed as the mean and 
standard deviation.
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Fig 2.7 Comparison o f % area in f i l t r a te  
obtained when gra fts  were stained by a
mixture o f 0X8 and W3/25 with tha t obtained
by calcu la ting the sum o f 0X8+W3/25
DA gra fts  were removed on d iffe re n t days 
a fte r transplantation from unmodified (n=5) 
and transfused (n=5) PVG rec ip ien ts . Cryostat 
sections were stained by immunoperoxidase 
with a mixture of MRC 0X8 and W3/25 and the % 
area in f i l t r a te  of labelled leucocytes was 
determined by morphometric analysis. Results 
are expressed as the mean and standard
deviation (a). Also shown is a graph o f the %
area in f i l t r a te  obtained when the sum o f the 
observed values fo r 0X8 and W3/25 was 
calculated(b).
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Fig 2.8 Morphometric analysis of 0X19 
staining of DA grafts in unmodified and 
transfused PVG recipients
DA g ra fts  were removed on d iffe re n t days 
a fte r  transplantation from unmodified (n=5) 
and transfused (n=5) PVG recip ients. Cryostat 
sections were stained by immunoperoxidase 
w ith MRC 0X19 and the % area in f i l t r a te  o f 
labe lled  leucocytes determined by 
morphometric analysis. Normal DA kidneys were 
stained as a contro l. Results are expressed 
as the mean and standard deviation.
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Fig 2.9 MRC 0X19 la b e lling  o f enhanced and 
re jec ting  DA a llog ra fts  in PVG recip ients 
(day 3)
Cryostat sections of enhanced and reject ing 
DA a l lograf ts , 3 days af ter transplantation 
were immunoperoxidase labelled with MRC 
0X19(1 abels al l  T ce l ls ) .
(a) Enhanced kidney labelled with 0X19 (x200)
(b) Rejecting kidney labelled with 0X19
(x200)
increased s l ig h t ly  but there was no s ign ifica n t difference between the 
groups. The k ine tics  of in f i l t r a t io n  found when sections were stained 
w ith W3/13 (T c e lls , neutrophils and plasma ce lls  ) (Fig 2.10) was 
s im ila r to  tha t found with 0X19, but the overall number o f ce lls  
stained was s lig h t ly  higher. There were no s ign ifica n t differences in 
leve ls  o f W3/13 positive ce lls  between the two groups.
In te re s tin g ly , activated ce lls  expressing the IL-2 receptor, as 
measured by la b e llin g  with 0X39 (Fig 2.11) were found in greater 
numbers in  enhanced than re jecting grafts at day 3, 2.6% +/- 0-7% vs
0.6% +/~0.5%, p<0.01. However by day 5 the numbers of 0X39 positive
c e lls  had risen rap id ly  in re jecting grafts compared with enhanced 
g ra fts  . The leve ls of 0X39 positive ce lls  remained low in enhanced 
g ra fts  at day 7.
3.4 . Cytotoxic function of cells in filtra tin g  enhanced and rejecting 
grafts
C ells were harvested from enhanced and re jecting grafts at day 5 post 
transp lan t, and along with splenocytes were tested fo r specific  and 
non-specific  c y to to x ic ity  in 6hr chromium release assays. I n i t ia l ly  
c e lls  were harvested using an enzymatic technique, which produced a 
lo t  o f c e ll debris. Experiments have subsequently been performed using 
c e lls  harvested mechanically, then separated over Percoll, which led 
to  a much cleaner ce ll preparation. A typ ica l y ie ld  of ce lls  was 
between 5-7xl07 ce lls  per g ra ft. The target ce lls  used in the k i l l in g  
assay were lymphoblasts of e ither donor (DA) or th ird  party (LEWIS)
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Fig 2.10 Morphometric analysis o f W3/13 
sta in ing  o f DA gra fts  in unmodified and 
transfused PVG recip ients 
DA gra fts  were removed on d iffe re n t days 
a fte r transplantation from unmodified (n=5) 
and transfused (n=5) PVG recip ien ts. Cryostat 
sections were stained by immunoperoxidase 
w ith W3/13 and the % area in f i l t r a te  o f 
labe lled leucocytes determined by 
morphometric analysis. Normal DA kidneys were 
stained as a contro l. Results are expressed 
as the mean and standard deviation.
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Fig 2.11 Morphometric analysis o f 0X39 
sta in ing  o f DA grafts in unmodified and 
transfused PVG recipients 
DA gra fts  were removed on d iffe re n t days 
a fte r transplantation from unmodified (n=5) 
and transfused (n=5) PVG recip ien ts. Cryostat 
sections were stained by immunoperoxidase 
w ith 0X39 and the % area in f i l t r a te  of 
labe lled leucocytes determined by 
morphometric analysis. Normal DA kidneys were 
stained as a contro l. Results are expressed 
as the mean and standard deviation.
genotype. While these ce lls  may not be appropriate in v itro  correlates 
o f the ta rge t ce lls  in kidney tissue,they do bare appropriate MHC 
antigens which would be recognised by host e ffecto r ce lls . Before 
using these c e lls  as targets, cytocentrifuge slide preparations of Con 
A b lasts o f various ra t strains were stained with 0X18 (anti-c lass I) 
and 0X6 (an ti-c lass I I )  monoclonal antibodies using the 
immunoperoxidase technique. In the ra t strains tested a ll of the Con A 
b lasts stained po s itive ly  fo r class I antigens, and about one th ird  
stained strongly positive fo r class I I  antigens. The ra t myeloma 
c e ll l in e  Y3 was used as a non-specific target and was found to 
express class I antigens very weakly, but did not express class I I  
antigens.
3.4.1 A comparison o f the specific  cy to tox ic ity  found in enhanced and 
re je c tin g  ra t renal a llog ra fts
A feature o f the assay in which the ce lls  were harvested 
enzym atica lly, was the marked "prozone" e ffec t at high e ffec to r to 
ta rge t ra t io s . The maximum level of release was found at an e ffector 
to  ta rge t ra t io  o f 50:1 and the results of 5 separate experiments are 
shown in Table 1.3. I t  can be seen that the levels o f specific  
c y to to x ic ity  produced by ce lls  from the enhanced gra fts  were s im ila r 
to  or exceeded those found in re jecting g ra fts . Third party cytotoxic 
a c t iv i ty  was assessed using Lewis Con A blasts as targets and was less 
than 6% in a ll experiments in which i t  was tested.(Table 1.3). When 
th is  experiment was repeated using g ra ft in f i l t r a t in g  ce lls  which had 
been harvested mechanically there was no prozone e ffec t and ce lls  from
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Table 1.3
S pec ific  c y to to x ic ity  o f g ra ft in f i l t r a t in g  ce lls  harvested from 
enhanced and re jecting rats 5 days a fte r transplantation
% 51chromium release at an e ffec to r:ta rge t ra tio  of 50:1
Experiment
Enhanced
vs
Re.iectinq
DA
Enhanced
vs
Re.iectinq
LEWIS
1 15 22 ND ND(a)
2 24 21 ND ND
3 29 17 6.0 1.0
4 13 13 5.0 5.0
5 21 14 2.0 4.0
(a) ND = not done
Table 1.3 G raft in f i l t r a t in g  ce lls  were harvested from enhanced 
and re je c tin g  PVG recip ients of a DA kidney, 5 days a fte r 
tra nsp la n ta tio n . The ce lls  were tested fo r cy to tox ic ity  against 
donor-specific  (DA) and th ird  party (LEWIS) Con A blasts in a 
Cr release assay. The results of 5 experiments at an 
e ffe c to r : ta rge t ra tio  of 50:1 are shown.
the enhanced gra fts  showed considerably higher levels of specific 
c y to to x ic ity  than the re jecting grafts(F ig 3.1). However th is  was 
not e n tire ly  specific  fo r donor alloantigen,since there were high 
leve ls  o f th ird  party a c tiv ity (F ig  3.2). The levels of specific 
c y to to x ic ity  found in the spleens of enhanced and re jecting rats in 5 
separate experiments are shown in Table 1.4 and the results of a 
typ ica l experiment are shown in Fig 3.3. Again there was no 
s ig n if ic a n t d ifference in the amount of cy to to x ic ity  generated by each 
group. Levels o f cy to to x ic ity  were s lig h tly  higher in the spleens than 
in the kidneys but not a ll of th is  k i l l in g  was directed towards donor 
a lloan tigen  as at least ha lf of th is  a c tiv ity  cross reacted with 
Lewis antigens (Table 1.4). In a number of experiments the spleens
were depleted o f macrophages but th is  did not consistently a lte r the 
leve ls  o f c y to to x ic ity  (results not shown). This suggests that most of 
the cy to tox ic  a c t iv ity  measured in the grafts was mediated by 
lymphocytes. Therefore no consistent difference could be shown between 
the leve ls  o f spec ific  cy to tox ic ity  found in the gra fts  or spleens of 
enhanced and re jec ting  ra ts.
3.4.2 A comparison of the non-specific cytotoxicity found in enhanced 
and rejecting rats
Non-specific c y to to x ic ity  was assessed by measuring cy to to x ic ity  
against the ra t myeloma Y3. Levels of non-specific cy to to x ic ity  found 
in the g ra ft in f i l t r a t in g  ce lls  harvested from enhanced and re jecting 
ra ts  in  f iv e  separate experiments are shown in Table 1.5. Surprisingly 
there was no prozone e ffec t, and th is  may have re flected subtle
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Fig 3.1 Cytotoxic a c t iv ity  o f g ra ft 
in f i l t r a t in g  ce lls  harvested from enhanced 
and re jecting  grafts  against DA con A blasts
Graft in f i l t r a t in g  ce lls  were harvested from 
enhanced (n=2) and rejecting(n=2) PVG 
recip ients 5 days a fte r transplantation with 
a DA kidney. They were then tested in v itro  
fo r  th e ir  a b il i ty  to lyse chromium-labelled 
DA con A blasts.
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Fig 3.2 Cytotoxic a c t iv ity  o f g ra ft 
in f i l t r a t in g  ce lls  harvested from enhanced 
and re jecting  grafts against LEWIS con A 
b lasts
Graft in f i l t r a t in g  ce lls were harvested from 
enhanced (n=2) and re jecting (n=2) PVG 
recip ients 5 days a fte r transplantation with 
a DA kidney. They were then tested in v itro  
fo r  th e ir  a b il i ty  to lyse chromium-labelled 
LEWIS con A blasts.
Table 1.4
S p ec ific  c y to to x ic ity  of splenocytes harvested from enhanced and 
re jec ting  rats 5 days a fte r transplantation
% 51Cr release at an e ffec to r:ta rge t ra tio  of 100:1
Experiment
Enhanced
vs
Re.iectinq
DA
Enhanced
vs
Re.iectinq
LEWIS
1 22 20 ND ND(a)
2 16 18 ND ND
3 26 30 17 16
4 22 19 14 10
5 26 25 18 10
(a) ND = not done
Table 1.4 Splenocytes were prepared from enhanced and re jecting  
PVG re c ip ien ts  o f a DA kidney, 5 days a fte r transplantation. The 
c e lls  were tested fo r cy to tox ic ity  against^donor-specific (DA) 
and th ird  party (LEWIS) Con A blasts in a 01Cr release assay. The 
re su lts  o f 5 experiments at an e ffec ton ta rge t ra tio  of 100:1 are 
shown.
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Fig 3.3 Cytotoxic a c t iv ity  found in the 
spleens o f enhanced and re jecting PVG rats 
against DA con A blasts
Splenocytes were prepared from an enhanced 
and re jecting PVG ra t 5 days a fte r 
transplantation with a DA kidney . They were 
then tested in v itro  fo r th e ir  a b il i ty  to 
lyse chromium-labelled DA con A blasts.
Table 1.5
N on-specific cy to to x ic ity  of g ra ft in f i l t r a t in g  ce lls  harvested 
from enhanced and re jecting rats 5 days a fte r transplantation
% 51Cr release at an e ffec to r:ta rge t ra tio  o f 100:1
Experiment
Enhanced
vs Y3
Rejectinq
1 15 22
2 29 17
3 13 13
4 21 14
5 24 21
Table 1.5 Graft in f i l t r a t in g  ce lls  were harvested from enhanced 
and re je c tin g  PVG recipients of a DA kidney, 5 days a fte r 
tra nsp la n ta tion . The ce lls  were tested fo r non-specific 
c y to to x ic ity  against the NK sensitive target Y3 in a Cr release 
assay. The resu lts  of 5 experiments at an e ffec to r:ta rge t ra tio  
o f 100:1 are shown.
d iffe rences in the interaction between the e ffecto r and target ce lls . 
The re su lts  o f a typ ica l experiment are shown in Fig 3.4. Levels of 
non-specific  k i l l in g  found were s lig h tly  higher in the enhanced than 
in the re je c tin g  group: the median and range fo r 5 separate
experiments was 21%(13-29%) fo r the enhanced group and 17%(13-22%) 
fo r  the re je c tin g  group. High levels of non-specific cy to to x ic ity  were 
found in the splenocytes of enhanced and re jecting rats and again
leve ls  were s lig h t ly  higher in the enhanced group (Table 1.6) The 
re su lts  o f a typ ica l experiment are shown in Fig 3.5. The medians and 
ranges fo r  the enhanced and rejecting groups in 5 separate experiments 
were 40%(35-74%) and 32%(29-68%).
3.5 A b ility  of lymph node cells from enhanced and rejecting rats to 
mediate GvH activ ity  in the popliteal lymph node assay
In order to  assess whether ce lls  from a ra t active ly  enhanced by 
blood transfusion could mount a GvH reaction, LNCs were harvested from 
a transfused and an unmodified ra t five  days post transplant. Three 
graded doses o f ce lls  were prepared from each group , then injected 
in to  the le f t  and r ig h t hind footpads of 3(DAXPVG) FI ra ts / ce ll
dose. A fte r 7 days the popliteal lymph node was removed and weighed. 
The dose response curve is shown in Fig 3.6 I t  can be seen that ce lls
from the enhanced animal responded as well as ce lls  from the re jecting 
animal there being no s ign ifican t difference between the two groups 
p< 0.05 .
3.6 MHC antigen expression in rejecting and enhanced renal allografts
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Fig 3.4 Non-specific cy to tox ic ity  found in 
enhanced and re jecting spleens and kidneys 
against Y3 targets
Graft in f i l t r a t in g  ce lls and spleens were 
prepared from a transfused and unmodified 
PVG recip ient 5 days a fte r transplantation 
w ith a DA kidney. Cells were then tested in 
v it ro  fo r th e ir a b ili ty  to lyse chromium 
labe lled  Y3 targets.
Table 1.6
Non-specific cytotoxicity of splenocytes harvested from enhanced and 
rejecting rats 5 days after transplantation
% 51Cr release at an e ffec to r:ta rge t ra tio  of 100:1
Experiment
Enhanced
vs Y3
Re.iectinq
1 35 29
2 40 32
3 45 47
4 39 30
5 74 68
Table 1.6 Splenocytes were harvested from enhanced and re jecting PVG 
re c ip ie n ts  o f a DA kidney, 5 days a fte r transplantation. The ce lls  
were tested fo r cnon-specific cy to tox ic ity  against the NK sensitive 
ta rge t Y3 in a 51Cr release assay. The results of 5 experiments at an 
e f fe c to r : ta rge t ra tio  of 100:1 are shown.
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Fig 3.5 Cytotoxic a c t iv ity  o f g ra ft 
in f i l t r a t in g  ce lls  prepared from enhanced and 
re jecting  grafts against Y3 targets 
Graft in f i l t ra t in g  ce lls  were prepared from 
enhanced (n=2) and re jecting (n=2) PVG 
recip ients 5 days a fte r transplantation with 
a DA kidney. Cells were tested in v itro  fo r 
th e ir  a b il i ty  to lyse chromium-labelled Y3 
targets.
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Fig 3.6 A b ility  of LNCs from enhanced and 
re jec ting  rats to respond in the poplitea l
lymph node assay
LNCs were prepared from an enhanced and a 
re jecting  PVG ra t 5 days a fte r 
transplantation with a DA kidney. Three doses
o f ce lls  (1,3 and 9 x 10b) fo r each group
were injected into the le f t  and rig h t hind
footpads of 3(DAxPVG)FI rats. A fte r 7 days 
the popliteal lymph node was removed and
weighed.
Seria l cryostat sections of enhanced and rejecting renal 
a llo g ra fts  were stained on days 1 ,3 ,5 ,and 7 a fte r transplant (5 
ra ts/group/tim e po in t),w ith  monoclonal antibodies to monomorphic and 
polymorphic determinants of class I and class I I  MHC antigens 
respective ly . The monoclonal antibodies MN4-91-6 and F17-23-2 
recognise polymorphic determinants of class I and class I I  
respective ly , which are expressed by DA but not PVG ra t strains. 
(M ilton et a l ,1986 ). This allowed the unequivocal detection of 
changes in donor MHC expression on the donor kidney tissue without the 
la b e llin g  o f host in f i l t r a t in g  ce lls .
3.6.1 Immunohistological study of class I expression in rejecting and 
enhanced renal allografts
To gain a baseline of MHC expression, cryostat sections of normal DA 
kidneys (n=4) and DA isografts (n=3) were labelled with the anti-class 
I antibodies MRC 0X18 and MN4-91-6.
Fig 3.7 shows the d is tr ib u tio n  of class I MHC antigens in normal DA 
kidney (ind ica ted by labe lling  with MN4-91-6). There was strong 
sta in ing  o f the in te rs t i t ia l areas(which includes dendritic type 
c e lls )  and the a r te r io la r and venous endothelium, but only moderate 
s ta in ing  o f glom eruli, weak staining of the cortica l tubules and 
occasionally some staining of medullary tubules. Similar staining was 
observed w ith 0X18. DA isografts examined at days 3,5 and 7 
occasionally showed s lig h t induction on tubular ce lls  but th is  was
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Fig 3.7 Immunoperoxidase la b e llin g  o f normal 
DA kidney with MN4-91-6
Cryostat sections of normal DA kidney were 
immunoperoxidase label led with MN4-91-6 
which labels a polymorphic determinant of DA 
but not PVG class I(x320)
much less than found with enhanced and re jecting a llog ra fts  and was 
not a consistent find ing. When DA renal a llog ra fts  from both 
unmodified and transfused PVG recipients were examined, widespread 
induction was found in both groups. There was an increase in tubular 
s ta in ing  as early as day 1 and by day 3 both re jecting Fig 3.8a and 
enhanced Fig 3.8b g ra fts  showed strong staining of a ll tubular cells 
and g lom eru li. S im ilar staining was found in day 5 re jecting, day 5 
enhanced and day 7 enhanced a llog ra fts . Kidneys from three long 
surv iv ing  enhanced a llog ra fts  were also labelled with MN4-91-6 and 
class I expression was found to have reverted to normal except fo r an 
absence o f donor in te rs t i t ia l  staining . When the same sections were 
labe lled  w ith MRC 0X18, a s im ilar pattern of expression was found 
except there were greater numbers of pos itive ly  staining in f i l t ra t in g  
c e lls  which were presumably recip ient dendritic  ce lls  ( MN4-91-6 
negative, MRC 0X18 pos itive ).
3.6 .2 Immunohistological study o f class I I  expression in re jecting and 
enhanced renal a llo g ra fts
Class I I  expression was detected by staining with F17-23-2 which 
allowed a precise determination of donor class I I  expression and also 
w ith MRC 0X6 which labelled a monomorphic determinant of class I I .  The 
d is tr ib u t io n  o f class I I  MHC antigen in normal DA kidney is shown in 
Fig 3.9 The notable features of th is  staining were strongly positive 
d e n d ritic -typ e  c e lls  scattered throughout the in te rs t it ia l areas of 
the kidney. There was weak class I I  expression by the renal tubules
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Fig 3.8 Immunoperoxidase labe ll ing  of 
enhanced and re jecting DA a llog ra fts  in PVG 
recip ients with MN4-91-6(day 3)
Cryostat sections of enhanced and rejecting 
DA al lograf ts ,  3 days a f te r  transplantat ion, 
were immunoperoxidase label led with MN4-91-6 
which labels a polymorphic determinant of DA 
but not PVG class I.
(a) Rejecting kidney label led with MN4-91-6 
(x200)
(b) Enhanced kidney label led with MN4-91-6 
(x200)
Fig 3.9 Immunoperoxidase labe ll ing  o f normal 
DA kidney with F17-23-2
Cryostat sections of normal DA kidney were 
immunoperoxidase label led with F17-23-2 which 
labels a polymorphic determinant of 
DA cl ass 11 (x200).
(mainly the basal ha lf of the proximal tubules ), however there was no 
evidence o f class I I  expression by vascular endothelium nor by 
glomeruli and the surrounding Bowman's capsule.
Day 1 enhanced a llogra fts  showed a s ligh t focal increase in donor 
class I I  antigen expression on proximal tubules which was not found in
re jec t ing  g ra f ts .  Both unmodified and transfused recipients showed a 
s l ig h t  decrease in the frequency of class I I  positive in te rs t i t ia l
de nd r it ic  ce l ls  at day 1. By day 3, both enhanced (Fig 3.10a) and 
re jec t ing  (Fig 3.10b) a llografts  had focal areas of increased class II  
expression , which appeared to be greater in the enhanced grafts than 
in the re jec t ing  grafts . Furthermore, only enhanced grafts showed 
induction o f class I I  antigen on a r te r io la r endothelium and on 
Bowman's capsules as well as a marked reduction in the number of 
i n t e r s t i t i a l  dendrit ic  ce lls . By day 5 the staining pattern was 
s im ila r  in both groups (Fig 3.11a and 3.11b). Grafts stained strongly 
fo r  donor class I I  antigen on a ll tubular ce lls, a r te r io la r
endothelium and Bowmman's capsules, however the glomeruli remained 
negative. There was v ir tu a l ly  no F17-23-2 positive in te rs t i t ia l  
de n d r it ic  c e l ls  and these did not appear to have been replaced by 
re c ip ien t dend r it ic  ce lls  (MRC 0X6 positive). A similar picture was 
seen in day 7 enhanced grafts. In long surviving enhanced grafts ( day 
100 ) ,  there was s t i l l  some class I I  expression on renal tubules and
occasional expression on arte r io la r vascular endothelium. These
g ra fts  contained a normal complement of recipient type dendritic cells 
( F17-23-2 negative, MRC 0X6 positive ) (Figs 3.12a and 3.12b). None of 
the DA isogra fts  examined at days 3,5 ,or 7 showed any increase in 
class I I  expression a fte r transplantation.
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Fig 3.10 Induction o f donor class I I  MHC 
antigens in enhanced and re jecting DA 
a llog ra fts  in PVG recipients (day 3)
Cryostat sections of enhanced and reject ing 
DA al lograf ts , 3 days af ter  transplantation 
were immunoperoxidase label led with F17-23-2 
which labels a polymorphic determinant of DA 
(donor) but not PVG (recipient) class I I .
(a) Enhanced kidney label led with F17-23-2 
(x200)
(b) Rejecting kidney label led with F17-23-2 
(x200)
Fig 3.11 Induction of donor class 11 MHC
antigens in enhanced and re jecting DA
allogra fts  in PVG recipients (day 5)
Cryostat sections of enhanced and reject ing 
DA al lograf ts in PVG recipients, 5 days af ter 
transplantation were immunoperoxidase 
labelled with F17-23-2 which labels a
polymorphic determinant of DA but not PVG
class I I .  , ,
(a) Enhanced kidney label led with
F17-23-2(x200) .
(b) Rejecting kidney label led with
F17-23-2(x200)
Fig 3.12 Class 11 expression in long term 
surviving enhanced PVG recip ients of a DA 
renal a l lo g ra f t
Cryostat sections of long term surviving(day 
100 post transplantation) DA kidneys in 
enhanced PVG recipients were immunoperoxidase 
label led with 0X6 (labels host and donor 
class I I  antigens) and F17-23-2 (labels donor 
class I I  antigens.
(a) Day 100 enhanced DA kidney labelled with
0X6 (X200) ...
(b) Day 100 rejecting DA kidney label led with
F17-23-2 (X200)
3.7 Discussion
I t  has been shown in th is chapter that although a single preoperative 
blood transfusion markedly prolongs a llog ra ft survival, there is an 
accelerated immunological response to the a llog ra f t .  This was 
characterised by a rapid and substantial leucocyte in f i l t r a t io n  ,early 
loss o f g ra f t  dendritic ce lls , both alloantigen-specific and 
non-specific cy to tox ic ity  and an accelerated and marked increase of 
donor s tra in  class I and class I I  MHC expression within the g ra ft .  
Such find ings raise interesting questions both about the immunological 
process o f renal a llog ra ft rejection and about the mechanism of 
induction o f active enhancement.
The observation that passenger leucocytes disappeared more rapid ly 
from the enhanced grafts was interesting in the l ig h t  of th e ir  
postulated ro le as mediators of host sensitisation (Lechler and 
Batchelor, 1982). I f  these cells travelled to a s ite  of sensitisation 
at an e a r l ie r  time point then th is  could explain the rapid appearance 
o f host in f i l t r a t in g  cells in the enhanced grafts. An a lternative 
explanation is that the host effector cells entering the g ra ft at an 
early  stage a f t e r  transplantation have k i l led  the dendritic  ce lls  in 
s i tu ,  hence removing an important alloantigenic stimulus.
The magnitude of the leucocyte in f i l t r a te  reached s im ilar levels in 
both groups by day 5, however there were phenotypic differences which 
may influence the outcome of the rejection response. There were 
s ig n if ic a n t ly  higher numbers of 0X8 positive ce lls  in the re jecting
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ra ts  compared to the enhanced rats at day 5 post transplant. I t  is not 
c lear from these results whether this re flects important functional 
d ifferences between the two groups. I t  would be interesting to look 
at both the p ro life ra t ive  and cytotoxic responses of purif ied  0X8 
pos it ive  ce l ls  harvested from the grafts to examine th is  p o ss ib i l i ty .  
Recently, Ruiz et a l , ( I 988) using FACS analysis of isolated g ra ft 
i n f i l t r a t i n g  ce lls  confirmed that the predominant in f i l t r a t in g  ce ll in 
ra ts  receiving prio r donor blood transfusion carried the 
CD8+phenotype.
I t  was in teresting that despite the greater numbers of 0X8 positive 
c e l ls  in the rejecting grafts at day 5 there was no s ign if ican t 
d iffe rence found between the two groups in the levels of specific 
c y to to x ic i ty .  This suggests that perhaps cy to tox ic ity  was not mediated 
by 0X8 positive  cells or that the quantitative difference was not 
great enough to exert any effect on in v i tro  levels of cy to tox ic ity . 
The fac t that few of the cells in f i l t r a t in g  either the enhanced or 
re je c t ing  gra fts  were 0X19 positive suggests that much of the g ra ft 
i n f i l t r a t e  may be made up of non-specific effectors such as NK ce lls  
and macrophages . Bradley,Mason & Morris, 1985 found that 0X8 
pos it ive  ce l ls  were the predominant phenotype of g ra ft i n f i l t r a t in g  
c e l ls  in untreated LEW recipients of BN kidneys . This was in 
comparison with passively enhanced and CsA treated rats where there 
were fewer 0X8 positive cells and W3/25 was the predominant phenotype. 
Overall these results imply that the re la tive  preponderance of 0X8 
pos it ive  ce l ls  in acutely rejecting grafts may play a ro le in the 
re jec tion  response.
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Another important finding was that 0X39 (anti-IL2R) positive ce lls  
in the enhanced grafts were higher than in the re jecting grafts at day 
3 post transplant. This indicates that the ir  were more activated cells  
present early in the response. However by day 5 there were twice as 
many activated ce lls  in the rejecting rats , suggesting that the 
enhanced rats were deficient in either th e ir  a b i l i t y  to make or 
respond to IL-2. This observation has been confirmed by Dallman, Wood 
and Morris(1989), who analysed single cell suspensions of g ra ft 
i n f i l t r a t e s  by flow cytometry. They also found higher numbers of IL-2 
receptor positive cells in the transfused rats compared with 
unmodified recipients at day 3. By day 5 the numbers in the re jecting 
group had risen considerably and were generally higher than the 
transfused group though the response was variable. Furthermore i t  was 
found tha t ce l ls  from the transfused rats had a lower p ro l i fe ra t ive  
response to IL-2 and that enhancement of g ra ft survival could be 
abrogated by the administration of high doses of IL-2 fo r the f i r s t  5 
days post transplant. The former finding suggests that there may be a 
defect in IL-2 responsiveness in the transfused animals, but i t  is 
debatable whether such high doses of IL-2 are physiological. This 
f ind ing  would appear to contradict the fact that cytotoxic ce lls  
which require IL-2 have been found in both enhanced and re jecting 
g ra fts  in th is  and other studies( Dallman et a l ,1987 Ruiz et a l ,1988). 
However Dallman suggests that IL-4 ,which can also expand precursor
cyto tox ic  ce l ls  , may be present and lead to maturation of the 
precursor c e l ls .  Further study at the molecular level to establish 
whether there is a switch o f f  of the genes fo r IL-2 is required to 
c la r i f y  th is  f ind ing.
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I f  the in f i l t r a te  is largely non-specific as suggested by the 
phenotypic analysis then this would explain why the levels of specific 
c y to to x ic i ty  found in graft in f i l t ra t in g  cells harvested from both 
unmodified and transfused rats was not very high. The low levels of 
c y to to x ic i ty  may be partly due to the fact that PVG is a low 
responder to DA (Butcher & Howard, 1982). I t  has been shown that CD4+ 
but not CD8+ T ce lls  are required to restore rejection of a DA kidney 
in a nude PVG recipient(Bolton et al,1989), perhaps indicating that a 
DTH response may be more important in th is strain combination (Bolton 
et a l ,1989).
A lte rn a t ive ly  the in v itro  assay may not be a true correlate of 
cyto tox ic  a c t iv i ty  in vivo where the targets are c learly  d if fe re n t.  
The precise targets of the rejection response are not known but i t  is 
thought that vascular endothelium may be one of the primary sites of 
damage. I t  might therefore be more appropriate to use such ce lls  as 
targets in cy to tox ic ity  assays. One other p o ss ib i l i ty  is that there 
may be qua li ta t ive  differences in the cytotoxic ce lls  present in 
transfused and untreated recipients. I f  specific cytotoxic T ce lls  do 
play a ro le  in the rejection response then they must be blocked in 
s i tu ,  e ithe r by blocking antibodies or specific suppressor ce lls .
An in vivo method of assessing the a b i l i ty  of ce lls  from enhanced 
and re jec t ing  rats to respond to donor alloantigen is the popliteal
lymph node assay(Ford,1970). When graded doses of splenocytes were
in jected in to the footpads of rats the local popliteal lymph node 
became enlarged. Furthermore the log dose /  log mean lymph node
weight p lo t was approximately linear throughout a range of doses.
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The a b i l i t y  of ce lls  from the transfused animals to respond to donor 
a lloantigen in the PLN assay did not appear to be impaired though 
c le a r ly  th is  would have to be repeated to confirm tfcis finding.
The induction of class I and class I I  antigens within re jecting 
g ra fts  was in agreement with previous studies ( Dallman & Mason,1983; 
S te in iger et a l ,1985; Milton et al 1985,1986a )However the substantial 
increase in class I and class I I  antigens in enhanced grafts was less 
expected, pa rt icu la r ly  in view of the fact that non-rejecting ra t 
renal a l lo g ra f ts  in cyclosporin treated recipients have been shown 
to have diminished induction of class I and no induction of class I I  
(Milton,Spencer & Fabre, 1986b). Induction of class I and class I I  
antigens in non-rejecting grafts in transfused recipients has been 
found by two other groups (Wood et a l ,1988; Priestley and Fabre, 
1989). This c lea rly  indicates that in the actively enhanced rats there 
must be activated T cells present which have d iffe ren tia ted to the 
stage o f secreting lymphokines such as gamma-interferon. The 
increased expression of class I and class I I  MHC antigens could 
contribute to the rejection response by activating host effectors and 
making targets more susceptible to k i l l in g .  In pa rt icu la r,spec if ic  
cyto tox ic  T ce lls  directed at class I targets may be augmented by 
increased expression of class I MHC antigens ,whereas DTH responses 
mediated by Th ce lls  , directed primarily at class I I  targets may be 
augmented by increased expression of class I I  MHC antigens. However i t  
appears that there is no correlation between increased MHC expression 
and re jec t ion . Priestley and Fabre (1989), suggest that blood 
transfusion results in heightened effector and suppressor responses, 
but do not suggest how the la t te r  dominates the former. In the
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a c t ive ly  enhanced animals which in i t i a l l y  show an accelerated response 
both in terms of MHC induction and ce llu la r in f i l t r a t io n ,  i t  may be 
tha t lymphokines released within the graft are having opposing 
e ffe c ts . The release of gamma interferon is normally associated with 
c e l lu la r  activation (Spiegel,1988)and lymphocyte recruitment in vivo 
(Issekutz,S ta lz and Meide, 1988). However i t  has also been shown that 
gamma interferon augments suppressor activity,(Holda,Maier & 
Claman,1988), suppresses IL-1 production( Ghezzi and D inare llo ,1988) 
and protects endothelial cells from lymphokine activated k i l l e r  
a c t iv i t y .  (Renkonen,Ristimaki and Hayry, 1988). The mechanism of th is  
pro tect ive  e ffec t remains unclear, but i t  does appear that such a 
phenomenon may also occur in vivo.
I t  appears that enhanced grafts are able to survive despite 
increased MHC expression, a considerable ce l lu la r in f i l t r a te  and the 
presence o f donor-specific cytotoxic ce lls . This suggests that the 
e ffe c to r  response to the graft is being blocked in vivo.
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CHAPTER 4
Fc RECEPTOR BLOCKING ACTIVITY IN THE SERUM OF ACTIVELY ENHANCED RAT
RENAL ALLOGRAFT RECIPIENTS
4.1 Introduction
The find ings of the previous chapter suggest that the state of 
enhancement present in blood transfused rats is quite d if fe ren t from 
transplanta tion tolerance, where animals are unable to respond 
normally to alloantigens. Rather i t  appears that actively enhanced 
animals have a normal repertoire of alloantigenic responses, but these 
are held in check by some form of immunosuppression.
Of the several possible mechanisms which may be responsible fo r 
active enhancement, the generation of suppressor cells has received 
most a tten tion  and convincing evidence exists that such ce lls  may be 
o f importance in preventing graft rejection a fter blood transfusion 
(Hutchinson, 1986; Quigley, Wood and Morris, 1989a,b,c). However there 
is  also a body of evidence from c lin ica l studies which suggests that 
a lloantibodies, induced by blood transfusion may be important (MacLeod 
et a l,  1982; 1985; 1988). The mode of action of such alloantibodies 
might be analagous to passive enhancement whereby pre-treatment of the 
rec ip ien t with hyperimmune serum leads to long term g ra ft survival 
(Morris, 1980).
The hypothesis that transfusion induced alloantibody plays a 
ro le  in in the beneficial effect of pre-transplant blood transfusion 
is  consistent with the c lin ica l observation that transfusion is 
associated with the generation of non-cytotoxic IgG FcR blocking 
antibodies. These are detected by the ir  a b i l i t y  to in h ib i t  the 
formation of EA rosettes by donor lymphocytes and th e ir  presence may
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corre la te  with subsequent a llograft survival (MacLeod et a l , 1982). 
Furthermore they appear to be alloantibodies rather then
autoantibodies, (MacLeod et al 1985; 1988). Such Fc blocking
antibodies have been found after platelet transfusion in man (Petranyi 
et a l , 1988) and in patients who are long term survivors of renal
a l lo g ra f ts  (Shohat,Cytron,Boner et al 1988). However a recent study of 
transfused renal dialysis patients, employing the EA rosette
in h ib i t io n  assay showed that graft survival correlated not with FcR 
blocking in the IgG serum fraction but instead with blocking a c t iv i ty  
in the high molecular weight >19S serum fraction (Forwell et al 1987).
The aim o f th is  chapter is to further elucidate the nature of Fc 
blocking antibodies and whether such antibodies could be demonstrated 
in the serum of transfused rats which had received a renal a l lo g ra f t .
4.2 Development o f the EARI assay
A study o f Fc blocking ac tiv ity  in the serum of transfused kidney 
transplant patients in our own renal unit had used the method of 
MacLean, Goudie, MacSween et a l (1984). The EA indicator ce lls  in th is  
assay were chick erythrocytes which had a rabbit an ti-chick
erythrocyte antibody bound. However the levels of rosetting between 
ra t  lymphocytes and these indicator cells were generally rather low 
(10-12%) and i t  was thought that th is  could be due to a weak 
in te rac tion  o f the Fc region of rabbit IgG with the Fc R on ra t
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splenocytes, or that the chick red cells were too large to allow 
rosette formation. In order to overcome th is problem a ra t anti-sheep 
erythrocyte serum was raised and sheep cells used as indicator ce l ls .
4.2.1 Preparation of a rat anti-sheep erythrocyte serum
Rat anti-sheep erythrocyte serum was prepared as described in 
section 2.8.1. 125ul of doubling dilutions of antiserum harvested from 
2 DA rats were prepared and added to 125ul of a 5% solution of sheep 
red c e l ls  and incubated at 37°C for 30 mins. The sheep ce lls  were 
washed, resuspended and rosetted with 2X106 DA splenocytes, by 
cen tr ifug ing  at lOOOrpm for 5 mins. The fixed ce lls  were counted and 
the % o f Fc rosetting cells calculated. The t i t r a t io n  curves of the 
two antisera are shown in Figs 4.1a and 4.1b. At high concentrations 
o f antisera, (neat-1:32) the red cells agglutinated, making the slides 
impossible to count. Maximum levels of rosetting were found at a 
d i lu t io n  o f between 1:64 and 1:256 in serum A and between 1:32 and 
1:128 in serum B. Therefore the two antisera were pooled and used in 
subsequent experiments at a 1:100 d ilu t ion . The antiserum was tested 
by in d ire c t  haemagglutination to see whether i t  contained IgG or IgM. 
B r ie f ly ,  two 5% solutions of sheep red cells were prepared one of 
which was sensitised as before. Doubling d ilu t ions of sheep a n t i- ra t  
IgG and sheep an t i- ra t  IgM were made from 1:10 to 1:50,000 in a 96 
well p late to which lOOul of 2% sensitised or unsensitised sheep ce lls  
were added. The plates were incubated at room temperature fo r  1 hr 
then tapped l ig h t ly  to pelle t the ce lls . Anti-IgG gave agglutination
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Fig 4.1 Titration of a ra t anti-sheep 
erythrocyte serum .
DA rats (n=2) were injected with 10y sheep 
red cells in Freund's complete adjuvant into 
the hind footpads of two Da rats. The rats 
were then bled 14 days a fter in jec t ion  and 
the serum samples (a) and (b) t i t ra te d  in the 
rosetting assay to determine the optimal 
d ilu t io n  for sensitising the red ce lls
up to a 1:640 d ilu t ion  while an ti- IgM gave agglutination up to a 
1:320 dilution.Therefore the antiserum appears to contain both IgG and 
IgM.
4.2.2 Conditions fo r erythrocyte antibody rosette inh ib it ion  assay
In order to assess the best conditions for the EARI assay a number 
o f parameters were varied (the number of lymphocytes, the % of EA and 
the volume o f EA). The results in Table 1.7 show that levels of 
between 20% and 30% were obtained but the optimum level of 
rosetting(30%) was obtained with 1x10  ^ splenocytes 1.25%, EA in 175uls 
o f Hanks/Hepes. These conditions were then employed in a l l  subsequent 
assays.
4.3 FcR blocking a c t iv ity  in serum from enhanced and re jecting ra t 
renal a l lo g ra f t  recipients
There were two main experimental groups namely;
1) Unmodified PVG(RT1C) recipients which were transplanted with a 
f u l l y  allogeneic DA(RTla) kidney.
2) Ac tive ly  enhanced PVG(RT1C) recipients which received 1.0 ml of 
heparinised donor strain whole blood i . v .  7 days p r io r  to 
transplantation with a DA (RTla) kidney.
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Table 1.7
Determination o f the conditions fo r maximum rosetting in the EAR1
assay
No. o f DA 
lymphocytes % of EA Volume of EA (ul)
% of rosetting 
lymphocytes
1 x 106 1.25 125 22
1 x 106 1.25 175 31
1 x 106 1.25 250 28
1 x 106 2.5 125 27
1 x 106 2.5 175 22
l—
>
X 1—
1 
o O
'*
2.5 250 not counted^3)
2.5 x 106 1.25 125 18
2.5 x 106 1.25 175 24
2.5 x 106 1.25 250 23
2.5 x 106 2.5 125 23
2.5 x 106 2.5 175 25.0
2.5 x 106 2.5 250 not counted^3)
Table 1.7 The number of DA lymphocytes, % of EA and volume of EA 
were varied in order to ascertain the conditions required for 
maximum rosetting. Lymphocytes and EAs were centrifuged at 200g 
fo r  5 mins to encourage rosette formation. Rosettes were then 
f ixed , stained, counted and the % of rosettes calculated.
(a) These slides were too crowded with red ce lls  and lymphocytes 
to allow counting.
Serum was obtained at day 5 post transplant from 4 unmodified PVG 
rec ip ien ts  bearing a rejecting DA kidney and from 6 transfused PVG 
rec ip ien ts  bearing an actively enhanced graft and tested fo r the 
presence o f FcR blocking activ ity  against donor (DA) or th ird  party 
(LEWIS) splenocytes. To remove the poss ib il i ty  of non-specific
in h ib i t io n  by aggregates the serum was ultracentrifuged, then added to 
the splenocytes. Serum from both groups showed specific inh ib ito ry  
a c t iv i t y  but inh ib it ion  was markedly higher in the enhanced sera 
( ind iv idua l values for EAI were 80%, 81%, 94%, 94%, 91% and 82% vs
22%, 21%, 54%, and 13%). This inh ib itory effect was donor specific
since EAI was consistently <10% when tested against th ird  party LEWIS 
splenocytes.
To determine which component of enhanced serum was responsible fo r 
donor spec if ic  EA rosette inh ib ition, 6 fractions of graded molecular 
weights were prepared from serum obtained from enhanced (n=4)and
re je c t ing  animals(n=4) by discontinuous gradient centrifugation. The
a b i l i t y  o f these fractionsto inh ib it  EA rosette formation with donor 
spe c if ic  (DA) and th ird  party (Lewis) lymphocytes is shown in Figs 
4.2a and 4.2b respectively. The inh ib itory a c t iv i ty  in enhanced sera 
was found predominantly in fractions 3-5, a l l of which showed high 
leve ls  o f in h ib it io n  (median: 66%,70%,63% respectively) when compared
with the the same fractions of rejecting sera (median:0%, 10%, 12% 
respective ly). Again th is ac tiv ity  was donor specific since inh ib it ion  
against th ird  party Lewis lymphocytes was minimal. The serum 
frac t ions  were screened by radial immunodiffusion to determine which 
frac t ions  contained IgG. The results in Table 1.8 show that IgG was
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Fig 4.2 A b i l i ty  of serum fractions from 
enhanced and rejecting rats to mediate Fc 
blocking a c t iv i ty  against donor (DA) and 
th ird  party (LEWIS) lymphocytes 
Serum was collected from enhanced (n=4) and 
rejecting (n=4) PVG recipients 5 days a fte r 
transplantation with a DA kidney. A fter 
fractionation over a discontinuous sucrose 
density gradient, enhanced(solid bars) and 
rejecting (open bars) serum fractions were 
tested for rosette inh ib it ion  against DA (a) 
and LEWIS (b) splenocytes. Results shown are 
the medians and ranges fo r each fraction 
tested.
Table 1.8
Determination of the concentrations of IgG and IgM found in enhanced 
and rejecting serum fractions by radial immunodiffusion
Serum fraction number
1 2 3 4 5 6
Enhanced 
[IgG] mg/L 0 0 5360 11900 1810
[IgM] mg/L 0 424 0 0 0 0
Re.iectinq 
[IgG] mg/L 0 0 6900 21200 5360
[IgM] mg/L 0 97.8 0 0 0 0
Table 1.8 5 ul of serum from an enhanced and rejecting PVG recip ient 
o f a DA kidney, 5 days post transplant were added to agar plates 
containing anti-IgG and anti-IgM (Seralab). P recip it in rings were 
measured with the aid of an eyepiece graticule and the concentration 
calculated from a standard curve supplied in the k i t .
present only in fractions 3-5 and was maximal in fraction 4. I t  seemed 
l i k e ly  tha t donor specific Fc blocking was mediated by an IgG 
alloantibody present in enhanced but not rejecting serum.
4.4 A b i l i t y  o f  serum from rats receiving single or double transfusion 
to  mediate Fc blocking ac tiv ity
In order to assess whether Fc blocking was a result of the in i t ia l  
blood transfusion given 12 days previously, serum fractions were 
prepared from rats 12 days after blood transfusion. As can be seen in 
Fig 4.3 re la t iv e ly  low levels of inhibition were found in a l l  of the 
frac t ions  in two of the rats though higher levels were found in 
f ra c t io n  5 o f one of the rats(53%). However i t  was not necessary for 
the second allogeneic stimulus to be a renal a llogra ft since a second 
transfusion given at the normal time of transplant also produced a 
marked increase in EA rosette inhibition in serum fractions 3-5 
(median:43%,53% and 37%)(Fig 4.3). Similarly rats given a transfusion 
and then an intraperitoneal injection of kidney homogenate 7 days 
la te r  also had high levels of Fc blocking ac t iv ity  in serum fractions 
3-5 5 days a fte r  the injection of homogenate (Table 1.9). These
experiments suggest that an IgG all oanti body produced a fte r a 
secondary allogeneic stimulus may be responsible fo r the Fc blocking
a c t iv i t y .
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Fig 4.3 Fc blocking activity in PVG 
recipients following single or double 
transfusion
PVG rats received a single transfusion on 
day -7 (n=6) of which 3 also received a
second transfusion on day 0 . Serum was
collected on day 5 and fractionated over a 
discontinuous sucrose density gradient. Serum 
fractions from rats receiving single(solid 
bars) or double (open bars) transfusion were 
tested for inh ib ition of rosette formation 
with DA lymphocytes. Results shown are the 
medians and ranges for each fraction
Table 1.9
Fc blocking activ ity  in the serum of PVG rats given a DA blood 
transfusion followed by an intraperitoneal injection of DA kidney 
homogenate
% EA rosette inhib ition vs DA splenocytes 
Fraction number Rat no. 1 Rat no. 2
1 0 0
2 0 0
3 60.3 0
4 73.6 51.6
5 50.9 67.9
6 61.8 24.9
Table 1.9 DA rats (n=2) were given an i .v .  in jection of 1.0ml of DA 
blood on day -7 then an i .p . injection of homogenised DA kidney on day 
0. Serum was collected on day 5 after the second injection and the 
serum fractionated over a sucrose density gradient into 6 fractions of 
graded molecular weight. Serum fractions were tested fo r Fc blocking 
a c t iv i t y  in an EARI assay using DA splenocytes as targets.
4.5 Fc blocking activity of purified IgG from enhanced serum
4.5.1 P u r if ica t io n  of IgG
IgG was prepared from enhanced serum and tested for EAR I a c t iv i ty  in 
order to confirm that the serum inh ib ition was due to IgG 
a l l  oanti body. I t  was necessary to find a method of purif ica tion  which 
required only small volumes of serum and gave good purity and y ie ld . 
A number of methods were tried including DEAE Cellulose
chromatography, Sepharose protein A absorption, and HPLC but a simple 
and e ffe c t ive  method was found to be purification by n-octanoic acid 
sedimentation. Using this method a typical y ie ld of protein from 
2.5mls o f s ta r t ing  serum was around lOmgs.IgG prepared by th is  method 
was tested fo r  purity by running the samples on an 8.5% SDS 
polyacrylamide gel under both reducing and non-reducing conditions 
against a commercial rat IgG standard and molecular weight standards 
(Fig 1.5). The IgG was found to be re la tive ly  pure with a s l igh t 
contaminant at 120K.
4.5.2 Conditions fo r  EAR I assay performed in m icro titre  plates
The o r ig ina l EAR I assay required large volumes of test sample so a 
new assay was set up in 96 well plates in order to test the small 
volumes o f IgG preparations. The number of lymphocytes, the % of EA, 
the volume o f EA and the incubation temperature were varied in order 
to  f in d  the best conditions for rosetting. The results shown in Table
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1.10 showed that higher levels of rosetting were obtained when
lymphocytes were incubated at 37°C rather than 4°C, however there was 
l i t t l e  difference when the other parameters were varied. Maximum 
leve ls o f rosetting (41%) were obtained when 25ul of lymphocytes at 
1x10 were incubated at 37°C with 50ul of 2% EA and these conditions 
were employed in subsequent assays.
4.5.3 A b ility  of IgG from enhanced serum to cause Fc blocking
IgG was prepared from 4 transfused PVG recipients on day 5 post 
transp lant and adjusted to lmg/ml in DAB. lOul of doubling d ilu t ions 
o f te s t  IgG or DAB were incubated with DA and LEWIS splenocytes to 
te s t  fo r  Fc blocking ac tiv ity . As shown in Fig 4.4 a ll of the IgG 
preparations showed donor specific inh ib ition across a range of 
d i lu t io n s .  There was no inhibitory a c t iv i ty  against LEWIS
splenocytes.
4.6 A b ility  of antibodies to rat leucocyte membrane antigens to cause 
Fc blocking
I t  had been shown previously that monoclonal antibodies to ra t class 
I and class I I  MHC antigens were able to cause Fc blocking in an EAR I 
assay (Power, Cunningham, Catto et al, 1987). In order to assess 
whether such antibodies had a similar inh ib itory e ffect in the EARI 
assay used in th is  study, DA splenocytes were incubated with various
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Fig 4.4 A b i l i ty  of Enhanced IgG to in h ib it  
rosette formation with DA lymphocytes 
Serum was collected from enhanced PVG 
recipients (n=4) of a DA kidney on day 5 
a fte r transplantation. IgG was purified from 
the serum samples by n-octanoic acid 
sedimentation and reciprocal d ilu t ions of 
IgG (from lOucj/well) were tested for the ir  
a b i l i t y  to block rosette formation with DA 
lymphocytes.
Table 1.10
Determination o f the conditions required fo r  maximum rosetting in the
m icro t itre  EARI assay
No. o f DA % of rosetting
lymphocytes % o f EA Volume of EA (u l) ‘
lymphocytes at 4°C at
37°C
2.5 x 105 1.0 10 23 28
2.5 x 105 1.0 25 16 32
2.5 x 105 1.0 50 19 29
2.5 x 105 2.0 10 18 30
2.5 x 105 2.0 25 23 35
2.5 x 105 2.0 50 17 41
5 x 105 1.0 10 22 23
5 x 105 1.0 25 15 24
5 x 105 1.0 50 16 30
5 x 105 2.0 10 20 33
5 x 105 2.0 25 24 26
5 x 105 2.0 50 16 22
Table 1.10 The number of DA lymphocytes, % o f EA, volume of EA and 
incubation temperatures were varied in order to f ind  the best 
conditions fo r  rosetting in m icro t itre  plates. Lymphocytes and EAs 
were centrifuged at 200g fo r 5 mins. Rosettes were fixed, stained , 
counted and the % o f rosette forming ce lls  calculated.
monoclonal antibodies against cell surface antigens. In the f i r s t  
experiment, lOul of doubling d ilu t ions  (from 1:800-1:100,000) of the 
fo llow ing monoclonal antibodies were tested MRC 0X18 (anti-c lass I ) ,  
MRC 0X6 (anti-c lass I I ,  I-A homologue), MRC 0X17 (anti-c lass I I ,  I-E 
homologue). A ll of the antibodies were at a concentration of 
approximately 4mg/ml. The results of th is  experiment are shown in Fig 
4.5. I t  can be seen that 0X6 and 0X18 were both very in h ib ito ry  and 
0X17 s l ig h t ly  less so: at a 1:800 d i lu t io n  the % of EARI were 89%,82% 
and 77% respective ly). The highest levels of in h ib it io n  were obtained 
when 0X6 and 0X18 or 0X6 and 0X17 were incubated together (82% and 93% 
at a 1:1600 d i lu t io n ) .  The experiment was repeated to test the 0X6 and 
0X18 again along with other monoclonal antibodies to ce ll surface
antigens; 0X12 (labels Ig on B c e l ls ) ,  and W3/13 (a l l  T ce l ls ,  some 
neutroph ils). T r ip l ing  d ilu t ions of antibody were prepared from 
neat-1 :18,000 and the lymphocytes were washed four times instead of 
twice since i t  was thought that unbound antibody could be contributing 
to the high levels of inh ib it ion  found even at high d i lu t io n s . This 
appeared to be the case since the inh ib ito ry  e ffec t t i t ra te d  out at a 
1:729 d i lu t io n .  However no inh ib it ion  was found with e ither 0X12 or 
W3/13( Fig 4.6). I t  seems from these experiments that antibodies which 
bind to ce ll  surface antigens near to the FcR on lymphocytes can 
cause Fc blocking and confirms that the assay could be detecting 
e ith e r an ti-c lass I or anti-class I I  alloantibodies in the serum.
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Fig 4.5 A bility  of monoclonal antibodies to 
MHC antigens to cause Fc blocking
Monoclonal antibodies 0X6,0X18, 0X17,0X6+0X18 
and 0X6+0X17, were tested fo r th e ir  a b i l i t y  
to block rosette formation with DA 
lymphocytes. A ll antibodies were at a 
concentration of 4-5mg/ml and lOul of 
doubling d ilu t ions  from 1:800 to 1:51,200 
were tested in the EARI assay.
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Fig 4.6 A b i l i t y  o f monoclonal antibodies to 
ra t  ce ll surface antigens to cause Fc 
blocking
Monoclonal antibodies 0X6.0X18,0X12 and 
W3/13 were tested fo r  T h e i r a d i  I i t y  to 
in h ib i t  rosette formation with DA 
lymphocytes. A ll antibodies were at 4-5mg/ml 
and lOul of t r ip l in g  d ilu t io ns  o f each from 
1:3 to 1:19,683 were tested.
4.7 MHC specificity of FcR blocking alloantibody in IgG from enhanced
serum
To determine the class of donor MHC antigen recognised by FcR 
blocking antibodies present in the purif ied  IgG preparations from 
enhanced g ra f t  recip ients, a series of absorption experiments was 
performed. I n i t i a l l y  IgG from 3 enhanced rats was absorbed with DA 
(donor) and LEWIS ( th ird  party) erythrocytes (which in the ra t only 
express class I) and tested for EARI with DA and LEWIS splenocytes. 
As can be seen in Table 1.11 absorption with both DA and LEWIS 
erythrocytes fa i le d  to remove any of the Fc blocking a c t iv i ty ,  
against DA splenocytes . There was no th ird  party Fc blocking (results 
not shown). Since i t  was not clear whether the absorption procedure 
had been e ffec t ive  the a b i l i t y  of the same 3 IgG samples before and 
a f te r  absorption to cause Fc blocking with splenocytes from the 
congenic ra t s tra in  PVG RTlr l was tested. The la t te r  ra t s tra in  is 
haploidentical with DA class I A-locus (RTlAaBcCcDc) , but otherwise 
syngeneic with recip ient PVG MHC. Table 1.12 shows that there was 
minimal in h ib i t io n  of Fc blocking in the absence of RTlBa and RTlDa 
class I I  MHC antigens. These results suggest that in h ib it io n  was 
predominantly mediated by anti-class I I  alloantibody. Since the 
appropriate recombinant ra t stra in expressing RTlBa and RTlDa class I I  
MHC antigens was not available i t  was not possible to tes t d ire c t ly  
whether absorption of DA class I I  MHC antigens alone eliminated Fc 
blocking in these experiments. The conclusion that antibodies to RTlAa 
were not contributing substantia lly  to EA rosette in h ib it io n  was 
supported in a fu rthe r experiment where IgG samples from two more 
enhanced rats were tested fo r in h ib ito ry  a c t iv i ty  against DA,
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Table 1.11
The e ffec t o f absorbing IgG with DA(donor) 
and LEWIS (th ird  party) erythrocytes
% of EAR1 in IgG samples
absorbed with: 
DA LEWIS 
IgG preparation non-absorbed rbc rbc
1 79 87 78
2 93 87 86
3 84 87 87
Table 1.11 Purified IgG preparations from transfused PVG 
rec ip ien ts  o f a DA kidney 5 days a fte r transplantation were 
absorbed with donor (DA) or th ird  party (LEWIS) erythrocytes and 
tested fo r  th e ir  a b i l i t y  to cause EA rosette in h ib it io n  with 
donor spec if ic  (DA) lymphocytes.
Table 1.12
Determination of MHC specificity of IgG alloantibody
% of EARI in IgG preparations 
assayed with lymphocytes of:
IgG preparation DA PVG RTlr l
1. unabsorbed 95 12
absorbed with DA rbc 92 0
2. unabsorbed 86 0
absorbed with DA rbc 88 3
3. unabsorbed 96 8
absorbed with DA rbc 97 0
Table 1.12 Unabsorbed and DA rbc absorbed IgG samples were 
prepared from 3 day 5 enhanced rats and tested fo r  th e i r . a b i l i t y  
to in h ib i t  rosette formation with e ither DA or PVG-RTlr l (which 
shares class I with DA) splenocytes.
PVG,PVG-RTlr  ^ and PVG-RT1a v (RT1AaBaCaDa) lymphocytes. Non-absorbed 
serum was again found to cause high levels of rosette inh ib it ion  
against DA (94% and 98%) and PVG-RTlavl (70% and 75%) lymphocytes, 
but not against PVG-RTl -^  ^ lymphocytes (14% and 10%). Samples were 
absorbed with DA erythrocytes, and PVG-RTlr  ^ splenocytes to confirm 
tha t removal o f anti-c lass I antibodies did not remove Fc blocking. 
Table 1.13 again shows that such absorptions did not s ig n if ica n t ly  
reduce in h ib i t io n  against any of the targets. However absorption of 
the IgG samples with DA splenocytes s ig n if ica n t ly  reduced in h ib it io n  
in one animal (from 94% to 14%) and completely removed in h ib it io n  in 
the other (from 98% to 0%). Taken together these results strongly 
suggest tha t the Fc blocking alloantibody found in enhanced rats is an 
an ti-c lass  I I  IgG alloantibody.
4.8 Fc blocking a c t iv i ty  in the DA to LEWIS s tra in  combination
In the DA to LEWIS stra in combination, rats normally re jec t th e ir  
kidney g ra fts  in 8 days, furthermore donor specific  transfusion given 
7 days before transplant does not usually cause prolongation of 
g ra f t  survival (Fabre and Morris, 1972b). Therefore i t  was interesting 
to see whether Fc blocking antibodies could be detected in LEWIS rats 
which had been transfused with DA blood and had received a DA kidney 
7 days la te r .  Serum was harvested 5 days post-transplant from 3 such 
ra ts and serum fractions and IgG were prepared . The serum fractions 
were tested fo r  th e ir  a b i l i t y  to cause rosette in h ib it io n  with DA 
(donor) and Brown Norway(BN), ( th ird  party) lymphocytes. Despite the
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Table 1.13
Determination of MHC specificity of IgG alloantibody
% of EARI in IgG preparations 
assayed with lymphocytes of:
IgG preparations
absorbed with: DA PVG-RTlr l  PVG PVG-RT11
1. unabsorbed 94 16 0 70
DA rbc 96 0 0 75
PVG-RTl1"1 84 10 8 74
DA splenocyte 14 ND ND ND
2. unabsorbed 98 10 0 75
DA rbc 84 10 8 74
PVG-RTlr l 87 0 10 84
DA splenocyte 0 ND ND ND
Table 1.13 IgG samples which had been absorbed with DA rbc; 
PVG-RTlr * splenocytes(which share class I antigens with DA) or DA 
splenocytes were tested fo r th e ir  a b i l i t y  to in h ib i t  rosette 
formation.with DA (RTla); PVG-RTlr I (RTlAaBcCcDc); PVG (RT1C) and 
PVG-RTla v l(RTlAaBaCaDa) lymphocytes.
F1 F2 F3 F4 F5 F6
Fraction number
Fig 4.7 Fc blocking ac tiv ity  in serum 
fractions from transfused Lewis recipients of 
a DA kidney
Serum was collected from DA transfused LEWIS 
recipients (n=3), 5 days a fte r
transplantation with a DA kidney . The serum 
fractions obtained by discontinuous gradient 
centrifugation were then tested fo r  th e ir  
a b i l i t y  to in h ib i t  rosette formation with 
donor DA (so lid bars) or th ird  party BN (open 
bars) lymphocytes. Results are expressed as 
the median and range fo r  each frac t ion  
tested.
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Fig 4.8 Ability of IgG from transfused Lewis 
recipients of a DA kidney to mediate rosette 
inhibition
Lewis rats (n=3) were given 1.0ml o f DA blood 
on day -7, transplanted with a DA kidney on 
day 0 and serum was collected on day 5 a fte r 
transplantation. Reciprocal d i lu t io ns  of 
IgG(from lOug/well) were tested fo r  th e ir  
a b i l i t y  to in h ib i t  rosette formation with DA 
lymphocytes.
fa i lu re  o f transfusion to prevent re jection , donor specific  rosette 
in h ib i t io n  was found in fractions 3,4 and 5(median values:25%,47% 
and 42% respectively) (Fig 4.7), although these levels were lower than 
those found in the corresponding serum fractions from active ly  
enhanced PVG recip ients. IgG prepared from these rats s im ila r ly  
produced high levels of rosette in h ib i t io n (Fig 4.8). This find ing does 
not ru le  out a ro le fo r anti-class I I  alloantibodies in the induction 
o f enhancement since i t  has been shown that i t  is d i f f i c u l t  to 
passively enhance survival in the DA to LEWIS stra in  combination 
(Fabre and Morris,1972a ;1973).
4.9 Discussion
Despite much debate, the mechanism responsible fo r  the prolonged 
survival o f MHC incompatible organ grafts a fte r p r io r  administration 
o f donor antigens or anti-donor antiserum remains elusive. Some early 
studies addressed the p o ss ib i l i ty  that alloantibodies were 
responsible fo r  prolonged survival of both active ly  and passively 
enhanced ra t renal a llogra fts  (Strom et a l ,1975; Soul i l lo u  et 
a l ,1976; Suthanthiran et a l , 1979). The la t te r  author found that
alloantibody responses were profoundly depressed in passively enhanced 
animals and only appeared 7 days a fte r transplant in animals active ly  
enhanced with donor splenocytes. The lack o f detectable anti-c lass I 
and an ti-c lass I I  in passively enhanced animals confirmed the e a r l ie r  
f ind ing o f Strom that IgG mediated vascu lit is  and glomerulonephritis 
were abolished in passively enhanced animals. A more positive ro le fo r
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antibody in the mechanism of enhancement was postulated by Soulil lou 
et al who provided strong evidence that anti-c lass I I  antibodies alone 
were responsible fo r passive enhancement of ra t renal a l lo g ra f ts .  He 
showed that hyperimmune serum which had been absorbed with red ce lls  
or p la te le ts  and which had no detectable cytotoxic or 
haemagglutinating a c t iv i ty  , was as effec tive  as unabsorbed serum in 
prolonging g ra ft  survival. Furthermore he showed that such sera could 
mediate donor-specific Fc blocking in a rosette in h ib it io n  assay. 
However there was contradictory evidence that the presence of 
antibodies which blocked the Fc receptor on lymphocytes was associated 
with g ra f t  loss ( Suthanthiran, Gailunas, St.Louis et a l , 1977b; 
Suthanthiran, Gailunas, Fagan et a l ,1978)
In th is  study the enhancing effect of blood transfusion on renal 
a l lo g ra f t  survival was found to correlate with the development of 
high levels o f donor-specific FcR blocking a c t iv i ty  in the 
post-transplant serum. When whole serum from enhanced animals was 
separated in to fractions of graded molecular weight and assayed fo r 
FcR blocking a c t iv i ty ,  inh ib it ion  resided in fractions 3-5 which 
contained most of the IgG. The suggestion that anti-donor IgG was the 
predominant FcR blocking factor in ultracentrifuged whole serum was 
supported by the observation that monomeric IgG isolated from 
enhanced serum by n-octanoic acid extraction showed high levels of 
donor-specific Fc blocking a c t iv i ty .  This is in support of the 
c l in ic a l  find ing that non-cytotoxic Fc blocking antibodies develop 
during a course of elective blood transfusions p r io r  to renal 
transplantation and that the presence of such antibodies correlated 
with improved cadaver donor renal transplant survival(MacLeod et
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a l ,1982). However, in another c l in ic a l study of patients given blood 
transfusions p r io r  to renal transplantation (Forwell et a l , 1987), 
subsequent g ra ft  survival correlated not with Fc blocking by the IgG
serum frac t ion  (7S) but instead with the level o f FcR blocking
mediated by a serum factor of high molecular weight (19S). In the 
present study, l i t t l e  blocking a c t iv i ty  could be detected in the (19S) 
f ra c t io n .  The discrepancies in the c l in ic a l  findings may re f le c t  
differences in the assay procedures, but the precise nature and 
s p e c i f ic i ty  of such blocking factors remains unclear.
Early reports on the apparent close association between B 
lymphocyte Fc receptors and class I I  antigens (Dickler & Sachs,1974: 
Suthanthiran, Garavoy, Fagan et a l ,1977) and the pertinent suggestion 
tha t EA rosette inh ib it ion  was mediated en t ire ly  by anti-c lass I I  
a lloantibodies led several groups to use the EA rosette in h ib it io n  
assay as a means of measuring anti-c lass I I  a c t iv i ty  (Sou lil lou et al 
1976; Suthanthiran et al 1979). On the other hand there was
c o n f l ic t in g  evidence in c l in ica l studies about the re lationship 
between Fc blocking and anti-HLA antibodies. Solheim, Thorsby & 
Moller (1976),found that anti-HLA antibodies could cause Fc blocking 
while Sou li l lou  & Peyrat (1979) were unable to f ind Fc blocking 
a c t iv i t y  against DRw determinants on B lymphocytes. However the
previous studies with monoclonal antibodies to class I and I I  MHC 
antigens (Power et a l ,1987) together with the results of th is  study 
suggest tha t inthe ra t antibodies directed against class I antigens 
may also in h ib i t  rosette formation. This may possibly re f le c t  
differences in a f f in i t y  fo r  MHC antigens between monoclonal antibodies 
and antibodies produced by alloimmunisation. I t  is possible that
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an ti-c lass  I antibodies can bind and cause blocking of the FcR in the 
absence o f anti-c lass I I  antibodies which may be of higher a f f in i t y  
and compete fo r  binding.
Nevertheless the finding that absorption o f anti-donor class I 
antibody from enhanced IgG fa iled  to abrogate i t s  FcR blocking 
a c t iv i ty ,  together with the in a b i l i ty  of the IgG from enhanced animals 
to cause EA rosette inh ib it ion  when tested against lymphocytes 
expressing only the donor RTla haplotype both indicated, in d ire c t ly  
that FcR blocking a c t iv i ty  of IgG in enhanced rats was due to 
an ti-c lass I I  alloantibody.
I t  was in teresting that high levels of EA rosette in h ib it io n  
could be induced not only by a renal a l lo g ra f t ,  but also by a second 
blood transfusion. Since a second antigenic stimulus would be expected
to re su lt  in an IgG response and a single challenge to resu lt in an
IgM response, the lack of FcR blocking a c t iv i ty  in re jecting compared 
with enhanced serum, might re f le c t a lower level of c ircu la t ing  IgG. 
This confirms the e a r l ie r  observation by MacLeod et al (1982) of 
increased levels o f FcR blocking a c t iv i ty  a fte r multip le transfusions. 
S im ila r ly ,  Power et a l (1987) found that FcR blocking a c t iv i ty  
developed in the serum of rats as a resu lt of multip le pregnancies, 
but in th is  case they appeared to be directed against class I
antigens alone. A lte rna tive ly  the lack of Fc blocking in the re jecting 
serum may be due to a lack of anti-c lass I I  antibodies. In the
transfused animals such antibodies could cause opsonisation o f donor 
dendr it ic  ce l ls  or masking of antigenic determinants on vascular 
endothelium. In the previous chapter i t  was shown that MHC class I I  
antigens are induced on the endothelium of both re jecting and active ly
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enhanced kidneys which could increase th e ir  susce p tib i l i ty  to attack. 
Furthermore i t  was noted that donor dendrit ic  ce lls  disappeared more 
qu ick ly from the enhanced kidneys.
This studyJ has demonstrated that the a b i l i t y  of donor stra in 
blood transfusion to prevent renal a l log ra f t  re jection in the DA to 
PVG ra t  s tra in  combination correlates with the appearance in the 
post-transplant serum of high levels of donor specific  FcR blocking 
a c t iv i t y ,  most l ik e ly  as a consequence of IgG anti-donor class I I  
antibody. I t  is not clear whether the generation of such alloantibody 
plays a ro le in prolonging g ra ft survival in th is  model, or whether 
the alloantibody response is an epiphenomenon with no d irec t bearing 
on g ra ft  surv iva l. I t  is notable that blood transfusion in the DA to 
Lewis s tra in  also resulted in high levels of EA rosette in h ib it io n  
in the post-transplant serum despite no prolongation of g ra ft
surv iva l. However th is  is consistent with the finding that i t  is 
extremely d i f f i c u l t  to passively enhance the DA to Lewis s tra in  by 
administration o f anti-donor alloantibody (Fabre & Morris, 1972a, 
1973). Further evidence fo r the immunosuppressive effects of 
transplantation induced anti-class I I  alloantibodies, was recently 
provided by Kamada et a l , (1986,1988), who showed that serum from rats 
which spontaneously accept l iv e r  a llog ra fts  was able, a fte r passive 
trans fe r to induce specific unresponsiveness.
In conclusion, the results reported here provide evidence that 
transfusion induced survival of ra t renal a llog ra fts  is  associated 
with the generation of Fc-blocking antibodies which appear to be 
an ti-c lass  I I  alloantibodies. Although such antibodies appear to play 
a ro le in passive enhancement of ra t renal a l lo g ra f ts ,  and
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spontaneous acceptance of ra t l iv e r  a l log ra f ts ,  fu rther investigation 
is  required to determine whether these antibodies might be 
responsible, in part, fo r  the beneficial e ffec t of blood transfusion 
on renal a l lo g ra f t  surviva l.
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CHAPTER 5
ALLOANTIBODY RESPONSES IN ENHANCED AND REJECTING RAT RENAL ALLOGRAFT
RECIPIENTS
5.1 Introduction
In the previous chapter i t  was shown that blood transfused rats 
bearing a non-rejecting renal a l lo g ra f t  had high levels of FcR 
blocking a c t iv i ty  in th e ir  serum 5 days a fte r transplantation. This 
FcR blocking a c t iv i ty  was attr ibu tab le  mainly to anti-c lass I I  
a lloantibody, suggesting that there are important differences in the 
nature and timing of the alloantibody responses to a renal a l lo g ra f t  
in transfused and non-transfused recipients.
There are no detailed comparisons of the alloantibody response to a 
kidney a l lo g ra f t  in blood transfused and unmodified ra ts, although 
there are a number of such studies in passively enhanced rats ( Strom 
et a l ,1973; Suthanthiran et a l ,1979). Strom et al found that the 
lymphocytotoxic antibody response was s im ilar in both unmodified and 
passively enhanced renal a l log ra f t recip ients. However, Suthanthiran 
reported that passively enhanced rats showed a minimal anti-c lass I I  
(measured by Fc blocking) and a weak an ti-c l ass I response 
(measured by haemagglutination and lymphocytoxicity). In teresting ly , 
th is  study also showed that rats in which active enhancement was 
induced by preoperative in jection with donor spleen ce lls ,  did not 
develop a detectable alloantibody response u n t i l  7 days a fte r 
transplantation. Other studies in both humans and rats have suggested 
that repeated transfusions , may lead to a reduction in alloantibody 
levels.(Opelz et al,1981;Fabre and Morris,1972b ; Lenhard et
a l ,1985).
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Since transfusion-induced a lterations in the nature of the 
alloantibody response to a renal a l lo g ra f t  may be of relevance to 
enhancement i t  was decided to undertake a detailed analysis of the 
alloantibody response of unmodified and transfused PVG rats to a renal 
a l lo g ra f t .
5.2 Kinetics of antibody response to class I antigens in enhanced and 
rejecting rats
The k ine tics  of the antibody response to DA class I antigens was 
measured in unmodified (re jecting) and transfused (enhanced) PVG
recip ients of DA a llog ra fts . Enhanced recipients were transfused with 
1.0ml o f DA blood on day -7 and along with unmodified recip ients were 
transplanted with a DA kidney on day 0. Rats were bled s e r ia l ly  on
days 1,3,5,7 and 10 from the ta i l  vein. Sera were heat-inactivated at
56°C fo r  30 mins , aliquoted and frozen at -70°C before use.
Quadrupling d i lu t io ns  of the antisera were incubated in duplicate 
with PVG.RTI3 red ce lls  which express only class I but not class I I  
antigens of the donor. Furthermore they express the same minor
antigens as the rec ip ient so a l l  of the antibody a c t iv i ty  is directed 
against class I MHC. The amount of antibody bound was then detected by 
the addition of a 125I labelled sheep a n t i- ra t  Ig antibody.
Background binding of the second antibody was measured by incubating
red ce l ls  with DAB. Results are expressed e ither in cpm with
background adjusted or as a percentage of a hyperimmune serum control
which was present in a l l  assays .
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The k ine tics  of the antibody response to class I MHC antigens can be 
seen in Fig 5.1 and 5.2. In Fig 5.1 the mean cpm is expressed as a 
percentage of the hyperimmune serum control, since test sera were not 
a l l  assayed on the same day. In unmodified rats an anti-c lass I 
response was detectable on day 5 a fte r transplantation and increased 
therea fter to 50% of the hyperimmune serum on day 10 a fte r 
transplantation . In contrast, transfused rats bearing an enhanced 
kidney fa i le d  to show a detectable anti-c lass I alloantibody response 
during the f i r s t  10 days a fte r transplantation. In Fig 5.2 individual 
curves are shown fo r enhanced and re jecting rats 5 days a fte r 
transplantation and results are expressed as cpm since a l l  the test 
sera were assayed simultaneously.
5.3 Kinetics of antibody response to class I in rats following single 
or double transfusion
In order to determine whether the lack of anti-c lass I in the serum 
o f enhanced animals was due to fa i lu re  to generate an antibody 
response, or due to absorption of antibody by the g ra ft ,  the levels of 
an ti-c lass I following single or double transfusion were measured. 
Seven PVG rats were given 1.0ml of DA blood i . v .  on day 0, three of 
which were given a second transfusion on day 7. Rats in both groups 
were bled s e r ia l ly  on days 7,8,10,12 14 and 17 a fte r the f i r s t  
transfusion. The k inetics of the anti-c lass I response are shown in 
Fig 5.3. The levels of response in both groups were s im ila r on day 7. 
The anti-c lass I a c t iv i ty  reached a peak in the single transfusion
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Fig 5.1 Kinetics o f antibody response to 
class I MHC antigens in the serum o f enhanced 
and re jec ting  PVG recip ients o f a DA kidney. 
Serum was collected from enhanced (n=3) and 
re jecting (n=3) PVG rats on days 0,3,5,7 and 
10 a fte r transplantation. Quadrupling 
d ilu t ions  of enhanced (open c irc le s )  and 
re jecting (open tr iangles) sera were tested 
fo r anti-c lass I a c t iv i ty  . The mean cpm at 
each d i lu t io n  is expressed as a percentage of 
the hyperimmune serum control.
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Fig 5.2 Antibody response to class I MHC 
antigens in the serum o f enhanced and 
re jecting rats 5 days a f te r  transplantation
Serum was harvested from four enhanced (so lid  
lines) and four re jecting (dashed lines) PVG 
rats 5 days a fte r transplantation with a DA 
kidney, and tested fo r  anti-c lass I a c t iv i ty .
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Fig 5.3 Kinetics o f antibody response to 
class I MHC antigens in PVG rats fo llowing 
single or double transfusion
PVG rats (n=6) were given 1.0ml o f DA blood 
on day 0, and three were given a second 
transfusion on day 7 . Both groups of rats
were bled on days 7,8,10,12,14 & 17 a fte r  the 
f i r s t  transfusion and the antibody response 
to class I MHC measured. The mean peak 
response is expressed as a % of the 
hyperimmune serum control fo r  the single 
transfusion group (open c irc le s )  and the 
double transfusion group (open tr ia ng le s ) .
group on day 8 a fte r transfusion (13% of the HI serum) while levels in 
the double transfusion group fe l l  to 4% of the HI serum contro l. The 
an ti-c lass  I a c t iv i ty  in the single transfusion group declined rapid ly 
between days 8 and 17 to 2% of the HI control and in the DT group fe l l  
to 1% of the con tro l. The second transfusion does not appear to 
provoke a secondary response and the primary response produces only 
low levels of antibody compared to those found in the re jecting ra ts.
5.4 Absorption o f serum with erythrocytes to remove anti-c lass I 
a c t iv i t y
Since there is no cell type in the ra t which expresses only class I I  
MHC antigens and there are no congenic strains which have the 
appropriate haplotype at the class I I  loci (RTlBa,Da), an ti-c lass I I  
antibody levels could not be assayed d ire c t ly .  Anti-class I a c t iv i ty  
was therefore removed by absorbing with DA red ce lls  and the resulting 
sera were then tested fo r antibodies to RTlBaDa by measuring binding 
to RTla LNC. Preliminary studies were carried out to find out how many 
absorption steps were required to remove the anti-c lass I a c t iv i ty  
from the day 10 samples which had been found to contain the most 
a c t iv i ty .  Two successive absorptions fo r 1 hr at 4°C with equal 
volumes o f packed DA erythrocytes at 4°C were found to remove only 50% 
o f the anti-class I a c t iv i ty ,  but the remaining a c t iv i ty  was
eliminated by a further 2 absorption steps (Figs 5.4a and 5.4b). To 
confirm that absorption with DA red ce lls  was not removing any of the 
anti-c lass I I  antibody ( by binding to contaminating leucocytes), two 
day 10 sera were absorbed with e ither DA (RTla)or PVG.RTlr l  red
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Fig 5.4 Antibody response to class I MHC 
antigens in serum before (a) and a fte r (b) 
absorption with DA erythrocytes.
Serum was harvested from enhanced (n=3) and 
re jecting (n=3) rats 10 days a fte r 
transplantation. Enhanced (broken lines) and 
re jecting (solid lines) sera were tested fo r 
antibody to class I MHC antigens before(a) 
and after(b) absorption with DA erythrocytes.
c e l ls .  Any contaminating leucocytes have the RTlAaBcCcDc haplotype and 
therefore w i l l  not bind antibody to RTlBaDa. Absorption decreased
a c t iv i t y  s l ig h t ly ,  probably as a result of d i lu t in g  the sample out
(the f in a l volume was generally twice that of the s tart ing  volume ). 
However there was l i t t l e  difference between the binding o f DA red cell 
absorbed and the PVG.RTlr  ^ red cell absorbed sera to PVG.RTla
LNC,(Figs 5.5a and 5.5b),so absorption is not removing notable amounts 
o f an ti-c lass I I  antibody.
5.5 K inetics o f antibody response to class I I  MHC antigens in  enhanced 
and re jec ting  rats
The antibody response to class I I  MHC antigens was measured in 3 
enhanced and 3 re jecting rats on days 1,3,5,7 and 10 a fte r
transplantation. A ll test sera were assayed simultaneously and the 
resu lts  are expressed as cpm after adjustment fo r background counts. 
The levels o f background counts were high (1000-2000 cpm),due to the 
binding o f the second antibody to immunoglobulin on B ce lls  . The mean 
cpm fo r  each d i lu t io n  in both groups was calculated . Fig 5.6 shows 
the binding curves fo r days 1,3,5 and 7 a fte r transplantation. I t  can 
be seen that on day 1 a fter transplantation levels o f an ti-c lass I I  Ab 
were s l ig h t ly  higher in the enhanced than in the re jecting group . By 
day 3 , levels in the enhanced serum had risen from 1700cpm to  3000cpm 
and there was three times the amount o f anti-c lass I I  Ab compared 
w ith the re jecting serum.The level of anti-c lass I I  Ab stayed around 
the same in the enhanced group on days 5 and 7 while in the re jec ting
139
cpm
4 0 0 0
R2
3000
2000
1000
4 64 1024 4 64 1024
reciprocal dilutions of serum
Fig 5.5 Comparison of the antibody response 
to class I I  MHC antigens in the serum o f rats 
a fte r absorption with DA or PVG.R1 red ce lls
Serum was collected from two PVG rats R1 (a) 
and R2 (b), 10 days a fte r  transplantation 
with a DA kidney. Unabsorbed ( open 
tr iang les), DA red ce ll absorbed (open
squares) and PVG.R1 red ce ll absorbed (open 
c irc les) sera was tested fo r  anti-c lass I I  
antibody a c t iv ity .
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Fig 5.6 Kinetics of antibody response to 
class I I  MHC antigens in enhanced and 
re jecting PVG recipients o f a DA kidney
Serum was harvested from enhanced (n=3) and 
rejecting (n=3) PVG rats on days 1,3,5 and 7 
following transplantation with a DA kidney. 
Enhanced (open c irc les) and re jec ting  (open 
triangles) sera were then tested fo r 
anti-class I I  antibody a c t iv i ty .
group the levels steadily rose. By day 10 the levels of an ti-c lass I I  
Ab were s t i l l  r is ing  in both groups,with levels s im ilar in each group: 
the mean peak level in the enhanced group was 3825 cpm compared with 
3828 cpm in the re jecting group. The day 5 sera were assayed again 
with four sera in each group which confirmed that levels of 
an ti-c lass I I  antibodies were considerably higher in the enhanced 
group compared with the rejecting group (Fig 5.7). The s p e c if ic i ty  of 
the antibody response was confirmed by testing serum from 3 enhanced 
and 3 re jecting rats 10 days a fter transplantation against th ird  
party (Lewis) LNCs.There was no net binding above background of day 
10 sera (results  not shown). IgG samples prepared by n-octanoic acid 
p rec ip ita t ion  from enhanced (n=4) and re jecting (n=4) PVG rats 5 days 
a f te r  transplantation with a DA kidney were tested fo r anti-c lass I I  
Ab a c t iv i ty .  The IgG samples at lmg/ml were absorbed with DA red ce lls  
as before and 50ul of doubling d ilu t ions assayed as usual. I t  can be 
seen in Fig 5.8 that IgG from enhanced rats had twice as much 
an ti-c lass I I  as IgG from rejecting rats.
5.6 Kinetics of anti-class I I  response following single or double 
transfusion
The levels of anti-c lass I I  antibody present in the single and double 
transfusion group described previously were also measured on days 8,10 
12 14 and 17 a fte r the f i r s t  transfusion. As with the anti-c lass I
response i t  appeared that the second transfusion did not evoke an 
immediate secondary response, though the levels of an ti-c lass I I  Ab
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Fig 5.7 Antibody response to class I I  MHC 
antigens in the serum o f enhanced and
rejecting rats 5 days a fte r  transplantation
Serum was harvested from four enhanced (so lid  
lines) and four re jecting (dashed lines) rats 
5 days after transplantation and tested fo r  
anti-class antibody a c t iv i ty .
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Fig 5.8 Antibody response to class I I  MHC 
antigens in IgG samples from enhanced and 
rejecting rats
IgG was prepared by n-octanoic acid 
prec ip ita tion from serum obtained from 
enhanced (n=4) and re jecting (n=4) PVG rats 5 
days a fte r transplantation with a DA kidney. 
Doubling d ilu tions of enhanced (so lid  lines) 
and rejecting (dotted lines) IgG(from 
50ug/well) were then tested fo r  anti-c lass I I  
antibody a c t iv i ty .
were r is in g  8 days after the second transfusion (Fig 5.9). The 
an ti-c lass I I  response in the double transfusion group was barely 
detectable immediately after the second transfusion, possibly due to 
absorption of antibody by the transfused blood. Levels of an ti-c lass 
I I  were maximal in the single transfusion group 14 days a fte r  the 
f i r s t  transfusion (33% of the HI serum control) while in the double
transfusion group they were maximal on day 17 a fte r the f i r s t
transfusion (12% of the HI serum contro l).
5.7 Cytotoxic antibody response in enhanced and re jecting rats
Serum was collected from enhanced(n=3) and rejecting(n=3) rats on 
days 1,3,5,7 and 10 as described for the alloantibody assays.Doubling 
d i lu t io n s  of anti sera were tested fo r complement-dependent 
c y to to x ic i ty  against DA con A blasts in the presence of guinea-pig 
serum. The k inetics of cytotoxic antibody production are shown in Fig 
5.10. On day 1 a fte r transplantation there was no detectable cytotoxic 
antibody in the re jecting sera while in the enhanced sera there was a 
peak response of 28% k i l l in g .  By day 3 levels of cy to tox ic ity  had 
risen to 28% in the rejecting rats while in the enhanced rats levels 
had fa l le n  to 18%. There was no change in cytotoxic antibody levels in 
the enhanced rats on day 5 , however in the re jecting rats the %
c y to to x ic i ty  had risen to 50%. There was l i t t l e  change on day 7 and
and 10 in the levels of k i l l in g  in the enhanced group, but levels 
continued to r ise  un t i l  day 10 in the re jecting group(not shown).
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Fig 5.9 Kinetics o f antibody response to 
class I I  MHC antigens in rats following 
single or double transfusion 
PVG rats (n=6) were given 1.0ml o f DA blood 
on day 0 , 3 of which were given a second
transfusion on day 7. The single(open 
c irc les) and double (open squares) 
transfusion groups were bled on days 
8,10,12,14 and 17 and antibody to class I I  
MHC antigens was measured. The mean peak 
response is expressed as a % of the 
hyperimmune serum con tro l.
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Fig 5.10 Kinetics of complement dependent 
cytotoxicity response in enhanced and 
rejecting PVG recipients of a DA kidney
Serum was collected from enhanced(n=3) and 
rejecting (n=3) PVG rats ,5 days a fte r 
transplantation with a DA kidney. Doubling 
d ilu t ions of enhanced (so lid  c irc les ) and 
rejecting (open circ les)sera were tested fo r 
cytotoxic antibody against DA blasts in the 
presence of guinea pig complement. Results 
are expressed as the % cy to tox ic ity .
There is  some evidence that the complement system in the ra t is 
not as e ffec t ive  as in other species ( French and Batchelor,1972), so 
i t  was important to establish whether the sera were also cytotoxic in 
the presence of recip ient ( PVG) serum. Serum was collected from 
enhanced (n=3) and rejecting (n=3) rats 5 days a fte r transplantation. 
The assay was performed essentially as before, however lOOul of a 1:4 
d i lu t io n  o f fresh PVG serum was added instead of guinea pig 
complement. The sp e c if ic ity  of the cytotoxic antibody response was 
also examined by using PVG.RTlr * con A blasts as targets along with DA 
blasts. In Fig 5.11 i t  can be seen that levels of cy to tox ic ity  
against DA con A blasts in the presence of guinea pig serum were 
higher in the 3 re jecting rats than the 3 enhanced rats as was shown 
before. However i f  fresh PVG serum was added there were only low 
leve ls o f cytotoxic antibody detectable in each group,the most 
dramatic reduction being in the re jecting group (Fig 5.12 ).
In te res ting ly , when the sera were assayed fo r complement dependent 
c y to to x ic i ty  in the presence of guinea pig complement, against 
PVG.RTlr *blasts(which share class I but not class I I  with DA), levels 
o f cy to to x ic i ty  in the rejecting group were the same as against DA 
blasts. However in the enhanced group there was no cy to tox ic ity  
against PVG.RTlr l  blasts, suggesting that any cy to tox ic ity  in th is  
group is  directed at class I I  MHC antigens( Fig 5.13 ).
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Fig 5.11 A b i l i ty  of serum from enhanced and 
re jecting rats to mediate complement 
dependent cy to tox ic ity
Serum was collected from enhanced (n=3) and 
rejecting(n=3) PVG rats 5 days a fte r
transplantation with a DA kidney. Doubling
d ilu t ions of sera were tested fo r  complement 
dependent cy to tox ic ity  against DA con A
blasts in the presence o f guinea pig
complement.
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Fig 5.12 A b i l i ty  o f serum from enhanced and
re jecting rats to mediate complement
dependent cy to tox ic ity  in the presence o f PVG 
serum
Serum was collected from enhanced (n=3) and 
re jecting (n=3) PVG rats 5 days a fte r
transplantation with a DA kidney . Doubling 
d ilu t ions  of sera were tested fo r complement 
dependent cy to tox ic ity  against DA con A
blasts in the presence of PVG serum.
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Fig 5.13 A b i l i ty  o f serum from enhanced and 
re jecting rats to mediate complement 
dependent cy to tox ic ity  against PVG.R1 blasts
Serum was collected from enhanced (n=3) and 
re jecting (n=3) PVG rats 5 days a fte r 
transplantation with a DA kidney. Doubling 
d ilu t ions  of sera were tested fo r complement 
dependent cy to tox ic ity  against PVG.R1 con A 
blasts in the presence o f guinea pig serum
5.8 Measurement of IgG and IgM in alloantibody response
A three-layer binding assay was used to detect the antibody class 
produced in response to either class I or class I I  MHC antigens. 
Briefly,equal volumes of serum samples from enhanced (n=3) and 
re jec ting  (n=3)rats on various days following transplantation were 
pooled. These were diluted 1:2 and were incubated in t r ip l ic a te  with 
e ithe r DA red ce lls  or LNC as for the alloantibody assay. Then a 
b io tiny la ted  anti-IgG or anti-IgM antibody was added at a 
pre-determined optimum d i1ution(1:50). The amount of second antibody 
bound was then detected by the addition of ^ I - l a b e l l e d  streptav id in . 
The % binding was then calculated fo r each serum sample.
Clearly the % binding is also a re f lec t ion  of the amount of 
an ti-c lass I or anti-class I I  antibody binding in the f i r s t  step.
However a comparison can be made about the amount of IgG re la t ive  to
the amount of IgM at a particu lar time point. Fig 5.14 shows the IgG 
and IgM components of the anti-class I response in enhanced and 
re jec ting  ra ts. The % binding was higher in the re jecting rats than 
in the enhanced rats as would be expected from the previous 
alloantibody results. The main component of the anti-c lass I response 
in the enhanced rats was IgG which was highest on day 3 post
transplant. There was a drop in serum IgG and IgM on day 5 post
transplant possibly as a result of absorption by the kidney which is
expressing large amounts of class I at th is  time.Thereafter the levels 
o f both IgG and IgM rose steadily un ti l  day 10 post-transplant. In the
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Fig 5.14 IgG and IgM component o f the 
antibody response to class I MHC antigens in 
enhanced (a) and re jecting (b) rats 
Sera were collected from enhanced (n=3) and 
rejecting (n=3) PVG rats on days 3 ,5 ,7 ,and 10 
afte r transplantation. These were pooled to 
give one sample fo r each group on each day. 
After incubation with DA red ce lls  
biotinylated anti-IgG or anti-IgM was added 
followed by 1 I -1abel1ed streptav id in . 
Results are expressed as % binding.
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Fig 5.15 IgG and IgM component o f the 
antibody response to class I I  MHC antigens in 
enhanced (a) and re jecting (b) rats 
Sera were collected from enhanced (n=3) and 
rejecting (n=3) PVG rats on days 1,5,7 and 10 
a fter transplantation. These were pooled to 
give one sample fo r each group on each day. 
After incubation with DA red ce lls  , 
biotinylated anti-IgG or anti-IgM was added 
followed by 1 I -1abel1ed streptavid in . 
Results are expressed as % binding.
re jec ting  rats on day 3 after transplantation only IgM was detected, 
the levels of which reached a peak on day 7 post-transplant. IgG was 
detected on day 5 post-transplant but by day 7 levels had increased 
greatly  and were equal to the levels of IgM .
The IgG and IgM components of the an ti-c l ass I I  response o f enhanced 
and re jecting rats can be seen in Fig 5.15 respectively. Despite 
high levels of background binding of a n t i- ra t  IgG (to Ig on B ce lls )  
there was s t i l l  net binding of IgG. The % binding to enhanced and 
re jec ting  animals was again indicative of the levels of an ti-c lass I I  
o r ig in a l ly  present. The majority of the antibody present in the 
enhanced animals was of the IgG class . On days 1,5,7 and 10 a fte r 
transplantation the % of IgG binding compared with IgM in the enhanced 
group was 35% vs 10%; 61% vs 12%; 60% vs 11% and 56% vs 10%,
respectively. In the rejecting animals IgG was detected as early as 
day 3 a fte r transplantation but levels dropped on day 5 and rose again 
on days 7 and 10. Levels of IgM were e ither equal or s l ig h t ly  less
than IgG on a l l  days tested. The % binding of both IgG and IgM on days
7 and 10 was not as high as would have been expected from the e a r l ie r  
Class I I  results .
5.9 Discussion
Previous studies on the blood transfusion e ffec t have not made a 
detailed study of the alloantibody response in transfused and
unmodified recipients following transplantation. Antibody has not 
been thought to be important in the mechanism of active enhancement,
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with the demonstration of suppressor ce lls  by a number o f groups, 
(Hutchinson ,1986 ; Quigley et a l , 1989a,b,c). Attempts to transfer 
suppression with serum have had varying degrees of success
(Tilney & B e l l ,1974 ) . Since IgG antibodies directed e ithe r at
class I or class I I  are able to transfer passive enhancement, i t  
seemed reasonable that active enhancement could be due to the 
presence of IgG antibodies induced by blood transfusion and therefore 
present at the time of grafting. As discussed in the previous chapter 
such antibodies could either in terfere with host sensitisa tion by 
removal o f dendrit ic  cells from the g ra ft or by binding to endothelium 
thereby blocking allorecognition and preventing vascular damage by any 
a lloactivated host ce lls .
Both anti-c lass I and anti-class I I  antibodies were measured s e r ia l ly  
fo llowing transplantation in enhanced and re jecting ra ts . In the DA to 
PVG stra in  combination enhanced animals had low levels of anti-c lass 
I compared with re jecting animals. I t  was thought that th is  might be 
due to absorption of antibodies by the g ra ft  but unfortunately 
animals were not bled before transplant in the transfused alone group. 
However the finding that there were high levels of an ti-c lass I 
antibody in the re jecting rats was in teresting since PVG has been 
shown to be genetically a low responder to RT1A (Butcher, Corralan, 
Licence et a l, 1982 ). The la t te r  authors showed that when splenocytes 
from PVG.RTlr l  ra ts( bearing an isolated class I d isp a r ity )  were 
injected into PVG rats there was a poor cytotoxic antibody response 
compared with PVG rats which had received splenocytes from a DA ra t 
( f u l l  MHC mismatch). Further experiments suggested that th is  defect in
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responsiveness to class I was due to an I r  gene e ffec t in the 
responder which could be overcome by help in the response to class I I .  
Therefore the lack of response to class I in enhanced animals could 
re su lt  from the removal of the class I I  stimulus necessary to provide 
help fo r  anti-c lass I antibody synthesis. A simpler explanation might 
be that the high amounts of class I MHC antigen presented by the blood 
resu lt in high-zone tolerance either at the B or T ce ll leve l. However
there are a number of reports which suggest that the antibody response
to MHC antigens (induced by splenocyte in jec t ion) in other ra t s tra in  
combinations is also directed mainly at class I I  MHC antigens (Gallico 
& Mason,1978; McKenzie,Fabre & Morris, 1980).
Single transfusion with donor blood also produced a poor anti-c lass 
I response, again suggesting that there may be some form of high-zone 
tolerance. A second transfusion led to fu rther reduction in the 
anti-c lass I response possibly as a resu lt of absorption . However 
antibody levels did not pick up and i t  could be that existing
antibody formed immune complexes with newly injected red ce lls
thereby preventing antigen from binding to memory ce lls  and tr iggering  
a secondary response. A lternative ly i t  has been suggested that the 
reduction in antibody levels found a fte r repeated blood transfusions 
is  mediated by suppressor cells (Lenhard et a l ,1985).
The anti-c lass I I  response found in the DA to PVG stra in  combination 
confirms the results of the previous chapter where i t  was postulated 
that Fc blocking antibodies found in enhanced rats were in fact 
anti-c lass I I  antibodies. High levels of an ti-c lass I I  antibodies were 
detected in the enhanced group compared with the re jec ting  group on
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day 5 a fte r transplantation,though levels in the re jec ting  group 
equalled those in the enhanced group by day 10 . Most o f the
a c t iv i ty  in the enhanced rats was of the IgG class while in the
re jec ting  rats there was l i t t l e  IgG as shown in binding studies. I t
should be noted , that i f  such antibodies are involved in the
induction of the enhanced state then the animals in the unmodified 
group are already rejecting the ir  grafts by the time the levels have 
risen to those found in the serum of enhanced ra ts . When IgG samples
prepared from enhanced and re jecting rats 5 days a fte r
transplantation were tested for anti-c lass I I  a c t iv i ty  a s im ila r
pattern was found . Only one of four re jecting IgG samples had
detectable antibody to class I I  MHC antigen while a l l  four enhanced 
IgG samples had high levels (2000cpm) of a c t iv i ty  at the optimum
d i lu t io n .  Double transfusion did not evoke such a good antibody
response but actually led to a reduction in anti-c lass I I  levels a fte r
the second transfusion. Such a reduction in alloantibody a fte r
m ult ip le  blood transfusion has been observed in humans (Opelz et 
a l ,1981 ) and in rats ( Fabre & Morris, 1972; Lenhard et al 1985).
The appearance of cytotoxic antibody in the re jecting and enhanced 
groups seemed to correlate with the appearance of antibody to class I 
and class I I  MHC antigens respectively. This was confirmed by 
measuring cytotoxic antibody levels against PVG.RTlr  ^ targets bearing 
an isolated class I d isparity , which showed high levels of k i l l i n g  
(comparable to those obtained against DA targets), while enhanced 
sera fa iled  to k i l l  PVG.RTlr l  blasts. This suggests that the high 
levels of cytotoxic antibody seen in the re jecting group are mainly
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anti-c lass I .  However i t  seems unlike ly that the presence of such 
antibodies in the rejecting rats, but not in the enhanced rats is  the 
cause of re jection . When normal PVG serum was used as a source of 
complement no k i l l in g  of donor blasts was seen. This confirms the 
e a r l ie r  observation by French and Batchelor,1969 that rats treated 
with hyperimmune serum, which would normally cause enhancement, 
rejected th e ir  grafts i f  injected with guinea pig complement. However 
th is  find ing does not rule out the p o s s ib i l i ty  of such antibody 
mediating damage in vivo via an ADCC type of mechanism.
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CHAPTER 6
ABILITY OF SERUM FROM ENHANCED AND REJECTING RAT RENAL ALLOGRAFT 
RECIPIENTS TO INHIBIT THE DONOR-RECIPIENT MLR
6.1 Introduction
The mixed lymphocyte reaction (MLR) in which T ce lls  are stimulated 
to p ro l i fe ra te  in response to allogeneic ce l ls ,  provides a model of 
c e l lu la r^a llo re a c t iv ity  which may, to some extent, be taken as an in 
v i t ro  correlate of graft re jection (Hayry and Defendi,1970). In 
general the ra t MLR is the result of CD4+T ce lls  responding to 
allogeneic class II(Green & Jotte,1985), though there is  increasing 
evidence that CD8+ can be activated to alloantigen in v i t ro (  Mason & 
Simmonds,1988). Previous studies in the ra t have shown that lymphoid 
ce l ls  from blood-transfused animals may, depending on the lymphoid 
compartment and time after transfusion,show reduced p ro l i fe ra t io n  in 
response to donor allogeneic ce lls ( Quigley et a l ,1988; 1989a,b,c ). 
Moreover the addition of lymphoid ce lls  as "regulator" ce l ls  to a 
normal allogeneic MLR may cause a decrease in p ro l i fe ra t io n  ind icating 
that blood transfused animals contain ce lls  with "in  v i t ro "  suppressor 
a c t iv i ty .
I t  is well known that alloantibody may in some circumstances in h ib i t  
the MLR,for example monoclonal antibody to class I I  antigens have been 
shown to in h ib i t  the allogeneic MLR (Green & Jotte,1985). In the 
previous chapter i t  was demonstrated that blood transfused PVG animals 
developed a more rapid alloantibody response to kidney donor (DA) 
class I I  MHC when compared to non-transfused g ra ft  recip ients . I t  
was therefore of interest to examine whether th is  difference would be 
re flected in the a b i l i t y  of serum from transfused and unmodified rats 
to in h ib i t  the allogeneic MLR.
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6.2 Determination of optimal conditions in the DA to PVG MLR
I n i t i a l  experiments were performed to determine the optimal 
conditions fo r the DA to PVG MLR. Normal PVG splenocytes and LNC at a 
concentration of 4x10^, were cultured with 4x10^ irrad ia ted (2000R) 
DA (DA*) spleen cells  over a period of 5 days in order to determine 
which responder population gave the greatest p ro l i fe ra t iv e  
response. In th is  particu lar experiment the ce lls  were cultured in 10% 
FCS. A consistent finding was that PVG LNC underwent a greater and 
more sustained p ro l i fe ra t ive  response than PVG spleen ce lls  (Fig 6.1).
The kinetics of the response were quite d if fe re n t fo r  spleen and
LNC responders. The maximum p ro life ra t ion  of splenocytes occured at 
48hrs and decreased thereafter while peak p ro l i fe ra t io n  of the LNC 
occured a fte r 96hrs in culture. The reason fo r the reduced and early 
response of spleen cell responders is not clear. On the basis of
these experiments PVG lymph node cells  were used as responder ce lls
in a l l  subsequent experiments.
To determine the optimal concentrations of responder and 
stimulator ce lls  d if fe ren t cell numbers and ra tios were added to the 
wells. Plates were pulsed with luCi of ^H-TdR at 24,48,72,96,120 and 
144 hrs a fte r in i t ia t io n  of culture. Fig 6.2 (a-d) shows the
p ro l i fe ra t iv e  response with time when LNC responders (0.5-4 x 105) 
responders were added to the cultures. I t  can be seen that there is  a 
steady increase in p ro life ra t ion  with increasing numbers of both 
responders and stimulators. Maximum p ro li fe ra t io n  was achieved when
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Fig 6.1 Comparison o f PVG splenocytes and 
lymph node ce lls  as responder ce l ls  in the 
DA* x PVG MLR
PVG splenocytes or lymph node ce lls  (at 
4x l0vwe ll)  were cultured with 4xlOb 
irradiated DA spleen stimulator c e l ls /w e l l . 
Cultures were pulsed fo r  18hrs with ^H-TDR( 
luCi/well) at 48,72,96 and 120 hrs a fte r  
in i t ia t io n  of the cu ltu re . Results are 
expressed as cpm.
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Fig 6.2 Kinetics of p ro l i fe ra t io n  in the DA* x PVG 
MLR
Various concentrations of PVG responder LNC were 
cultured with 0.5(asterisk),l(opep c ir c le ) ,  
2(open square), or 4(open tr iang le )x lO D irrad ia ted 
DA stimulator ce l ls .  Cultures were pulsed fo r 
18hrs with 3H-TDR (luC i/w e ll)  at 24,48,72,96,120 
and 144 hrs a fte r the in i t ia t io n  o f the culture. 
Results are expressed as cpm.
4x10^ responders and 4x10^ stimulators were cultured together (R:S 
ra t io  o f 1:1). The peak p ro l i fe ra t ive  response was again found to be 
96hrs a fte r the in i t ia t io n  of the c u l tu re .( Fig 6.2d)
I t  was f e l t  that i t  might be more physiological i f  MLR experiments 
were established in homologous ra t serum rather than FCS.A DA to PVG 
MLR was set up as before in the presence o f e ithe r 5% heat 
inactivated FCS or 5% heat inactivated normal PVG serum. Cultures 
were pulsed 72,96 and 120 hrs a fte r the in i t ia t io n  of cu ltu re . Again, 
maximum p ro l i fe ra t ion  occured when 4x10^ responders and stimulators 
(R:S,1:1) were cultured fo r 96 hours. However there was a s tr ik in g  
difference in the levels of p ro l i fe ra t ion  between responders cultured 
in foetal c a l f  serum(FCS)(Fig 6.3a) and those cultured in normal ra t 
serum (Fig 6 .3b).At the peak of the response counts obtained in FCS 
(188xl0^cpm) were three times higher than obtained in normal ra t serum 
(60xl0^pm). However the levels of background counts obtained when 
responders were cultured alone were decreased from 18,000cpm in FCS to 
35cpm in normal ra t serum. This implies e ithe r tha t the FCS was 
mitogenic or that there was some inh ib ito ry  factor in the normal ra t 
serum or possibly a combination of these effec ts . Since the levels of 
background obtained were lower with ra t serum and levels of 
p ro l i fe ra t io n  were s t i l l  good , i t  was decided to carry out a l l  future 
experiments in 5% homologous ra t serum.
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Fig 6.3 Comparison o f foetal c a l f  serum(FCS) 
and normal ra t serum (NRS) in the DA*xPVG MLR
4xl05 PVG respopder/well were cultured with 
0 .5 ,1 ,2 ,or 4xlOb irradiated DA stimulator 
ce lls  in medium containing e ither 5% FCS (a) 
or 5% -NRS (b). Wells were pulsed fo r  18nrs 
with 3H-TDR(luCi/well) at 72,96 and 120 hrs 
a fte r the in i t ia t io n  of the cu ltu re .
6.3 A bility  of serum from enhanced and rejecting rats to inh ib it the 
donor-specific proliferative response
Serum was obtained from unmodified and transfused PVG recip ients 5 
days a fte r transplantation with a DA kidney. The tes t serum was 
heat-inactivated, s te r i le - f i l te re d ,  and then frozen down in small
aliquots at -70°C . Doubling d ilu t ions  of each tes t serum sample,
s ta rt ing  at 5% (v/v) were then added to a DA* x PVG MLR. In order to 
compensate fo r those cultures containing less than 5% tes t serum 
appropriate amounts of normal ra t serum were added such that a l l  
cultures contained a to ta l of 5% rat serum. Control MLRs were set up 
in 5% PVG serum. Cell concentrations o f 4x10^ ce lls  per well o f both 
responders and stimulators were used and ce lls  harvested at 72 and 
96hrs a fte r the in i t ia t io n  of the cu lture. The results o f one such 
t i t r a t io n  are shown in Fig 6.4. Both enhanced serum samples displayed 
substantial inh ib ito ry  a c t iv i ty  while the re jecting serum samples
showed less in h ib it io n . When th is  experiment was repeated with two 
fu rthe r serum samples in each group levels of in h ib it io n  obtained with 
enhanced serum were s ig n if ica n t ly  higher than those obtained with
re jecting serum Fig 6.5 (p<0.05 ).
Following the demonstration in the previous set o f experiments that 
enhanced, and to a lesser extent re jecting sera can appreciably 
in h ib i t  the p ro l i fe ra t ive  response of the DA*xPVG MLR, the s p e c if ic i ty  
o f th is  inh ib ito ry  effect was investigated. Serum samples 3 and 4 
were added to the DA stimulated and Lewis-stimulated PVG MLR. The MLRs 
were performed simultaneously under optimal conditions and the plates
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Fig 6.4 Effect of t i t r a t in g  enhanced and 
re jecting serum into the DA*x PVG MLR
Doubling d ilu tions of enhanced (El and E2) 
and rejecting (R1 and R2) serum samples(at 
an in i t i a l  concentration of 5%/well)were 
added to the DA*xPVG MLR under optimal 
conditions. Normal ra t serum at varying 
concentrations was added to the wells to 
maintain a f ina l concentration of 5% 
serum/well.Cultures were incubated fo r  96hrs 
then pulsed with luCi/well o f ^H-TdR fo r  
18hrs then harvested. Results are expressed 
as a % of the normal MLR .
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Fig 6.5 A b i l i ty  o f serum from enhanced and 
re jecting rats to in h ib i t  p ro l i fe ra t io n  in 
the DA*xPVG MLR
Serum was collected from enhanced (n=4) and 
rejecting (n=4) PVG recip ients of a DA
kidney, 5 days a fte r  transplantation and
added to the DA*xPVG MLR to give a
concentration of 5% serum/well. The results 
are expressed as a percentage o f the control 
MLR which contained 5% normal PVG serum.Error 
bars denote the standard error o f the mean.
pulsed a fte r 96 hrs. The thymidine uptake fo r a normal LEWIS*xPVG MLR 
was found to be lower than that of the DA*xPVG MLR by approximately 
50%. The results(table 1.14) are therefore expressed as a percentage 
of the control MLR for each stra in combination. Both enhanced and 
re jecting  sera inhib ited the donor-specific and the th ird  party MLR. 
The enhanced sera were 10 fold more potent in both th e ir  specific  
and non-specific inh ib ito ry  a c t iv i ty  than re jecting  sera. However 
there did not appear to be any difference in the level of 
donor-specific and th ird  party inh ib it ion  in e ither the enhanced or 
re jecting group.
6.4 A b i l i t y  o f monoclonal antibodies to class 1 and class I I  MHC 
antigens to block p ro life ra t ion  in the MLR
Monoclonal antibodies directed to both monomorphic (0X18 and 0X6) 
and polymorphic (MN4 and F17) determinants of ra t class I and class 
I I  MHC antigens were added to determine whether they were able to 
in h ib i t  the MLR. Cultures were set up under optimum conditions as 
before and doubling d ilu t ions of antibody added. I t  can be seen from 
Fig 6.6 that at a concentration of 2ug/ml a l l  o f these antibodies are 
potent inh ib ito rs  of the MLR . The anti-c lass I I  monoclonal 
antibodies 0X6 and F17 inhib ited the response to a greater extent 
than the anti-class I antibodies 0X18 and MN4.
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Table 1.14
Serum Stimulators CPM ± SEM % o f normal MLR
NRS DA 23636 + 2198
LEW 11002 + 1538 -
ENH 3 DA 311 + 32 1.33 + 0.14
LEW 656 + 122 5.96 + 1.11
ENH 4 DA 168 + 1.5 0.72 + 0.006
LEW 132 + 3.5 1.2 + 0.03
REJ 3 DA 4767 + 518 20.4 + 2.22
LEW 2637 + 425 23.97 + 3.86
REJ 4 DA 3724 + 339 15.94 + 1.45
LEW 2191 + 442 19.91 + 4.02
Table 1.14 A b i l i t y  o f enhanced and re jec ting  serum samples 
to in h ib i t  a donor-specific and th ird  party MLR
Enhanced (n=2) and rejecting (n=2) sera were collected from transfused 
and unmodified PVG recipients, 5 days a fte r  transplantation with a DA 
kidney. Sera were added at a f ina l concentration o f 5% /  well to a 
donor-specific DA*xPVG MLR or a th ird  party LEW*xPVG MLR under optimal 
conditions.Control MLRs were set-up in 5% normal PVG ra t serum. 
Cultures were pulsed 96 hrs la te r  with JH-TdR ( lu C i/w e ll) fo r  
18hrs,harvested and counted. Results are expressed as cpm and as a % 
of the normal MLR.
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Fig 6.6 Inh ib ito ry  a c t iv i ty  o f monoclonal 
antibodies to class I and class I I  MHC
antigens in the DA*xPVG MLR.
Monoclonal antibodies to monomorphic (0X18
and 0X6) and polymorphic (MN4 and F17)
determinants of class I and class I I  MHC 
antigens were added (at 2ug/well) in
t r ip l ic a te  to the DA*xPVG MLR under optimal 
conditions.Cultures were pulsed as before 
96hrs a fte r the in i t ia t io n  o f the cu ltu re . 
Results are expressed as a % o f the control 
MLR carried out in normal PVG ra t serum.Error 
bars denote the standard error o f the mean.
6.5 A b i l i t y  o f enhanced and re jecting IgG to in h ib i t  p ro l i fe ra t io n  in 
the HLR
IgG samples were prepared by n-octanoic acid sedimentation from 
enhanced (n=4) and rejecting (n=4) PVG ra ts , 5 days a fte r 
transplantation with a DA kidney. Purity of the preparations was 
assessed by SDS PAGE and found to be good apart from a small band at 
around 120K (Fig 1.5). Doubling d ilu t ions  of IgG samples from a 
s ta rt ing  concentration of 250ug/ml were added to the wells and each 
MLR was performed in t r ip l ic a te .  I t  can be seen in Fig 6.7 that the 
enhanced IgG samples showed greater in h ib it io n  than the re jecting  IgG 
samples ( p<0.05 ). The % of normal MLR obtained with 4 enhanced IgG 
samples (at 250 ug/ml) were 60%,40%,38% and 8% compared with 
83%,77%,77% and 60% for the re jecting IgG samples. Levels of 
in h ib it io n  were considerably lower than achieved with whole serum and 
th is  may be due in part to the removal of non-specific in h ib ito ry  
factors during the IgG preparation. In addition the concentration of 
IgG used in these experiments was only about 5% of that found in 
serum samples (assuming a serum IgG concentration of 16mg/ml).
The s p e c if ic i ty  of the inh ib ito ry  e ffect was investigated by adding 
IgG samples to both donor-specific and th ird  party MLRs. Levels of 
donor-specific inh ib it ion  were not as high in th is  experiment since 
the f in a l concentration of IgG added to the MLR was lower(125ug/ml). 
I t  can be seen from Fig 6.8 that generally there was greater 
s p e c if ic i ty  in the inh ib it ion  mediated by enhanced IgG samples
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Fig 6.7 Inh ib itory  a c t iv i ty  o f  enhanced and 
rejecting IgG in the DA*XPVG MLR
IgG was prepared from enhanced(n=4) and 
rejecting (n=4) PVG sera 5 days a fte r  
transplantation with a DA kidney. This 
IgG(at 250ug/ml) was tested in t r ip l ic a te  
fo r inh ib ito ry  a c t iv i ty  in the DA*xPVG MLR 
under optimal conditions and pulsed as before 
The mean of each t r ip l ic a te  is expressed 
as a % of the control MLR which was set up 
in 5% normal PVG serum. Error bars denote the 
standard error of the mean.
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Fig 6.8 A b i l i ty  o f enhanced and re jec t ing  IgG 
to in h ib i t  the donor-specific and th i rd  party 
MLR
IgG was prepared from enhanced (n=5) and 
rejecting (n=5)  ^ PVG sera 5 days a fte r
transplantation with a DA kidney. This IgG
(at 125ug/ml) was tested in t r ip l i c a te  fo r
inh ib ito ry  a c t iv i ty  in the DA*xPVG MLR under
optimal conditions and pulsed as before. The 
mean of each t r ip l ic a te  is expressed as a % 
of the control MLR carried out in 5% PVG 
serum.Error bars denote the standard error of 
the mean
compared to the rejecting IgG samples however there was no s ign if ica n t 
difference between the two groups when tested in e ither the specific  
or the th ird  party MLR.
These results do not accord with the previous experiment and suggest 
that the concentrations of IgG used were too low to detect in h ib ito ry  
a c t iv i ty .
6.6 Investigation of the capacity of enhanced and rejecting serum 
fractions to inhibit the MLR
Sera from enhanced (n=3) and re jecting (n=3) PVG rats 5 days a fte r 
transplantation with a DA kidney, were fractionated over a 
discontinuous sucrose density gradient as described previously. This 
yielded six fractions which were dialysed into RPMI 1640 medium and 
f i l t e r  s te r i l ise d . Doubling d ilu t ions of each frac tion  were added in 
t r ip l ic a te  (50ul/well) to 4xl03 PVG responders and 4xl03 DA
stimulators in medium containing 5% normal ra t serum. Cultures were 
pulsed with luCi/well of 3H-TdR a fte r 96 hrs and harvested a fte r 
18hrs. Results have been expressed as a % of the normal MLR occuring
in ra t serum alone.
The results of t i t r a t in g  fractions from one o f the enhanced and one 
of the re jecting serum samples are shown in Figs 6.9 and 6.10 
respectively. When fractions were added neat to the MLR i t  was found 
that a l l  of the enhanced serum fractions produced some degree of 
in h ib it io n  but the greatest inh ib it ion  was in fractions 3,4 and 5(% 
in h ib it io n  30%,1% and 1% respectively). The pattern was s im ila r in 
the serum samples from the re jecting animal with most of the
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Fig 6.9 A b i l i ty  o f serum frac tions  from
enhanced rats to in h ib i t  the DA*xPVG MLR
Serum was collected from an enhanced PVG ra t 
5 days a fte r transplantation with a DA 
kidney. Six serum frac tions of graded 
molecular weight were prepared by
discontinuous gradient cen tr ifugation . 
Doubling d ilu t ions  of each frac t ion  were
added in t r ip l ic a te  (50ul/well) to the 
DA*xPVG MLR under optimal conditions and
pulsed as before. The mean of each t r ip l ic a te  
is expressed as a % of the normal MLR which 
was set up in 5% normal PVG serum.
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Fig 6.10 A b i l i t y  o f re jec ting  serum 
fractions to in h ib i t  the DA*xPVG MLR
Serum was collected from an enhanced PVG rat 
5 days a fte r transplantation with a DA 
kidney. Six serum fractions of graded 
molecular weight were prepared by 
discontinuous gradient centrifugation 
Doubling d ilu t ions  of each frac t ion  were 
added in t r ip l ic a te  (50ul/well) to the 
DA*xPVG MLR under optimal conditions and 
pulsed as before. The mean o f each t r ip l ic a te  
is expressed as a % o f the normal MLR which 
was set up in 5% normal PVG serum.
in h ib it io n  in fractions 5 and 6 ( % in h ib it io n  12% and 1%
respectively) and some inh ib it ion  in frac tion  4 (73%). A s im ila r
pattern of in h ib it io n  was found in the serum fractions of the other 
two enhanced and re jecting serum samples tested. The results are 
summarised in Fig 6.11 . The least in h ib it io n  (though th is  s t i l l
represented about 50% of the normal MLR) was found in the high 
molecular weight fractions (FI to F3),in both the enhanced and 
re jec ting  ra ts . The greatest inh ib it ion  was found in frac tion  4,5 and 
6 fo r  the enhanced rats and in fractions 5 and 6 fo r the re jecting 
ra ts .
As was shown in chapter 4 , fractions 4,5 and 6 contain the IgG peak 
pa rt icu la r ly  frac tion  4. I t  was therefore in teresting that the level 
o f in h ib it io n  in fraction  4 of the re jecting rats (median=52%) was far 
less than the enhanced rats(8%) confirming the findings with the 
pu rif ied  IgG . I t  should be noted that the concentration of IgG in 
frac tion  4 was higher than the s tarting concentration used in the IgG 
experiments( see Table 1.8). I t  was in teresting however that the 
greatest in h ib it io n  was in fractions 5 and 6 in both groups. When an 
SDS PAGE gel of the fractions was analysed i t  could be seen that in 
fractions 4,5 and 6 apart from the IgG band there was also a very 
large band at around 68K , which corresponds to albumin (Fig 1.4). 
One p o s s ib i l i ty  is that the non-specific in h ib it io n  found in the 
serum could be due to the high levels of albumin in the cultures, but 
th is  was not tested d ire c t ly .
156
100
80
f  60
co
Ek_o
|  4 0
20
1
\
/
A
/
/
F 1 F2 F3 F4 F5 F6 
Fraction Number
Fig 6.11 A b i l i t y  o f enhanced and re jecting 
serum fractions to in h ib i t  the DA*xPVG MLR
Serum was obtained from enhanced (n=3) and 
re jecting (n=3)PVG rats 5 days a fte r 
transplantation with a DA kidney. Sera were 
fractionated into six serum fractions of 
graded molecular weight(FltoF6). Each 
frac tion  (50ul/well) was added to the DA*xPVG 
MLR under optimal conditions and pulsed as 
before. Results shown are the medians and 
ranges.Enhanced = open bars, Rejecting = 
hatched bars.
6.7 Discussion
In th is  chapter the optimal conditions fo r PVG lymphoid ce lls  
responding in an MLR to irradiated DA stimulator ce lls  were 
established. I t  was found that the p ro l i fe ra t iv e  response o f LNCs was 
greater than splenocytes and th is  may have been due to suppressor 
macrophages within the spleen ce ll population which have previously 
been shown to in h ib i t  the MLR( Oehler,Heberman, Campbell et al,1977; 
Weiss and Fitch, 1977). Maximum pro!iferationoccurred at day 4 ,which 
is  consistent with the results of previous workers studying 
p ro l i fe ra t io n  in ra t MLR systems (Quigley et a l ,1988; Mason and 
Simmonds, 1988). MLR cultures were carried out in the presence of 
normal ra t serum rather than FCS. Although levels of p ro l i fe ra t io n  
were considerably lower than in FCS, i t  was thought that th is  might 
be more physiological. I t  was not clear whether th is  was due to 
mitogenic a c t iv i ty  in the FCS or inh ib ito ry  a c t iv i ty  in the ra t serum. 
However,previous reports have indicated that mouse sera can in h ib i t  
the p ro l i fe ra t iv e  response in an MLR by preventing T ce ll activation 
and th is  may be due to an IL2 antagonist (Lelchuk and P layfa ir , 
1985).
Having established the optimal conditions fo r  the MLR the e ffec t of 
adding serum collected from unmodified and transfused PVG recip ients, 
5 days a fte r transplantation with a DA kidney , was tested. There 
was s ig n if ic a n t ly  greater in h ib it io n  in enhanced serum samples 
compared with re jecting serum samples. Only two o f the samples in each
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group were tested fo r th ird -party  inh ib ito ry  a c t iv i ty  and th is  was 
found to be substantial in both groups. I t  cannot be completely 
excluded from the present study that the non-specific MLR in h ib it io n  
may be due to antibody cross-reactive with th ird  party
alloantigens. However, th is  seems un like ly  since no c ross-reac tiv ity  
was found when the serum was assayed against LEWIS alloantigens in the 
alloantibody assay. Furthermore, a DA blood transfusion does not 
enhance survival of a LEWIS kidney in a PVG rec ip ient so i f
4
cross-reac tiv ity  is the explanation , then an assay of the 
in h ib ito ry  a c t iv i ty  of enhanced and re jecting sera in the MLR is not a 
good correlate of g ra ft survival. I t  seems more l ik e ly  that the 
in h ib it io n  is due to some other serum protein and th is  w i l l  be 
discussed in re la tion  to the findings of serum frac tiona tion .
To eliminate the problem of contaminating proteins, enhanced and 
re jecting  IgG samples were tested fo r in h ib it io n  of the donor and 
th ird  party MLR .Levels of inh ib it ion  were fa r  lower than found in 
serum. This may be due to a concentration e ffec t,  since levels of 
IgG were around 5% of that found in the serum. Enhanced IgG samples 
caused s ig n if ic a n t ly  greater inh ib it ion  of the MLR than re jecting  IgG 
samples, at a concentration of 250ug/ml. This implies that an IgG 
alloantibody present in greater amounts in enhanced than in 
re jecting animals may be responsible fo r  the MLR in h ib i t io n .  I t  was 
shown in the previous chapter that levels of an ti-c lass I I  antibodies 
are considerably higher in enhanced than in unmodified a l lo g ra f t  
re c ip ien ts ,5 days a fte r transplantation. However both enhanced and 
re jecting  IgG samples caused high levels o f in h ib it io n  in a th ird  
party MLR and th is  inh ib it ion  cannot be explained by specific
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alloantibody unless there is some degree of c ross-reac tiv ity  with 
Lewis antigens. One p o ss ib i l i ty  is that the contaminating protein seen 
on the SDS gel or trace amounts of caprylic acid which have not been 
removed by d ia lys is , cause some non-specific in h ib it io n  o f the MLR, 
and that specific  alloantibody is responsible fo r  the difference 
found between enhanced and re jecting rats. Experiments in which an 
a lte rna tive  pu r if ica t io n  procedure to obtain IgG eg. by HPLC may 
c la r i f y  these p o s s ib i l i t ie s .
Mouse monoclonal antibodies to ra t class I and class I I  MHC 
antigens were able to in h ib i t  the ra t MLR. This find ing was 
s l ig h t ly  surprising since p ro l i fe ra t ion  in the MLR is generally 
regarded to be a helper response driven by class I I  a l io -  antigens 
(Green & Jotte,1985). However the anti-c lass I monoclonal antibody 
also markedly blocks the response which is contradictory to the 
findings of Green and Jotte. Further experiments are required to 
elucidate whether th is  inh ib it ion  is a specific  phenomenon or 
non-specific due to s ter ic  in h ib it io n . This could be c la r i f ie d  by 
preincubating e ither responder or stimulator ce ll populations with the 
anti-c lass I and anti-c lass I I  antibodies. I f  an ti-c lass I antibody is 
able to block the MLR then re jecting sera which have high levels of
anti-c lass I at day 5 a fte r transplantation would also be expected to
block the MLR . I t  is perhaps not surprising then that both enhanced
and re jecting sera are able to block the MLR. The varying degrees of
blocking may re f le c t  the greater a b i l i t y  o f an ti-c lass I I  compared 
with anti-c lass I antibody to block the MLR.
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When enhanced and rejecting sera were fractionated by discontinuous 
gradient centrifugation into serum fractions of graded molecular 
weight i t  was found that fractions 5 and 6 from both groups caused 
the greatest inh ib it ion  of the MLR. Fraction 4 of the enhanced but 
not the re jecting group also caused a high level of in h ib i t io n  and i t  
is  possible that th is  is responsible fo r the specific  in h ib it io n  found 
in the serum and IgG from the enhanced rats and that the non-specific 
in h ib it io n  is due to fractions 5 and 6. SDS gel analysis of the serum 
fractions showed that in fractions 5 and 6, and to a lesser degree 
frac tion  4, there was a large band migrating to the same level as 
albumin in the molecular weight markers. The th ird -p a rty  a c t iv i ty  of 
the serum fractions has not yet been investigated but th is  may 
establish whether there is donor-specific in h ib ito ry  a c t iv i ty  in 
frac tion  4.
Addition of ra t albumin at concentrations equivalent to those found 
in fractions 5 and 6 would indicate whether th is  was responsible fo r 
non-specific inh ib it ion  in the MLR. Attempts were also made to 
remove alloantibody a c t iv i ty  from the tes t sera by absorption of sera 
with splenocytes(results not shown). However when the sera were 
re-tested in the alloantibody assay, absorption was incomplete and 
there was considerable residual alloantibody. I t  was not possible, 
therefore, to look at the e ffect of alloantibody-absorbed serum on the 
MLR.
I f  there is  a corre lation between in v i t ro  p ro l i fe ra t io n  and 
p ro l i fe ra t io n  of a lloreactive ce lls  in vivo then i t  may be that the 
greater a b i l i t y  o f enhanced serum compared with re jec ting  serum to 
in h ib i t  the in v i t ro  p ro l i fe ra t ive  response to donor alloantigen may
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also occur in vivo. Further studies are required to elucidate 
whether passively transferred alloantibody from enhanced animals is 
able to prevent re jection by blocking p ro l i fe ra t io n  in vivo.
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CHAPTER 7 
FINAL DISCUSSION
7.0 Final Discussion
The beneficia l e ffect of pre-operative blood transfusion in c l in ic a l  
renal transplantation was a s tr ik ing  discovery although i ts  
consequences have become less obvious as improved immunosuppressive 
drugs have been introduced. Terasaki (1988) reported that in 1987 
one year survival fo r untransfused patients was 70% compared with 77% 
fo r  patients who had received transfusion . Moreover, in some animal 
models preoperative donor-specific transfusion leads to long term 
g ra f t  survival even in the absence of any additional immunosuppressive 
drugs. Clearly, therefore, a greater understanding of the mechanisms 
underlying the blood transfusion e ffect are important and may, in the 
long term, lead to strategies of inducing specific  unresponsiveness 
towards an organ g ra ft and thereby reduce or eliminate the side 
effects of non-specific immunosuppression.
Despite intensive study of the blood transfusion e ffec t in both 
humans and animal models, there is as yet no unifying hypothesis to 
explain why blood transfusion prolongs renal a l lo g ra f t  surv iva l. This 
may be a re f lec t ion  of the complexity o f the blood transfusion 
response and the wide ranging effects i t  produces on many aspects of 
both the c e l lu la r  and humoral arm of the immune response to a 
subsequent a l lo g ra f t .
This study has u t i l is e d  the ra t renal a l lo g ra f t  model to study the 
donor-specific blood transfusion e ffec t. The DA to PVG ra t s tra in  
combination was chosen because the PVG ra t is a low responder to DA 
alloantigens (Butcher and Howard, 1982) and was therefore l ik e ly  to be
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read ily  susceptible to the induction of active enhancement. 
Furthermore antibodies were available which labelled class I and class 
I I  determinants of DA but not PVG, thereby allowing unequivocal 
evaluation of donor MHC expression. Therefore th is  study has the 
obvious l im ita t io n  that the findings obtained may not necessarily be 
applicable to other rat stra in combinations. Caution is also necessary 
in extrapolating the findings in the ra t model to human renal
transplantation because there are important differences in the immune 
systems of ra t and man. In particu la r renal a l log ra fts  in the ra t 
appear less susceptible to antibody mediated damage, possibly as a 
resu lt  o f a defect in the complement system (French and Batchelor, 
1972).
The experiments reported herein, revealed several in teresting 
findings which contribute to an understanding of the blood transfusion 
e ffe c t.  The immunohistological and functional analysis of g ra ft 
i n f i l t r a t in g  ce lls  reported in Chapter 3 revealed that the heavy 
mononuclear ce ll in f i l t r a t io n  which occurs in re jecting renal 
a llog ra fts  was not prevented by donor-specific blood transfusion. 
Instead, transfusion appeared to "sensitise" the rec ip ient since the 
in f lu x  of mononuclear ce lls  into the non-rejecting grafts  was
accelerated . I t  was also notable that at day 3 a fte r transplantation, 
enhanced grafts in blood-transfused rats showed a greater number of 
"activated" ce lls  bearing the IL-2 receptor. Although in f i l t r a t io n  of 
mononuclear ce lls  into re jecting grafts occurred more slowly, by day 
5 there was a substantial i n f i l t r a te  compared to enhanced grafts  and 
there was a marked preponderance of ce lls  bearing the CD8 antigen.
Many of these CD8+ ce lls  appeared to have a phenotype (0X8+0X19")
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consistent with NK ce lls  rather than CD8+T ce lls  although fu rthe r 
analysis using double labe ll ing techniques are necessary to confirm 
th is .
Previous studies have shown that treatment of ra t renal a l lo g ra f t  
recip ients with CyA or with anti-donor alloantibody(passive 
enhancement) prevents the in f i l t r a t io n  of the g ra ft  by ce lls  which 
display in v i t ro  cytotoxic a c t iv i ty  against donor s tra in  lymphoblasts 
(Mason & Morris, 1984; Bradley et a l , 1985). However, Dallman et al
(1987) have recently shown that non-rejecting kidneys in blood 
transfused recipients contain in f i l t r a t in g  ce lls  which display in 
v i t ro  specific  cy to tox ic ity  sim ilar to or in excess of that seen in 
re jec ting  g ra fts . This finding was confirmed in th is  study and raises 
questions about the role of specific  cytotoxic T ce lls  in g ra ft 
re jec tion . There is convincing evidence that specific  cytotoxic T 
ce l ls  contribute to g ra ft re jection (reviewed in chapter 1). I t  may be 
that in active ly  enhanced rats the cytotoxic effectors are "blocked" 
from mediating th e ir  e ffector function, possibly by the presence of 
alloantibody. A lte rna tive ly  i t  may be that assessment of cytotoxic
function using donor lymphoblast targets is not relevant to the in
vivo function of cytotoxic ce lls  in g ra ft re jec tion . The precise 
c e l lu la r  target in renal a l log ra ft  re jection is not known with 
certa in ty , but i t  seems l ik e ly  that the vascular endothelium is a 
prime target of the re jection response. Future studies in which the 
a b i l i t y  of g ra ft  i n f i l t r a t in g  ce lls  from re jecting  and active ly  
enhanced renal a llog ra fts  are tested fo r  th e ir  a b i l i t y  to damage
donor vascular endothelium in v i t ro  may help to c la r i f y  th is .
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The a b i l i t y  o f blood transfusion to prevent g ra ft  re jection  could not 
be explained by a lack of target molecules on the donor ce l ls  w ith in 
the kidney. The immunohistological analysis of donor class I and class 
I I  MHC expressiondemonstrated convincingly that marked induction of 
both class I and class I I  MHC antigens occurred in enhanced kidneys 
and was more rapid than the induction which occured in re jecting 
kidneys. This is in keeping with the accelerated g ra ft  i n f i l t r a t e  in 
enhanced kidneys because the induction of MHC antigens may be brought 
about by the release of lymphokines from the g ra ft  i n f i l t r a t in g  ce l ls .  
Other groups have subsequently confirmed the accelerated induction of 
MHC antigens in renal a llogra fts  in blood transfused rats (Wood et 
a l ,1988); Priestley & Fabre,1989). The apparent lack o f any major 
differences in the ce llu la r  response to a renal a l lo g ra f t  in 
unmodified and transfused recipients led to an examination of the 
e ffec t of blood transfusion on the alloantibody response to a renal 
a l lo g ra f t  as th is  could contribute to the transfusion e ffec t.
The p o s s ib i l i ty  that Fc blocking antibodies might contribute to g ra ft 
survival induced by blood transfusion was investigated. Considerably 
higher levels of Fc blocking a c t iv i ty  were found in serum of enhanced 
rats compared with re jecting rats on day 5 a fte r transplantation. This 
a c t iv i ty  was also found in serum fractions which corresponded to the 
7S IgG peak and in purif ied  IgG prepared from day 5 post transplant 
serum. Further experiments in which serum was absorbed with red ce lls  
to remove anti-c lass I a c t iv i ty  suggested that th is  Fc blocking 
a c t iv i ty  was mediated by anti-c lass I I  a lloantibodies and th is  was 
substantiated by the demonstration that such antibodies could not 
block Fc receptors on congenic targets which share class I I  with PVG.
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The find ing that anti-class I I  antibodies were responsible fo r  Fc 
blocking was in agreement with previous studies (D ickler & Sachs, 
1974); Soulil lou et a l , 1975; Suthanthiran et a l , 1977). However th is  
may have been a fortu itous finding in the l ig h t  of the demonstration 
that anti-c lass I monoclonal antibodies also mediate Fc blocking but 
that the predominant antibody induced by blood transfusion was an IgG 
anti-c lass I I  antibody.
As mentioned in the introduction IgG anti-c lass I I  antibodies are 
potent inducers of passive enhancement. I t  was therefore in teresting 
that IgG anti-c lass I I  antibodies were present in higher amounts in 
the serum of enhanced rats than the re jecting rats early a fte r 
transplantation. One mechanism which has been proposed to explain 
passive enhancement is that the presence of IgG anti-c lass I I  antibody 
at the time of transplantation results in the removal of g ra ft 
dendrit ic  ce lls  by opsonisation. This could a l te r  the course of 
normal host sensitisation leading to the induction of suppressor 
ce l ls .  I t  would therefore be interesting to fo llow the fate of 
dendrit ic  ce lls  in the enhanced grafts to see whether they appear in 
the local lymph node or spleen. I t  was noted in chapter 3 that 
dendrit ic  ce lls  disappeared more quickly from the enhanced gra fts  than 
the re jecting g ra fts . A lternative ly  anti-c lass I I  antibodies could 
prevent recognition of class I I  antigen on donor endothelium which has 
been shown to be capable of presenting donor antigen in vivo 
(Ferry,Halttunen, Leszczynski et a l ,1987). Since class I I  antigens 
are the main stimulators of the p ro l i fe ra t iv e  response i t  is un like ly  
that anti-c lass I antibody present in higher amounts in the re jecting 
animals would prevent sensitisation.
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Clearly some degree of sensitisation has taken place as there are 
spec if ic  cytotoxic cells within the grafts though they may have been 
induced by blood transfusion and levels of cy to to x ic ity  were low. 
However the paucity of cells expressing the I1-2R does suggest some 
down-regulation of the activation process. Anti-c lass I I  antibodies 
could also bind to shed donor antigen and prevent uptake of shed 
donor-class I I  antigen by host antigen presenting ce l ls ,  thereby 
diminishing sensitisation.
Whether the dichotomy in the antibody response to the g ra ft  is true 
o f other s tra in  combinations remains to be elucidated, but previous 
studies have shown that in the DA to Lewis s tra in  combination the 
alloantibody response induced by splenocyte in jec t ion  was directed 
mainly at class I I  antigens (Gal 1ico & Mason, 1978).
The greater inh ib it ion  of the MLR by enhanced serum and IgG could 
also be attr ibuted to the higher levels of anti-c lass I I  antibodies 
present in the enhanced serum on day 5 a fte r transplantation. Further 
experiments are required to confirm whether the an ti-c lass I I  
antibodies are cross-reactive with Lewis antigens. A lte rna tive ly , 
in h ib it io n  in vivo and in v i t ro  (as seen in the MLR) of the response 
to DA may be mediated by a n t i- id io typ ic  antibody which is able to 
block the receptors fo r antigen on T ce lls .  As mentioned in the 
introduction a n t i- id io typ ic  antibodies capable o f in h ib it in g  the MLR 
have been described in a number of studies on the blood transfusion 
e ffe c t.  This is an area which was not investigated in the present 
study but which could be pursued both in re la tion  to both blocking of 
the MLR and blocking of in v i t ro  cy to tox ic ity .
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There are arguments against anti-class I I  antibodies playing a major 
ro le in transfusion-induced suppression of g ra ft  re jec tion . The fact 
tha t pu rif ied  erythrocytes can enhance survival of ra t renal
a l lo g ra f ts  (Wood et a l , 1985) and mouse L-ce lls  bearing only
transfected class I can enhance survival of mouse cardiac a llog ra fts  
(Superina et a l , 1985;1987; Madsen et al,1988) could be taken as 
evidence that antibody is not important. However IgG anti-c lass I 
antibody has also been found to be capable of passively enhancing 
kidneys, so presumably i f  IgG anti-class I is induced by erythrocytes 
th is  might have some effects s im ilar to IgG anti-c lass I I .  
A lte rna tive ly  the immunosuppressive mechanisms induced by 
pre-treatment with class I alone may be e n t ire ly  d if fe re n t from those 
evoked by whole blood containing a fu l l  MHC mismatch.
In conclusion, the mechanisms underlying the transfusion e ffec t are 
undoubtedly complex, and are complicated by the fact that both the 
re jection response and the induction of enhancement are influenced by 
s tra in  combination effects. A possible ro le fo r transfusion-induced 
IgG antibody has been highlighted and attempts to passively enhance 
naive PVG rats with day 5 enhanced sera may elucidate whether they are 
involved in g ra ft  survival. However, there are d i f f i c u l t ie s  in th is  
approach since, as mentioned in the introduction, the dosage and
timing o f antibody administration are c r i t i c a l  in passive enhancement 
and therefore in terpretation of such experiments is d i f f i c u l t .
Moreover, most of the studies claiming a ro le fo r  suppressor ce lls  
u t i l i s e  adoptive hosts which have been l ig h t ly  ir rad ia ted , and th is  
might be required in order to demonstrate the suppressive e ffec t of 
serum.
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The relevance of the findings reported here to the transfusion e ffec t 
in the c l in ic a l  setting are s t i l l  unclear. There is con f l ic t ing  
evidence from human studies about the enhancing e ffec t of anti-c lass 
I I  antibodies. I t  may be that in humans the beneficial e ffec t of such 
antibodies is masked by the fact that antibody may also be cytotoxic 
and therefore detrimental to g ra ft surviva l. I f  so, the future fo r 
antigen pretreatment in the c l in ica l setting w i l l  depend on finding 
ways to induce non-cytotoxic enhancing antibody.
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APPENDIX
Table A .I.
Effect o f Pretreatment with various donor ce lls  on 
g ra ft survival
Donor c e l ls  used 
fo r  Dretreatment
A lIograft 
Model
Strain
Combination
Graft
Survival Ref
Renal BN--Wag ++ l
Renal LEW--BN ++ 2
Renal DA--LEW ++ 3
Renal BN--LEW ++ 4
Ervthrocvtes
Renal DA--LEW ++ 5
Renal LEW--DA ++ 5
Renal (DAxLEW)F l--DA ++ 5
Renal DA--(DAxHS)Fl - 6
Cardiac (LEWxBN)Fl--LEW ■ - 7
Renal (DAxLEW)F l--DA ++ 8
Renal DA--(DAxHS)n + 6
Platelets
Renal BN--LEW ++ 4
Renal DA--LEW + 3
Renal DA--LEW ++ 3
B ce lls Renal LEW--DA ++ 9
Cardiac (LEWxBN)Fl--LEW ++ 7
T ce lls Renal DA--LEW + 3
(CD41- but not CD8T)
Renal LEW--DA ++ 9
Cardiac (LEWxBN)Fl--LEW - 7
Dendritic ce lls Renal DA--LEW + 3
Cardiac
(mouse)
C57BL/10--DBA/2 - 10
++ = prolonged survival 
+ = s l ig h t ly  prolonged survival
= no effect on survival
Table A.2.
References used in table A .I .  
Ref No. Author and Journal
1 Jeekel J, van Dongen J, Majoor G et al (1977)
Transplantation Proceedings 9: 969-972
2 Majoor GD, van de Gaar M-JWH, Vlek LFM et al
Transplantation 31: 369-375
3 El-Maiik, F., Malik, S.T.A. Varghese, Z. et al 
Transplantation 38: 213-216
4 Martin DC, Hewitt CF, Osborne JG et al (1982
Transplantation Proceedings 14: 407-409
5 Wood KJ, Evins J & Morris PJ (1985) 
Transplantation 45: 759-767
6 Hibberd AD & Scott LJ (1983)
Transplantation 35: 622-624
7 Lauchart W, Alkins BJ & Davies DAL (1980) 
Transplantation 29: 259-261
8 Batchelor JR, Welsh K & Burgos (1977) 
Transplantation Proceedings 9: 931-936
9 Cranston D, Wood KJ & Morris PJ (1986) 
Transplantation 42: 302-306
10 Peugh WN, Austyn JM, Carter NP et al (1987) 
Transplantation 44: 706-710
(1981)
(1984)
Table A.3
Buffers fo r SDS-PAGE
Upper Tank Buffer:
Tris  - 31.6 g
Glycrine - 20.0 g Make up to 1 l i t r e  with d is t i l le d  HoO
SDS - 5.0 g 1
Lower Tank Buffer:
T r is  - 60.5 g Add 800 mis of d is t i l le d  Ho0
SDS - 5.0 g Adjust pH to 8.1
Make up to 1 l i t r e  with d is t i l le d  H2 O
30% Acrvlamide:
Acrylamide - 28.5 g Dissolve in 100 mis of d is t i l le d  H£0
Bis-Acrylamide - 1.5 g
Running Gel Buffer:
Tris  - 18.5 g Add 50.0 mis of d is t i l le d  Ho0
SDS - 0.4 g Adjust pH to 8.9
Make up to 100 mis with d is t i l le d  H2 O
Stacking Gel Buffer:
Tris - 5.9 g Add 50.0 mis of d is t i l le d  H2 O
SDS - 0.4 g Adjust pH to 6.7
Make up to 100 mis with d is t i l le d  H2 O
Sample Buffer:
Reducing conditions Non-reducing conditions
Stacking Gel Buffer - 2.5 mis Stacking Gel Buffer -5.0mls
2-Mercaptoethanol - 2.5mls SDS -l.Og
SDS - l.Og
Warm u n t i l  SDS dissolves then add 1.0ml of glycerol and 4.0mls o f
1% bromophenol blue.
A ll  reagents from Gibco, Paisley except 2-Mercaptoethanol (Sigma 
Chemical Co., Poole, Dorset).
REFERENCES
^bnas’ . AAK->. Corson> J -M-> Carpenter, C.B., Galvanek, E.G., M e r r i l l ,  
in r  ^amm^ n’ G.J. (1974a) Immunologic enhancement of ra t renal 
a l lo g ra f ts  I .  Comparative morphology o f acutely re jecting and 
passively enhanced grafts . American Journal of Pathology. 75, 255-271.
Abbas, A.K., Corson, J.M., Carpenter, C.B., Galvanek, E.G., M e r r i l l ,  
J.P. and Dammin, G.J. (1974b) Immunologic enhancement of ra t renal 
a l lo g ra f ts  I I .  Immunohistology of acutely re jecting and passively 
enhanced g ra fts . American Journal of Pathology. 75, 271-280.
Aherne, W.A. & Dunnill, M.S. (1982) In Morphometry. 33, London: 
Arnold.
Ascher, N.L., Ferguson, R.M., Hoffman, R.A. & Simmons, R.L. (1979) 
Partia l characterisation of cytotoxic ce lls  in f i l t r a t in g  sponge matrix 
a l lo g ra f ts .  Transplantation. 27, 254-259.
Austyn, J.M., Steinman, R.M., Weinstein, A., Granel1i-Piperno, A. & 
Palladino, M.A. (1983) Dendritic ce lls  in i t ia te  a two-stage mechanism 
fo r  T lymphocyte p ro l i fe ra t ion . Journal of Experimental Medicine. 157, 
1101-1115.
Bach, F.H. & Hirschkorn, K. (1964) Lymphocyte in teractions: A
potentia l h is tocom patib ility  test in v i t ro .  Science, 143, 813-814.
Bach, F.H., Widmer, M.B., Bach, M.L. & Klein, J. (1972) Serologically 
defined and lymphocyte defined components o f the major 
h is tocom patib il ity  complex in the mouse. Journal of Experimental 
Medicine, 136, 1430-1444.
Bach, F.H., Bach, M.L. and Sondel, P.M. (1976) D if fe ren t ia l function 
o f major h istocompatib ility  complex antigens in T lymphocyte 
activa tion . Nature, 259, 273-281.
Bailey, D.W. (1975) Genetics of h is tocom patib ility  in mice I .  New loc i 
and congenic lines. Immunoaenetics, 2, 249-256.
Barber, W.H., Hutchinson, I.V. & Morris, P.J. (1984) The ro le of 
suppressor ce lls  in maintaining passively enhanced ra t kidney 
a l lo g ra f ts .  Transplantation, 38, 548-551.
Barclay, A.N. (1981) The loca lisa tion of populations of lymphocytes 
defined by monoclonal antibodies in ra t lymphoid tissues. Immunology, 
42, 593-600.
Barkley, S.C., Sakai, R.S., Ettenger, R.B., Fine, R.N. & Jordon, S.C.
(1987) Determination of a n t i- id io typ ic  antibodies to anti-HLA IgG 
fo llowing blood transfusions. Transplantation, 44, 30-34.
Basham, T., Smith, W., Lanier, L., Morhenn, V. & Merigan, T. (1984) 
Regulation of expression of class I I  major h is tocom patib il i ty  antigens 
on human peripheral blood monocytes and Langerhans ce lls  by 
in terferon. Human Immunology, 10, 83-93.
170
Batchelor, J R. ,  Brent, L. & Kilshaw, P.J. (1977) Absence of
suppressor ce lls  from rats bearing passively enhanced kidney
a l lo g ra f ts .  Nature. 270, 522-524.
Batchelor, J.R., Welsh, K. & Burgos, H. (1977) Immunological
enhancement. Transplantation Proceedings. 9, 931-936.
Batchelor, J.R., P h il l ips , B.E. & Grennan, D. (1984) Suppressor ce lls
and th e ir  ro le in the survival of immunologically enhanced ra t kidney 
a l lo g ra f ts .  Transplantation. 37, 43-46.
Batchelor, J . R.(1989) Anti- id io typ ic  responses in the suppression of 
a l lo g ra f t  re jection . Transplantation Proceedings. 21,57-58.
Benson, E.M., Colvin, R.B. & Russell, P.S. (1985) Induction of la
antigens in murine renal transplants. Journal of Immunology. 134, 7-9.
Betuel, H., Cantarovitch, D., Robert, F., Gebuhrer, L., Touraine,
J .L . ,  Dubernard, J.M. & Traeger, J. (1985) P late le t transfusions 
preparative fo r kidney transplantation. Transplantation Proceedings, 
17, 2335-2337.
Biesecker, J .L . ,  Fitch, F.W., Rowley, D.A. & Stuart, F.P. (1973)
C e llu la r and humoral immunity after allogeneic transplantation in the 
ra t .  I I I .  The effect of passive antibody on c e l lu la r  and humoral
immunity a fte r allogeneic renal transplant. Transolantation, 16,
432-440.
Billingham, R.E., Brent, L. & Medawar, P.B. (1953) "Actively acquired 
tolerance" of foreign ce lls . Nature, 172, 603-606.
Blankenhorn, E.P. & Cramer, D.V. (1985) Orientation of the loci 
encoding RT1.B. polypeptides in the major h is tocom patib il ity  complex 
o f the ra t .  Immunoqenetics, 21, 135-142.
Bodmer, J. & Bodmer, W. (1978) Evolution and function of the HLA
system. B r it ish  Medical B u lle t in , 34, 309-316.
Bodmer, W.F. (1986) HLA today. Human Immunology, 17, 490-503.
Bodmer,W.F., A lbert, E., Bodmer, J.G., Dupont,B., Mach, B., Mayr,W., 
Sasazuki, T., Schreuder, G.M.T, Svejgaard, A.& Terasaki, P .I.
(1988). Nomenclature fo r factors of the HLA system. Immunoqenetics, 
28, 391-398.
Bolton, E.M., Gracie, J.A., Briggs J.D., Kampinga,J. & Bradley, J.A.
(1989) Cellu lar requirements fo r renal a l lo g ra f t  re jection in the 
athymic nude ra t. Journal of Experimental Medicine, 169, 1931-1946.
Bore! J.D. (1976) Comparative study on in v i t ro  and in vivo drug 
e ffec ts  on ce ll mediated cy to tox ic ity . Immunology, 31, 631-641.
171
Borle ffs , J.C.C., Neuhaus, P., van Rood, J.J. & Balner, H. (1982)
P la te le t transfusions improve kidney a l log ra f t  survival in rhesus
monkeys without inducing cytotoxic antibodies. Lancet. 1, 1117-1118.
Bradley, J .A ., Mason, D.W. & Morris, P.J. (1985) Evidence that rat 
renal a llog ra fts  are rejected by cytotoxic T ce lls  and not by 
non-specific effectors. Transplantation. 39, 169-175.
Brent, L., Brown, I. & Medawar, P. (1962) Quantitative studies on 
tissue transplantation immunity. IV. Hypersensitivity reactions
associated with the rejection of homografts. Proceedings of the Roval 
Society of London fB io l l . 156, 187-209.
Brideau, R.J., Carter, P.B., McMaster, W.R., Mason, D.W. & Williams,
A.F. (1980) Two subsets of rat T lymphocytes defined with monoclonal 
antibodies. European Journal of Immunology. 10, 609-615.
Burnet, F.M. & Fenner, F. (1949) The production of antibodies. 
Second Edition, Melbourne and London, Macmillan.
Butcher, G.W., Corralan, J.R., Licence, D.R. & Howard, J.C. (1982)
Immune response genes contro lling responsiveness to major 
transplantation antigens. Specific major h is tocom patib il ity  
complex-linked defect fo r antibody responses to class I alloantigens. 
Journal of Experimental Medicine. 155, 303-320
Butcher, G.W. & Howard, J.C. (1982) Genetic control of transplant 
re jec t ion . Transplantation. 34, 161-166.
Caine, R.Y. (1960) The rejection of renal homografts: in h ib it io n  in 
dogs by 6-mercaptopurine. Lancet. 1, 417-418.
Caine, R.Y., Alexandre, G.P.J. & Murray, J.E. (1962) A study of the 
e ffects  of drugs in prolonging survival of homologous renal 
transplants in dogs. Anna is of the New York Academy of Sciences, 99, 
743-761.
Caine, R.Y., White, D.J.G., Thiru,S., Evans, D.B., McMaster, P., Dunn,
D.C., Craddock, G.N., Pentlow, B.D. & Rolles, K. (1978) Cyclosporin in 
patients receiving renal a llografts  from cadaver donors. Lancet, 2, 
1323-1327.
Cantor, H. & Boyse, E.A. (1975a) Functional subclasses of T
lymphocytes bearing d if fe ren t Ly antigens. I .  The generation of 
func tiona lly  d is t in c t  T cell subclasses is a d i f f e r e n t i a t e  process 
independent of antigen. Journal of Experimental Medicine, 141,
1376-1389.
Cantor, H. & Boyse, E.A. (1975b) Functional subclasses of T
lymphocytes bearing d if fe ren t Ly antigens. I I .  Cooperation between 
subclasses of Ly+ cells  in the generation of k i l l e r  a c t iv i ty .  Journal. 
o f Experimental Medicine, 141, 1390-1399.
172
Cantor, H. & Gershon, R.K. (1979) Immunological c i rc u i ts :  c e l lu la r  
composition. Federation Proceedings. 38, 2058-2064.
Cantre ll, D.A., Robins, R.A., Brooks, C.G. & Baldwin, R.W. (1982) 
Phenotype of ra t natural k i l l e r  cells defined by monoclonal antibodies 
marking ra t lymphcyte subsets. Immunology. 45, 97-103
C e r i l l i ,  J.G. & Brasile, L. (1988) Tissue specific antigens. A role 
in organ transplantation. Theory fo r the existence of t issue-spec if ic  
antigens. In Organ Transplantation and Replacement, ed. C e r i l l i  J.G. 
Philadelphia, Lippincot.
Chapman, J.R., Taylor, C.J., Ting, A. & Morris P.J. (1986) 
Immunoglobulin class and spec if ic ity  of antibody causing positive T 
ce ll  crossmatches. Transplantation. 42, 608-613.
Chapman, J.R., Fisher, M., Ting, A. & Morris, P.J. (1985) P latelet 
transfusion before renal transplantation in humans. Transplantation 
Proceedings. 17, 1038-1040.
Christmas, S.E. & MacPherson, G.G. (1982a) The role of mononuclear
phagocytes in cardiac a llog ra ft re jection in the ra t .  I.
U ltras truc tu ra l and cytochemical features. Cellu lar Immunology. 69, 
248-270.
Christmas, S.E. & MacPherson, G.G. (1982b) The role of mononuclear
phagocytes in cardiac a llog ra ft re jection in the ra t.  I I .
Characterisation of mononuclear phagocytes extracted from ra t cardiac 
a l lo g ra f ts .  Cellu lar Immunology. 69, 271-290.
C ic c ia re l l i ,  J.C., Chia, D., Terasaki, P.T, Barnett, E V.& Shirama, S. 
(1980) Human IgM anti-IgM cytotoxin of E lymphocytes. Tissue Antigens, 
15, 275-282.
Cochrum, K.C., Salvatierra, 0. & Belzer, F.0. (1974) Correlation 
between MLC stimulation and graft survival in l iv in g  related and 
cadaver transplants. Annals of Surgery, 180, 617-622.
Cranston, D., Wood, K.J. & Morris, P.J. (1986) Abrogation of the 
immunosuppressive effect of donor spleen ce lls  on renal a l log ra fts  in 
the ra t by ir rad ia t ion  or heat treatment. Transplantation, 42,
302-306.
Cranston, D. Wood, K.J., Carter, N. & Morris, P.J. (1987) 
Pretreatment with lymphocyte subpopulations and renal a l lo g ra f t  
survival in the ra t.  Transplantaion, 43, 809-813.
Daar, A.S., Fuggle, S.V., Fabre, J.W., Ting, A. & Morris P.J. (1984) 
The detailed d is tr ibu tion  of MHC class I I  antigens in normal human 
organs. Transplantation, 38, 293-298.
173
Dallman, M.J., Mason, D.W. & Webb, M. (1982) The roles of host and 
donor ce l ls  in the rejection of skin a llog ra fts  by T ce ll deprived
Scii^e5ll syn9eneic T ce lls . European Journal of Immunology.12) o i l~ b l8 •
Dallman, M.J.& Mason, D.W.(1983) Induction of la antigens on murine 
epidermal ce lls  during the re jection of skin a l log ra f ts .  
Transplantation. 36, 221-224.
Dallman, M.J., Wood, K.J & Morris P.J. (1987) Specific cytotoxic T 
ce lls  are found in the non-rejected kidneys of fclood-transfused rats. 
Journal of Experimental Medicine. 165, 566-571.
Dallman, M.J., Wood, K.J. & Morris, P.J. (1989) Recombinant 
in te rleuk in -2  ( IL -2) can reverse the blood transfusion e ffec t. 
Transplantation Proceedings. 21, 1165-1167.
Damle, N.K. & Engelman, E.G. (1983) Immunoregulatory T ce ll c irc u its  
in man. Alloantigen-primed inducer T ce lls  activate 
a lloantigen-specific  suppressor T ce lls  in the absence of the in i t i a l  
antigenic stimulus. Journal of Experimental Medicine. 158, 159-173.
Dausset, J. (1958) Iso-leuco-anticorps (Iso-leuco-antibodies). Acta 
Haematologica. 20, 156-166.
Davies, D.A.L. & Alkins, B. (1974) What abrogates heart transplant 
re jec tion  in immunological enhancement? Nature. 247, 294-297.
Davies, D.A.L. & Staines, N.A. (1976) A cardinal ro le fo r  I region 
antigens ( la) in immunological enhancement and the c l in ic a l
implications. Transplantation Reviews. 30, 18-39.
D ickler, H.B. & Sachs, D.H. (1974) Evidence fo r  id e n t i ty  or close 
association of the Fc-receptor of B lymphocytes and alloantigens
determined by the I r  region of the H-2 complex. Journal of
Experimental Medicine. 140, 779-796.
Dossetor, K.J., MacKinnon, K.J., Gault, M.H. & MacLean, L.D. 
(1967) Cadaver kidney transplants. Transplantation, 5, 844-853.
Duncan, Wakeland and Klein (1979) H istocompatibility-2 system in wild 
mice. V I I I .  Frequencies of H-2 and la antigens in wild mice from 
Texas. Immunoqenetics. 9, 261-272.
El-Maiik, F., Malik, S.T.A., Vargese, Z., Sweny, P. & Moorhead, J.F. 
(1984) The enhancing and sensitising effects of donor blood 
components, including dendritic ce lls , in a ra t renal a l lo g ra f t  model. 
Transplantation. 38, 213-216.
Emma, D.A. & Jacobs, B.B. (1981) Prolongation o f skin a l lo g ra f t  
survival following donor irrad ia tion  and organ culture explantation. 
Transplantation, 31, 138-139.
174
Fabre, & Morris, P.J. (1972a) Experience with passive
enhancement of renal a llografts  in a (DA x LEWIS)FI to Lewis s tra in 
combination. Transplantation. 13, 604-609.
Fabre, J.W. & Morris P.J. (1972b) The effect of donor s tra in  blood
pretreatment on renal a llog ra ft re jection in ra ts. Transplantation,
14, 608-617.
Fabre, J.W. & Morris, P.J. (1972c) The mechanism of specific
immunosuppression of renal a llog ra ft re jection by donor s tra in  blood.
Transplantation. 14, 634-640.
Fabre, J.W. & Morris, P.J. (1973) Dose response studies in passive
enhancement of ra t renal a llogra fts . Transplantation. 15, 397-403.
Fabre, J.W. & Morris, P.J. (1974) Passive enhancement of homozygous
renal a l log ra fts  in the ra t. Transplantation. 18, 429-435
Fabre, J.W. & Morris, P .J.(1975) Studies on the specific  suppression
of renal a l lo g ra f t  rejection in presensitised ra ts. Transplantation, 
19, 121-133.
F a g n i l l i ,  L. & Singal, D.P. (1982) Blood transfusions may induce
anti-T  cell receptor antibodies in renal patients. Transplantation
Proceedings, 14, 319-321.
Fellous, M., Nir, U., Wallach, D., Merlin, G., Rubinstein, M. & Revel, 
M. (1982) Interferon-dependent induction of mRNA fo r the major 
h is tocom patib il ity  antigens in human fibrob lasts  and lymphoblastoid 
ce l ls .  Proceedings of the National Academy of Sciences. 79, 3082-3091.
Ferry, B., Halttunen, J .,  Leszczynski,D., Schellekens, H., van der
Meide, P.H. & Hayry, P. (1987) Impact of class I I  major
h is tocom patib il ity  complex antigen expression on the immunogenic
potentia l of isolated ra t vascular endothelial ce l ls .  
Transplantation, 44, 499-503.
Forbes, R.D.C., Parfrey, N.A., Gomersall, M., Darden, A.G. & Guttman, 
R.D. (1986) Dendritic cell-lymphoid cell aggregation and major
h is tocom patib il i ty  antigen expression during ra t cardiac a l lo g ra f t  
re jec t ion . Journal of Experimental Medicine, 164, 1239-1258.
Ford, W.L., Burr, W. & Simonsen, M. (1970) A lymph node weight assay 
fo r  the graft-versus-host a c t iv i ty  of ra t lymphoid ce l ls .  
Transplantation, 10, 258-266
Forwell, M.A., Cocker, J.E., Peel, M.G., Tsakiris , D.J., Briggs,
J.D ., Junor, B.S.R., MacSween, R.N.M. & Sandilands, G.P. (1987)
Correlation between high molecular weight Fc receptor blocking 
factors in serum and renal a llog ra ft surviva l. Transplantation, 44, 
227-233.
175
Foster, S., Wood, K.J. & Morris, P.J. (1987) Suppression of renal 
a l lo g ra f t  re jection in the rat using purif ied  plasma membrane and 
endoplasmic reticulum preparation expressing donor class I major 
h is tocom patib il ity  complex antigen. Transplantation Proceedings. 19,
French, M.E. & Batchelor, J.R. (1969) Immunological enhancement of ra t 
kidney g ra fts . Lancet, i i ,  1103-1106.
French, M.E. & Batchelor, J.R. (1972) Enhancement of renal a llog ra fts  
in rats and man. Transplantion Review. 13, 115-141.
Fuggle, S.V., Errasti, P., Daar, A.S., Fabre J.W, Ting, A.& Morris, 
P.J. (1983) Localisation of major h istocompatib ility  complex (HLA-ABC 
and DR) antigen in 46 kidneys. Transplantation. 35, 385-390.
Fukomoto, T., McMaster, W.R. & Williams, A.F. (1982) Mouse
monoclonal antibodies against rat major h is tocom patib il ity  antigens: 
two la antigens and expression of la and class I antigens in ra t 
thymus. European Journal of Immunology. 12, 237-243
Galfre, G., M ils te in , C & Wright, B. (1979) Rat x ra t hybrid myelomas 
and a monoclonal anti-sd portion of mouse IgG. Nature. 277, 131-133.
Gallico, G. & Mason, D.W. (1978) Correlation between an aberrant
serological response to transplantation antigens and renal a l lo g ra f t
enhancement in allogeneic recipients. Transplantation. 26, 46-51.
Gallico, G.G., Butcher, G.W. & Howard, J.C. (1979) The role of
subregions of the rat major h istocompatib ility  complex in the 
re jec tion  and passive enhancement of renal a l log ra f ts .  Journal of 
Experimental Medicine. 149, 244-253.
Ghezzi,P. & Dinarello, C.A (1988) IL-1 induces IL-1. Specific 
in h ib i t io n  of IL-1 production by interferon- gamma. Journal of
Immunology. 140, 4238-4244.
Gibson, T. & Medawar, P.B. (1943) The fate of skin homografts in man. 
Journal of Anatomy. 77, 299-310.
G i l l ,  T.J. I I I .  (1978) Report of the f i r s t  international workshop on 
a lloantigen ic systems in the ra t. Transplantation Proceedings, 10, 
271-285.
G i l l ,  T.J. I I I . ,  Kunz, H.W., Misra, D.N. & Hassett, A.L.C. (1987) 
The major h istocompatib ility  complex of the ra t.  Transplantation, 43, 
773-785.
Gilman, S.C., Rosenberg, J.S. & Feldman, J.D. (1982) Membrane 
phenotype of the ra t cytotoxic T lymphocyte. Journal of Immunology, 
129, 1012-1016.
176
Gorer, P.A. (1936) The detection of antigenic differences in mouse
erythrocytes _by the employment of immune sera. B r it ish  Journal of 
Experimental Pathology. 17, 42-50. ----------------------------
Gorer, P.A. (1937) Further studies on antigenic differences in mouse
erythrocytes. B rit ish  Journal of Experimental Pathology. 18, 31-36.
Gorer, P.A. (1938) The antigenic basis of tumour transplantation.
Journal of Pathology and Bacteriology. 47, 231-252.
Gorer, P.A., Lyman, S. & Snell, G.D. (1948) Studies on the genetic
and antigenic basis of tumour transplantation. Proceedinos of the
Roval Society. B.. 135, 499-505.
Green, J. & Jotte, R. (1985) Interactions between T helper ce lls  and 
dendr it ic  ce lls  during the rat mixed lymphocyte reaction. Journal of 
Experimental Medicine. 162, 1546-1560.
Grey, H.M. & Chestnut, R. (1985) Antigen processing and presentation 
to T ce lls .  Immunology Today. 6, 101-106.
Gurley, K.E., Lowry, R.P. & Forbes, R.D.C. (1983) Immune mechanisms in 
organ a l lo g ra f t  re jection. I I .  T helper ce lls ,  delayed-type 
hypersensitiv ity  and rejection of renal a l log ra fts . Transplantation. 
36, 401-405.
Flalasz, N.A., O rlo ff ,  M.J. & Hirose, F. (1964) Increased survival of 
renal homografts in dogs after in jection of g ra ft  donor blood. 
Transplantation. 2, 453-458.
Hall, B.M., Dorsch, S. & Roser, B. (1978) The c e l lu la r  basis of
a l lo g ra f t  re jection in. vivo. I. The ce llu la r  requirements fo r f i r s t  
set re jection of heart grafts. Journal of Experimental Medicine. 148, 
878-889.
Hall, B.M., de Saxe, I .  & Dorsch, S.E. (1983) The c e l lu la r  basis of 
a l lo g ra f t  re jection in vivo. I I I .  Restoration of f i r s t  set re jection 
o f heart grafts  by T helper cells in irradiated ra ts. Transplantaion. 
36, 700-705.
H all, B.M., Bishop, G.A., Farnsworth, A., Duggin, G.G., Horvath,
J .G ., Sh ie l, A.G.R. & T i l le r ,  D.J. (1984) Ide n t if ica t ion  of the
c e l lu la r  subpopulations in f i l t r a t in g  re jecting cadaver renal 
a l lo g ra f ts .  Transplantation. 37, 564-570.
H all, B.M., Duggin, G.G., Philips, J .,  Bishop, G.A., Horvath, J.S. & 
T i l l e r ,  D.J. (1984) Increased expression of HLA-DR antigens on renal 
tubular ce lls  in renal transplants: relevance to the re jection
response. Lancet. 2, 247-250.
Hall B M. (1985) Mechanisms maintaining enhancement o f a l log ra f ts .  
I .  Demonstration of a specific suppressor c e l l .  Journal— of 
Experimental Medicine, 161, 123-133.
177
Hancock, W.W., Thomson, N. & Atkins, R.C. (1983) Composition of 
i n t e r s t i t i a l  ce l lu la r  in f i l t r a te  iden tif ied  by monoclonal antibodies 
in renal biopsies of re jecting human renal a l log ra fts .  
Transplantation. 35, 458-463.
Hart, D.N.J. & Fabre, J.W. (1981a) Endogenously produced la antigens 
w ith in  ce lls  of convoluted tubules of ra t kidney. Journal of 
Immunology. 126, 2109-2113.
Hart, D.N.J. & Fabre, J.W. (1981b) Demonstration and characterisation 
o f la posit ive dendritic  cells in the in te r s t i t ia l  connective tissues 
o f ra t heart and other tissues, but not brain. Journal of Experimental 
Medicine. 154, 347-361.
Hart, D.N.J. & Fabre, J.W. (1981c) Passive enhancement of ra t renal 
a l lo g ra f ts  using mouse monoclonal xenoantibodies. Transplantation, 32, 
431-436.
Hart, D.N.J. & Fabre, J.W. (1982) Mechanism of induction of passive 
enhancement. Evidence for an interaction of enhancing antibody with 
donor in te r s t i t ia l  dendritic ce lls . Transplantation. 33, 319-321.
Hayry, P. & Defendi, V. (1970) Mixed lymphocyte cultures produce 
e ffec to r ce l ls :  model in v i tro  for a l log ra f t  re jection . Science, 168,
133-134.
Hayry, P., von Willebrand, E. & Soots, A. (1979) In s itu  e ffector 
mechanisms in ra t kidney a llog ra ft re jection. I I I .  Kinetics of the 
inflammatory response and generation of donor-directed k i l l e r  ce l ls .  
Scandinavian Journal of Immunology, 10, 95-108.
Hendry, W.S., Tilney, N.L., Baldwin, W.M., Graves, M.J., M ilford , E., 
Strom,T. B. & Carpenter, C.B. (1979) Transfer of specific
unresponsiveness to organ a llografts  by thymocytes. Journal of 
Experimental Medicine, 149, 1047-1055.
Herbert, J & Roser, B.(1987) Lymphocyte subpopulations and memory of 
MHC antigens. I .  Quantitative aspects of neonatal heart g ra ft
re jec tion  in normal and immune rats. Transplantation, 43, 556-560.
Hibberd, A.D. & Scott, L.J. (1983) Allogeneic p la te le ts  increase 
survival of ra t renal a llogra fts . Transplantation, 35, 622-624.
H i l l  is ,  A.N., MacLeod, A.M., Al-Muzairai, A., Innes, A., Stewart, 
K.N., Power, D.A., Bone, M.J., Sells, R.A. & Catto, G.R.D (1989) 
A n t i id io typ ic  a c t iv i ty  and sensitisation a fte r donor-specific
transfusion (DST) given with and without cyclosporin A (CsA).
Transplantation Proceedings, 21, 1820-1821.
Hirschberg, H., Evenson, S.A., Henriksen, T. & Thorsby, E. (1975) 
The human mixed lymphocyte-endothelium culture in teraction. 
Transp lan ta t ion  (Baltimore_l, 19, 495-504.
178
Hirschberg, H., Bergh, O.J, & Thorsby, E. (1980) Antigen-presenting 
properties  ^ of human vascular endothelial ce l ls .  Journal of
Experimental Medicine. 152, 249-255. -----------------
Holda, J.H., Maier, T. & Claman, H.N. (1988) Evidence that in terferon- 
is  responsible fo r natural suppressor a c t iv i ty  in GVHD spleen and 
normal bone marrow . Transplantation. 45, 772-777
Hourmant, M., Soulil lou, J.P. & Bui-Quang, D. (1979) Beneficial 
e f fec t of blood transfusion. Role of the time interval between the 
la s t  transfusion and transplantation. Transplantation. 28, 40-43.
Hsiung, L.M., Barclay, A.N., Brandon, M.R., Sim, E. & Porter, R.R.
(1982) Purif ica tion of human C3b inac tiva to r by 
monoclonal-antibody a f f in i t y  chromatoqraohv. Biochemistry Journal, 
203, 293-298.
Hutchinson, I.V. & Zola, H. (1977) Antigen-reactive ce ll opsonisation 
(ARCO). A mechanism of immunoloqical enhancement. Transplantation, 23, 
464-469.
Hutchinson, I.V. (1980) Antigen-reactive cell opsonisation (ARCO) and 
i t s  ro le in antibody mediated immune suppression. Immunology Reviews, 
49, 167-197.
Hutchinson, I.V. & Brent, L. (1982) Effect of decomplementation with
cobra venom factor on the passive immunological enhancement of mouse
skin a l log ra f ts .  Transplantation, 34, 64-67.
Hutchinson, I.V. (1986) Suppressor T ce lls  in allogeneic models.
Transplantation, 41, 547-555.
Hutchinson, I.V. & Morris, P.J. (1986) The role of major and minor
h is tocom patib il ity  antigens in active enhancement of ra t kidney 
a l lo g ra f t  survival by blood transfusion. Transplantation. 41, 166-170.
Inamura, N., Nakahara, K., Kino, T., Goto, T., Aoki, H., Yamaguchi, 
I . ,  Kohsaka, M. & Ochiai, T. (1988) Prolongation of skin a l lo g ra f t  
survival in rats by a novel immunosuppressive agent FK-506. 
Transplantation, 45, 206-209.
Issekutz,T.B., Staltz,J.M. & Meide, P.V.D. (1988) Lymphocyte 
recruitment in delayed-type hypersensitiv ity: the ro le of IFN- .
Journal o f Immunology, 140, 2989-2993.
Jeekel, J . ,  van Dongen, J .,  Majoor, G. & Harder, F. (1977) 
Enhancement of ra t renal a l log ra f t  with antibodies against 
erythrocyte-associated antigens (EAA). Transplantation Proceedings, 9, 
969-972.
Jenkins, A.McL. & W oodru ff ,  M.F.A. (1971) The e ffec t o f p r io r  
administration of donor stra in blood or blood constituents on the 
survival of cardiac a llografts  in rats. Transplantation, 12, 57-60.
179
Jerne, N.K (1974) Towards a network theory of the immune system. 
Annales d Immunologie ( In s t i tu t  Pasteurl. 125C, 373-389.
Jones, M.C., Power, D.A., Cunningham, C & Catto G.R.D. (1988) The
influence of repeated transfusions and cyclosporine on secondary
alloantibody responses in inbred rats. Transplantation. 45, 1094-1099
Kaliss, N. & Molomut, N. (1952) The effect of p r io r in jections of 
tissue antiserum on the survival of cancer homoqrafts in mice. Cancer 
Research. 12, 110-112.
Kamada, N., Shinomiya, T., Tamaki, T. & Ishiguro, K. (1986)
Immunosuppressive a c t iv i ty  of serum from l iv e r  grafted rats.
Transplantation. 42, 581-587.
Kamada, N., Sumimoto, R., Baguerizo, A., Yoshimatsu, A., Teramoto, K. 
& Yamaguchi, A. (1988) Mechanisms of transplantation tolerance induced 
by l iv e r  grafting in rats: involvement of serum factors in clonal
de letion. Immunology. 64, 315-317.
Katz, D.H., Graves, M., Dorf, M.E., Dimuzio,H & Benacerraf B. (1975)
Cell interactions between histoincompatible T and B lymphocytes.
Cooperative responses between lymphocytes are controlled by genes in 
the I region of the H-2 complex. Journal of Experimental Medicine.
141, 263-268.
Kaufman, J .F ., Auffray, C., Korman, A.J., Schackelford, D.A. &
Strominger J. (1984) The class I I  molecules of the human and murine
major h is tocom patib ility  complex. C e ll. 36, 1-13.
Kearns, J.E. & Reid, S.E. (1949) Successful transplantation of skin
from parents to sons. Plastic and Reconstructive Surgery. 4, 502-507.
Kim, B., Rosenstein, M., Weiland, D., Eberlun, T.J. & Rosenberg, S.A.
(1983) Clonal analysis of the lymphoid cells  mediating skin a l lo g ra f t  
re jec t ion . Transplantation. 36, 525-532.
Kino, T., Hatanaka, H., Hashimoto, M., Nishiyama, M., Goto, T., 
Okuhara, M., Kohsaka, M., Aoki, H. & Imanaka, H.(1987) FK-506, a 
novel immunosuppressant isolated from Streptomyces. I Fermentation, 
iso la t ion  and physico-chemical and biological characte ris tics. Journal 
o f A n tib io t ics  (Tokyo). 40, 1249-1255.
Kino, T., Hatanaka, H., Miyata, S., Inamura, N., Nishiyama, M., 
Yajima, T., Goto, T., Okuhara, M., Kohsaka, M., Aoki, H et al (1987) 
FK-506, a novel immunosuppressant isolated from a Streptomyces. I I
Immunosuppressive effect of FK-506 in v i t ro .  Journa] of
Antib io tics(Tokvo), 40, 1256-1265.
Kissmeyer-Nielsen, F., Olsen, S., Petersen, V.P. & Fjeldborg 0 
(1966) Hyperacute re jection of kidney a llog ra fts  associated with 
pre-existing humoral antibody against donor ce l ls .  Lancet,, 2, 662-665.
180
Kissmeyer-Nielsen, F., Svejgaard A. & Hauge, M. (1968) Genet ics of the 
human HL-A transplantation system. Nature. 219, 1116-1119.
Klein, J. (1975) The biology of the mouse h is tocom patib ility-2
complex. New York: Springer Verlag.
Klein, J . , Juretic , A., Baxevanis,C.N. & Nagy, Z.A. (1981) The
tra d it io n a l and a new version of the mouse H-2 complex. Nature, 291, 
455-460.
Krensky, A., Reiss, C., Mier, J .,  Strominger, J. & Burkaroff, S.
(1982) Long term human cy to ly t ic  T cell lines a l lospec if ic  fo r HLA DR6 
antigen are 0KT4+. Proceedings of the National Academy of Sciences, 
USA. 79, 2365-2369.
Laemmli, U.K.(1970) Cleavage of strucural proteins during the assembly 
o f the head of bacteriophage T4. Nature. 227, 680-685.
La ffe rty , K.J., Bootes, A., Dart, G. & Talmage, D.W. (1976) Effect of
organ culture on the survival of thyroid a llog ra fts  in mice.
Transplantation. 22, 138-149.
Lai a, P.K., Chatterjee-Hasrouni, Kearns, M., Montgomery, B. &
Colavincenzo, V. (1983) Immunobiology of the feto-maternal interface. 
Immunological Reviews, 75, 87-116.
Lancaster, F., Chiu, Y.L., & Batchelor, J.R. (1985) A n t i- id io typ ic  T 
ce l ls  suppress re jection of renal a llog ra fts  in ra ts . Nature. 315,
336-337.
Larsen, C.P., Morris, P.J., & Austyn, J.M. (19901 Migration of
dendr it ic  leucocytes from cardiac a llog ra fts  into nost spleens. A 
novel pathway fo r in i t ia t io n  of re je c t ion .Journal of Experimental 
Medicine, 171, 307-313.
Lauchart, W., Alkins, B.J. & Davies,D.A.L. (1980) Only B lymphocytes 
induce active enhancement of rat cardiac a l log ra fts . Transplantation, 
29, 259-261.
Lechler, R.I. & Batchelor, J.R. (1982) Restoration of immunogenicity 
o f passenger cell-depleted kidney a llogra fts  by the addition of donor 
s tra in  dendrit ic  ce lls . Journal of Experimental Medicine, 155, 31-41.
Lechler, R .I . ,  Lombardi, G., Batchelor, J.R., Reinsmoen, N. & Bach
F.H. (1990) The molecular basis of a l lo re a c t iv i ty .  Immunology Today, 
11, 83-88.
Lelchuk, R.,& P layfair, J.H.L (1985) Serum 11-2 in h ib i to r  in mice. 
Increase during in fection. Immunology, 56, 113-118.
Lenhard, V., Renner, D., Hansen, B. & Opelz, G. (1985) Suppressor 
cell-mediated regulation of antibody response and g ra ft  survival 
fo llowing multip le donor-specific transfusions in the ra t.  
Transplantation Proceedings, 17, 1093-1096.
181
Lew, A.M., L i l le h o j,  E.P., Cowan, M.L., Maloy, M.R., Van Shiavenijk,
M.R. & Colijan, J.E. (1986) Class I genes and molecules: an update.
Immunology. 57,
Loveland, B.E., Hogarth, P.M., Ceredig, R. & McKenzie, I.F.C. (1981)
Cells mediating g ra ft rejection in the mouse. I .  Lyt 1 ce lls  mediate
flS]1! re jection. Journal of Experimental Medicine. 153,
1044-1057. ------------------------------
Loveland, B. & Simpson, E. (1986) The non-MHC transplantion antigens: 
neither weak nor minor. Immunology Today. 7, 223-229.
Lowry,R.P., Gurley,K.E. & Forbes, R.D.C. (1983) Immune mechanisms in 
organ a l lo g ra f t  re jection. I .  Delayed-type hypersensitiv ity  and 
lymphocytotoxicity in heart g ra ft re jection . Transolantation. 36.
391-401.
Lowry, R.P. & Gurley, K.E. (1983) Immune mechanisms in organ a l lo g ra f t  
re jec t ion . I I I .  Cellu lar and humoral immunity in re jection of organ 
a l log ra fts  transplanted across MHC subregion d ispa r ity  RT.l.B. 
(RT1.D). Transplantation. 36, 405-411.
Lynch, D.H., Weiland,D.J., Rosenberg, S.A. & Hodes, R.J. (1987)
D iffe ren t sp e c if ic it ie s  of cloned T ce lls  assessed by in v i t ro
p ro l i fe ra t io n  assays and by the a b i l i t y  to mediate skin g ra ft
re jec tion  in vivo. Transplantation. 43, 408-411.
MacLean, C.A., Goudie, B.M., MacSween, R.N.M & Sandilands, G.P. 
(1984) Serum Fc gamma-receptor-like molecules in primary b i l ia r y
c ir rh os is : a possible immunoregulatory mechanism. Immunology, 53,
315-324.
MacLeod, A.M., Mason, R.J., Stewart, K.N., Power,D.A., Shewan, W.G., 
Edward, N. & Catto, G.R.D. (1982) Association of Fc receptor blocking 
antibodies and human renal transplant surviva l. Transplantation, 34, 
273-279.
MacLeod, A.M., Power, D.A., Mason, R.J., Stewart, K.N., Shewan, W.G., 
Ward, N. & Catto, G.R.D. (1982) Possible mechanism of action of the 
transfusion effect in renal transplantation. Lancet, 2, 468-470.
MacLeod, A.M., Mason, R.J., Power, D.A., Mather, A .J., Edward, N., 
Stewart, I.C.N., Shewan, W.G., Urbaniak, S. & Catto, G.R.D. (1985) 
Evidence that protective Fc receptor blocking antibodies in renal 
transplantation are alloantibodies not autoantibodies. 
Transplantation. 39, 520-523.
MacLeod, A.M., Stewart, K.N., Urbaniak, S. & Catto, G.R. (1988) 
Renal transplantation - HLA linked, non-cytotoxic antibodies 
develop a fte r blood transfusion. C lin ical Science, 74, 385-388.
182
Madsen, J .C ., Superina, R.A., Wood, K.J. & Morris, P.J. (1988) 
Immunological unresponsiveness induced by recip ient ce lls  transfected 
with donor MHC genes. Nature. 332, 161-164.
Marquet, R.L., Heystek, G.A. & Tinbergen, W.J. (1971) Specific 
in h ib it io n  of organ a llog ra ft re jection by donor blood. Transolant 
Proceedings. 3, 708-710.
Marquet, R.L. & Heystek, G.A. (1981) Induction of suppressor ce lls  
by donor-specific blood transfusions and heart transplantation in 
ra ts . Transplantation. 31, 272-274.
Marrack, P. & Kappler, J. (1988) T ce lls  can distinguish between 
allogeneic major histocompatibility complex products on d if fe re n t ce ll 
types. Nature. 332, 840-843.
Martin, D.C., Hewitt, C.W., Osborne, J.G., Dowdy,S.F., Fristoe, T .L., 
Russell, L.A. & Cote, J. (1982) Enhanced kidney g ra ft  survival in 
rats by single or multiple blood transfusions and various blood 
products. Transplantation Proceedings. 14, 407-409.
M a r t in e l l i ,  G.P., Racelis, D., Giannone, G., M i l le r ,  C.M., Gretz, E.
& Schanzer, H. (1983) Interaction of pretransplant blood transfusions 
and cyclosporin-A in rats. Transplantation Proceedings. 15, 988-993.
M a r t in e l l i ,  G.P., Horowitz, C., Chiang, K., Racelis, D.& Schanzer H.
(1987) Pretransplant conditioning with donor-specific transfusions 
using heated blood and cyclosporine. Preservation of the transfusion 
e ffec t in the absence of sensitisation. Transplantation, 43, 140-145.
Mason, D.W., Pugh, C.W. & Webb, M. (1981) The ra t mixed lymphocyte 
reaction: roles of a dendritic cell in in te rs t ina l lymph and T-cell 
subsets defined by monoclonal antibodies. Immunology, 44, 75-87.
Mason, D.W. & Morris, P.J. (1984) Inh ib it ion  of the accumulation, in 
ra t kidney a llog ra fts , of specific -but not nonspecific-cytotoxic 
ce l ls  by cyclosporin. Transplantation, 37,46-51.
Mason, D.W. & Simmonds, S.J. (1988) The autonomy o f CD8+ T ce l ls  in
v i t r o  and in vivo. Immunology. 65, 249-257.
McDevitt, H.0. & Tyan, M.L. (1968) Genetic control o f  the antibody
response in inbred mice. Journal of Experimental Medicine, 128, 1-11.
McDevitt, H.0. & Benaceraff, B. (1969) Genetic control o f spec if ic
immune responses. Advances in Immunology, 11, 31-74.
McKenzie, I.F .L . & Henning, M. (1977) The H-2 complex: immunogenic i ty  
and enhancement studies o f H-2K region alloantigens. Journal._gf 
Immunoqenetics, 4, 249-257.
183
McKenzie, J .L . ,  Fabre, J.W. & Morris, P.J. (1980) Studies on the 
content o f a n t i- la  and anti-SD antibodies in ra t allosera raised 
oQr07Q7m?o2r  histocompatib ility complex differences. Transplantation,
McMaster, W.R., Williams, A.F. (1979) Ide n t if ica t ion  of la 
glycoproteins in ra t thymocytes and pu r if ica t ion  from ra t spleen. 
European Journal of Immunology.9. 426-433.
McWhinnie, D.L., Thompson, J.F., Taylor, H.M., Chapman, J.R., Bolton, 
E.M., Wood, R.F.M. & Morris P.J. (1985) Leucocyte in f i l t r a t io n  
patterns in renal a llografts  assessed by immunoperoxidase staining 
o f 245 sequential biopsies. Transplantation Proceedings. 17, 560-561.
McWhinnie, D.L., Thompson, J.F., Taylor, H.M., Chapman, J.R., Bolton,
E.M., Carter, N.P., Wood, R.F.M. & Morris, P.J. (1986) Morphometric 
analysis of ce l lu la r  in f i l t r a t io n  assessed by monoclonal antibody 
lab e ll ing  in sequential human renal a l lo g ra f t  biopsies. 
Transplantation, 42, 352-358.
Medawar, P.B. (1944) The behaviour and fate of skin autografts and
skin homografts in rabbits (A report to the War Wounds Committee of
the Medical Research Council). Journal of Anatomy, 78, 176-199.
Medawar, P.B. (1945) A second study of the behaviour and fate of skin 
homografts in rabbits (A report to the War Wounds Committee of the 
Medical Research Council). Journal of Anatomy, 79, 157-176.
Medawar, P.B. (1946) Immunity to homologous grafted skin: I I .  The
re la tionsh ip  between the antigens of blood and skin. B r it ish  Journal 
o f Experimental Pathology, 27, 15-24.
Meuer, S.C., Hussey, R.F., Penta, A.C., Fitzgerald, K.A., Stadler,
B.M., Schlossman, S.F. and Reinherz, E.L. (1982) Cellu la r o r ig in  of 
in te r leuk in  2 (IL2) in man - Evidence fo r s timulus-restric ted IL2
production by T4+ and T8+ T lymphocytes. Journal of Immunology, 129, 
1076-1079.
M il le r ,  C.M., M a rt ine ll i ,  G.P., Racelis, D. & Schanzer, H. (1982) 
Prolongation of ra t cardiac a llografts  by pretransplant administration 
o f blood transfusions and cyclosporin A. Transplantation, 33, 335-337.
M ilton, A.D. & Fabre, J.W. (1985) Massive induction of donor-type 
class I and class I I  major h istocompatib ility  complex antigens in
re jec ting  cardiac a llografts  in the ra t.  Journal of Experimental 
Medicine, 161, 98-112.
M ilton, A.D., Spencer, S.C. & Fabre, J.W. (1986a) Detailed analysis 
and demonstration of differences in the k inetics of induction of
class I and class I I  major h istocompatib ility  complex antigens in
re jec ting  cardiac and kidney a llogra fts  in the ra t .  Transplantation, 
41, 499-508.
184
Milton, A.D., Spencer, S.C. & Fabre, J.W. (1986b) The effects of
cyclosporin on the induction of donor class I and class I I  antigens 
IJ-, anc* Sidney a llografts  in the ra t.  Transplantation, 42,
337-347.
Mintz, B. & Silvers, W. (1970) H istocompatib ility  antigens on
melanoblasts and hair f o l l i c le  ce lls : ce l l- lo ca l ised homograft
re jec tion  in allophenic skin grafts . Transplantation. 9, 497-505.
Mohagheghpour, N., Damle, N.K., Takada, S. & Engleman, E.G. (1986) 
Generation of antigen receptor-specific suppressor T ce ll clones in 
man. Journal of Experimental Medicine. 164, 950-955.
Morris, P.J. (1980) Suppression of re jection of organ a l log ra fts  by 
alloantibody. Immunological Reviews. 49, 93-125.
Morris, P.J. (1988) In Kidney Transplantation. Principles and
Practice.3rd Edition.Chapter 30, pp737-758.Philadelphia, W.B.Saunders.
M ott iron i, V.D. & Terasaki, P.I. (1970) Detection of non-HLA
antibodies. In Histocompatibility Testing, ed. Terasaki, P .I. pp 
301-308. Copenhagen: Munksgaard.
Mullen, Y., Raison, R. & Hildemann, W. (1977) Cytotoxic versus 
immunoblocking effects of specific alloantibodies. Effects o f IgM, 
IgG and IgG2 on ra t kidney a l log ra f t surviva l. Transplantation. 24, 
99-105.
Murray, J .E ., M e rr i l l ,  J.P., Harrison, J.H., Wilson, R.E. & Dammin,
G.J. (1963) Prolonged survival of human kidney homografts by 
immunosuppressive drug therapy. New England Journal of Medicine. 268, 
1315-1323.
Nagata, M., Ochiai, T., Asuno, T., Gunji, Y., Enomoto, K., Nakajima, 
K., Uematsu, T. & Sato H. (1984) Role of la -pos it ive  ce lls  in the 
beneficia l e ffect of donor blood transfusion and induction of 
suppressor ce lls  in cardiac a llo transplantation of ra ts. 
Transplantation, 38, 522-526.
Natori, T., Ohashi, T., Inomata, T., Fujimoto, Y., Ishida, Y., 
Kosahara, M. & Aizawa, M. (1983) Immunochemical evidence fo r  multip le 
B units of the class I I  molecules in the ra t .  Journal of 
Immunogenetics, 10, 439-452.
Nemlander, A., Saksela, E. & Hayry, P. (1983) Are natural k i l l e r  
ce l ls  involved in a l log ra f t  rejection? European Journal of Immunology, 
13, 348-350.
185
y  M., Nakajima, K., Susuki, T., Sakamoto, K.,
Enomoto, K., Gunji, Y., Uematsu, T., Goto, T., Hori, S., Kenmoch, T., 
Nakagouri, T., Asano, T., Isono, K., Hamaguchi, K., Tsuchida, H., 
Nakahara, K., Inamura, M.& Goto, T (1987) Studies on the e ffec t of 
FK506 on renal a llogra fting  in the beaqle dog. TransDlantation. 44. 
729-733. -----------------------
Ochiai, T., Nakajima, K., Nagata, M., Hori, S., Asano, T. & Isono, K.
(1987) Studies on the induction and maintenance of long-term g ra ft 
acceptance by treatment with FK506 in heterotopic cardiac 
a llo transplantation in rats. Transplantation. 44, 734-738.
Ockner, S.A., Guttman, R.D. & Linquist, R.R. (1970a) Renal 
transplantation in the inbred ra t. Modification of re jection by 
active immunisation with bone marrow ce lls . Transplantation. 9, 31-38.
Oehler, J.R., Heberman, R.B., Campbell, D.A & Djeu J.Y. (1977) 
In h ib it io n  of ra t mixed leucocyte cultures by suppressor 
macrophages. Cellu lar Immunology. 29, 238-250
Oikawa, T., Yoshida, M.C., Satoh, H., Yamishmia, K., Sasaki, M. & 
Kobayashi, H. (1983) Provisional chromosome assignment of the ra t 
major h is tocom patib il ity  complex. Japanese Journal of Genetics. 58, 
327-336.
Opelz, G., Sengar, D.P.S., Mickey, M.R. & Terasaki, P .I. (1973) Effect 
o f blood transfusions on subsequent kidney transplants. 
Transplantation Proceedings. 5, 253-259.
Opelz, G. & Terasaki, P.I. (1974a) Poor kidney transplant survival in 
recip ients with frozen blood transfusions or no transfusions. Lancet. 
2, 696-698.
Opelz, G., Mickey, M.R. & Terasaki, P .I. (1974b) HL-A and kidney 
transplants: re-examination. Transplantation. 17, 371-382.
Opelz, G. & Terasaki, P.I. (1978) Improvement of kidney g ra ft 
survival with increased numbers of blood transfusions New England 
Journal o f Medicine. 299, 799-803.
Owen, R.D. (1945) Immunogenetic consequences of vascular anastamoses 
between bovine twins. Science, 102, 400-401.
Padberg, W.M., Lord, R.H.H., Di Stefano, R., Araneda, D. Tilney,N. & 
Kupiec-Weglinski, J.W. (1988) Synergy between subtherapeutic doses of 
cyclosporine and immunologic enhancement in ra t recip ients of cardiac 
a l lo g ra f ts .  Transplantation, 45, 162-168.
Pallardo, L.M.,Montoro, J . ,  Moll, J.M., Sanchez, J . ,  Soler, M.A., 
Marty M & Cruz, J.M. (1985) P latelet transfusions do not improve
cadaveric renal a l log ra f t survival. Transplantation Proceedings, 17, 
2338-2339.
186
Parish, C.R. & Hayward, J.A. (1974) The lymphocyte surface. I. 
Relation between Fc receptors C3 receptors and surface Ig. 
Proceedings of the Roval Society of London R. 87, 47-63
Park, M.S., Terasaki, P.I. & Bernoco, D. (1977) Autoantibody against B 
lymphocytes. Lancet. 2, 465-468.
Payne, R & Rolfs, M.R. (1958) Fetomaternal leucocyte incom patib il ity . 
Journal of C lin ical Investigation. 37, 1756-1763.
Payne, R., Tripp, M., Weigle, J .,  Bodmer, W.F. & Bodmer, T. (1964) A 
new leucocyte iso-antigen system in man. Cold Spring Harbor Symposia 
on Quantitative Biology. 29, 285-295.
Perlmann, P. & Holm, G. (1969) Cytotoxic effects of lymphoid ce lls  in 
v i t ro .  Advances in Immunology. 11, 117-193.
Persijn, G.G., D'Amaro, J. & Van Rood, J.J. (1984) Pretransplant blood 
transfusions and lonq term renal a l lo g ra f t  surv iva l. Lancet. 2, 
1043-1044.
Peugh, W.N., Austyn, J.M., Carter, N.P., Wood, K.J. & Morris, P.J.
(1987) In a b i l i ty  of dendritic ce lls  to prevent the blood transfusion 
e ffec t in a mouse cardiac a llog ra ft model. Transplantation. 44, 
706-770.
P la t t ,  J .L . ,  Le Bien, T.W. & Michael, A.F.J. (1982) In te r s t i t ia l  
mononuclear cell populations in renal g ra ft re jec tion . Journal of 
Experimental Medicine. 155, 17-30.
Pober, J.S., Gimbrone, M.A., Cotran, R.S., Reiss, C.S., Burakoff, 
S .J., Fiers, W. & Ault, K.A. (1983) la expression by vascular 
endothelium is inducible by activated T ce lls  and by human 
- in te rfe ron . Journal of Experimental Medicine. 157, 1393-1353.
Pohanka, E., Manfro, R.C., Oto, C., Colombe, B.W., Melzer, J .,  
Feduska, N., Salvatierra, 0. & Garavoy, M.R. (1989) A n t i- id io typ ic
antibodies to HLA afte r donor-specific blood transfusion (DST). 
Transplantation Proceedings, 21, 1806-1809.
Power, D.A., Cunningham, C. & Catto, G.R.D. (1987) The ro le of RT1 
antigen differences in semi-allogeneic ra t pregnancy. C l in ica l 
Science. 72, 37-45.
Priestley, C.A.. & Fabre, J.W. (1989) D ifferent patterns of donor MHC 
antigen induction in ra t kidney a llog ra fts  following active and 
passive enhancement. Transplantation, 48, 275-280.
P riestley, C.A., Dalchau, R., Sawyer, G.J. & Fabre, J.W. (1989) A 
detailed analysis of the potential o f water-soluble class I MHC 
molecules fo r the suppression of kidney a l lo g ra f t  re jection and in 
v i t ro  cytotoxic responses. Transplantation, 48, 1031-1038.
187
Quigley, R«L., Wood, K.J. & Morris, P.J. (1988) Investigation of the
mechanism of active enhancement of renal a l lo g ra f t  survival by blood 
transfusion. Immunology. 63, 373-381.
Quigley, R.L., Wood, K.J. & Morris, P.J. (1989a) Transfusion induces
463°470OnOr S^ ec suppressor ce lls . Journal of Immunology. 142,
Quigley, R.L., Wood, K.J. & Morris, P.J. (1989b) Mediation of antigen 
induced suppression of renal a l log ra f t re jection by a CD4 (W3/25+) T 
Cell. Transplantation. 47, 684-688.
Quigley, R.L., Wood, K.J. & Morris, P.J. (1989c) Mediation of the 
induction of immunologic unresponsiveness following antigen
pretreatment by a CD4 (W3/25+) T ce ll appearing trans ien tly  in the
splenic compartment and subsequently in the TDL. Transplantation, 47. 
689-695.
Radojcic, A., Stranick, K.S., Locker,J., Kunz, H.W. & G i l l ,  T.G. I l l
(1989) Nucleotide sequence of a ra t class I cDNA clone. 
Immunogenetics, 29, 134-37.
Reed, F.M., Peel, M.G., Ja rre tt ,  F. & Sandilands, G.P. (1983) 
Modulation of human peripheral blood lymphocyte Fc receptors by 
immune complexes: recovery of Fc receptors in the presence of normal
human serum. Immunology, 48, 281-289.
Renkonen, R., Soots, A., von Willebrand, E. & Hayry, P. (1983) 
Lymphoid ce ll subclasses in re jecting renal a llog ra fts  in the ra t.  
Cell Immunology, 77, 187-195.
Renkonen, R. Ristimaki, A. & Hayry P (1988). Interferon- protects 
human endothelial ce lls  from lymphokine activated k i l l e r  cell-mediated 
ly s is .  European Journal of Immunology, 18, 1839-1842.
Roberts, & Hayry, P. (1976) Sponge matrix a l lo g ra fts .  A model fo r 
analysis of k i l l e r  ce lls  in f i l t r a t in g  mouse a l log ra f ts .  
Transplantation, 21, 437-445
Rosenberg, A.S., Mizouchi, T. & Singer, A. (1986) Analysis of T-cell 
subsets in re jection of KD mutant skin a llog ra fts  d i f fe r in g  at class I 
MHC. Nature, 322, 829-831.
Ruiz, P., Coffman, J.M. & Howell D.N. (1988) Evidence that 
pretransplant donor blood transfusion prevents ra t renal a l lo g ra f t  
dysfunction but not the in s itu  ce l lu la r  alloimmune or morphologic 
manifestations of re jection. Transplantation, 45, 1-7.
Ruiz, P., Howell, D.N., Baldwin, W. & Sanfilippo F. (1989) 
S im ila r i t ie s  in long-term alloreactive T ce ll l ines propagated from 
transfusion-enhanced and contro l-re jecting ra t renal a l lo g ra f ts .  
Transplantation, 47, 390-394
188
Salvatierra, B., Vincenti, F., Amend, W., Potter, D., Iwaki, Y.,
E i J i f t i j ’ ^ Cochrum,K., Hanes, D.,Stoney,R.& Feduska
, N .J .(1980) Deliberate donor specific blood transfusions p r io r  to 
l iv in g  related renal transplantation. A new aDDroach. Annals of 
Surgery. 192, 543-552.------------------------------------------------------------- --------------
Salvatierra , 0., Amend, W., Vincenti, R., Potter, D., Iwaki, Y.,
Opelz, G., Terasaki, P., Duca, R., Hanes, D., Cochrum, K.C., Hopper, 
S. & Feduska, N.J. (1981a) Pretreatment with donor-specific blood 
transfusions in related recipients with high MLC. Transplantation 
Proceedings. 13, 142-149.
Salvatierra, 0., Iwaki, V., Vincenti, F., Amend, W., Potter, D.,
Opelz, G., Terasaki, P., Duca,R., Hopper, S. & Feduska, N. (1981b)
Incidence, characteristics and outcome of recip ients sensitised 
a f te r  donor-specific blood transfusions. Transplantation. 32, 528-531.
Salvatierra , 0 ., Melzer, J .,  Vincenti, F., Amend, W.J.C.,
Tomlanovich, S., Potter, D., Husing, R., Garovoy, M. & Feduska, N.J.
(1987) Donor-specific blood transfusions versus cyclosporine - The DST 
story. Transplantation Proceedings. 19, 160-166.
Salvatierra , 0., Melzer, J .,  Potter, D., Garovoy, M., Vincenti, R., 
Amend, W.J., Husing, R., Hopper, S. & Feduska, N.J. (1988) A seven
year experience with donor specific blood transfusion: results and
considerations fo r maximum efficacy. Transplantation. 40, 654-659.
Schwartz, R. & Dameshek, W. (1959) Drug induced immunological 
tolerance. Nature (Lond), 183, 1682-1683.
Schwartz,R.H.(1985) T lymphocyte recognition of antigen in association 
with gene products of the major h is tocompatib ility  complex. Annual 
Reviews in Immunology,3, 237-261
Setta f, A., Milton, A.D., Spencer, S.C., Houssind, D. & Fabre, J.W.
(1988) Donor class I and class I I  major h is tocom patib il ity  complex 
antigen expression following l iv e r  a llog ra ft ing  in re jecting and non 
re jec ting  ra t s tra in combinations. Transplantation, 46, 32-40.
Shelby, J . ,  Wakely, E. & Corry, R.J. (1984) Suppressor ce ll induction 
in donor specific  transfused mouse heart rec ip ients. Surgery, 96, 
296-300.
Sherwood, R., Brent, L. & Rayfield, L.S. (1986) Presentation of
alloantigens by host ce lls . European Journal of Immunology, 16,
569-574.
Shohat, B., Cytron, S., Boner, C. & Damony, L. (1987) Blocking 
antibodies and T cell subsets in long term survivors o f renal 
a l lo g ra f ts .  Transplantation, 44, 34-37.
189
Singal, D.P., Joseph, S. & Szewczulc, M.R. (1982) Possible mechanism 
of the beneficial e ffect of pretransplant blood transfusions on 
renal a l lo g ra f t  survival in man. Transplantation Proceedings. 14,
Singal, D.P., Ludwin, D., Joseph, S., Blajchman, M.A., Ofosu, F.A. & 
Liad, S.K. (1986) Induction of a n t i- id io typ ic  antibodies by blood 
transfusions. Characterisation of T-cell a lloantigen-specific  
receptors by sera from transfused mice. Transplantation. 42, 632-635.
Singh, S.K., Marquet, R.L., de Bruin, R.W.F., Westbroek, D.L. & 
Jeekel, J. (1987) The role of suppressor ce lls  in the blood 
transfusion phenomenon. Transplantation Proceedings. 19, 1442-1444.
Skinner, M . & Marbrook, J. (1976) An estimation of the frequency of
precursor ce lls  which generate cytotoxic lymphocytes. Journal of 
Experimental Medicine. 143, 1562-1567.
Smith, M.D., Williams, J.D., Coles, G.A. & Salaman, J.R. (1983) Blood 
transfusions, suppressor T ce lls , and renal transplant surviva l. 
Transplantation. 36, 647-650.
Snell, G.D. (1948) Methods fo r the study of h is tocom patib il ity  genes. 
Journal o f Genetics. 49, 87-103.
Solheim, B.G., Thorsby, E. & Moller E. (1976) Inh ib it ion  of the Fc 
receptor of human lymphoid cells  by antisera recognising determinants 
o f the HLA system. Journal of Experimental Medicine. 143, 1568-1573.
Sou li l lou , J.P., Carpenter, C.B., d'Apice, A.J.F. & Strom, T.B. 
(1975) The role of non classical, Fc receptor associated, Ag-B(Ia) 
antigens in ra t a l log ra f t enhancement. Journal o f Experimental 
Medicine. 143, 405-421.
S ou li l lou , J.P., Peyrat, M.A., Guenel, J. (1978) Studies of the 
antibodies against HLA, Ia-Like, Fc and or C3 receptors present in 
pre-transplant sera : anti-B cell antibodies not associated with
accelerated g ra ft loss. Transplant Proceedings. 10, 475-477
S ou li l lou , J.P. & Peyrat, M.A. (1979) Failure to block lymphocyte Fc 
receptor with anti-B lymphocyte sera (anti-DRw) in man. Immunology, 
36, 319-525.
S ou li l lou , J.P., Blandin, F., Gunter, E. & Lemoine, V. (1984) 
Genetics o f the blood transfusion effect on heart a l log ra fts  in rats. 
Transplantation. 38, 63-67.
S ou li l lou , J.P., Blandin, F. & Gunter, E. (1985) Sharing o f RT1-B 
region between organ donor and blood donor is required fo r  optimal 
prolongation of heart a llogra fts  by blood transfusion. 
Transplantation Proceedings, 17, 1914-1915.
Spiegel, J .P .(1988) Effects of interferon- on the activa tion o f human 
T lymphocytes. Cellu lar Immunology, 111, 461-472.
190
Sgits» J-’ Terl?orst’ c - & De Vries, J.E. (1982) The role
O' T cell d if fe re n t ia t io n  markers in antigen-specific and
lectin-dependent ce l lu la r  cy to tox ic ity  mediated by T8+ and T4+ human 
cytotoxic T ce ll clones directed at class I and class I I  MHC antigens. 
Journal of Immunology. 129, 1563-1569.
Sprent, J . ,  Shaefer, M., Lo, D. & Korngold, P. (1986) Properties of
pu r if ied  T ce ll subsets. I I .  In vivo responses to class I and class I I
H-2 differences. Journal of Experimental Medicine. 163, 998-1011.
Staines, N.A., Guy, K. & Davies, D.A.L. (1975) The dominant ro le of 
la antibodies in the passive enhancement of H-2 incompatible skin 
g ra fts .  European Journal of Immunology. 5, 782-789.
Staines, N.A., Gray, K., Fish, F., Sworn, J .L . ,  Davies, D.A.L. & 
Festenstein, H. (1977) Passive enhancement and antigens of d if fe re n t 
regions o f  the mouse H-2 complex. Transplantation Proceedings. 9,
941-943.
Steinbuch, M. & Audran, R (1969) The iso la tion of IgG from mammalian 
sera with the aid of caprylic acid. Archives of Biochemistry and 
Biophysics, 134, 279-284
Stein iger, B., Klempnauer, J. & Wonigeit, K. (1985) Effect of the 
re jec tion  process on class I and class I I  major h is tocom patib il ity  
complex antigen expression in the ra t pancreas. Transplantation 
Proceedings, 17, 407-411.
Steinman, R.M. & Witner, M.D. (1978) Lymphoid dendrit ic  ce lls  are 
potent stimulators of the primary mixed leucocyte reaction in mice. 
Proceedings of the National Academy of Science, USA, 75, 5132-5136.
Steinman, R.M., Gutchinov B., Witner, M.D. & Nussenzweig, M.C. (1983) 
Dendritic ce lls  are the primary stimulators of the primary mixed 
leucocyte reaction in mice. Journal of Experimental Medicine, 157, 
613-627.
Strassman, G. & Bach, F. (1984) 0KT4+ cytotoxic T ce lls  can lyse 
targets via class I molecules and can be blocked by monoclonal 
antibody against T4 molecules. Journal of Immunology, 133, 1705-1709.
Strom, T.B., Carpenter, C.B., Garaway, M., Abbas, A.K., Carson, J.M., 
Bear, R.A. & Soulil lou, J.P. (1975) Modification of the ra t alloimmune 
response by enhancing antibodies and the role of blocking factors 
in the survival of renal g ra fts . Transplantation, 20, 368-380.
Strom, T.B., Tilney, N.L., Paradysz, J.M., Bancewicz, J. & Carpenter, 
C.B.(1977) Cellu lar components of a l lo g ra f t  re jec tion : id e n t ity ,
s p e c i f ic i ty ,  and cytotoxic function o f ce lls  in f i l t r a t in g  acutely 
re jec ting  a l log ra f ts . Journal of Immunology, 118, 2020-2026.
191
Stuart, F.P., Scollard, D.M., McKearn, T.J. & Fitch, F.W. (1976) 
C e llu la r and humoral immunity a fte r allogeneic transplantation in the 
ra t .  Appearance of an t i- id io typ ic  antibody and i ts  re la tionship to 
c e l lu la r  immunity a fte r treatment with donor spleen ce lls  and 
alloantibody. Transplantation (Baltimore). 22, 455-466.
Stuart, F.P., Saitoh, T. & Fitch, F.W. (1968) Rejection of renal
a l lo g ra f ts :  specific immunologic suppression. Science. 160, 1463-1465.
Stuart, F.P., McKearn, T.J. & Fitch, F.W. (1979) Enhancement of ra t
renal a llog ra fts  with monoclonal antibody. Surgery. 86, 30-34.
Stuart, F.P., Fitch, F.W. & McKearn, T.J. (1982) Enhancement of ra t
renal a llog ra fts  with id io typ ic  and a n t i- id io ty p ic  monoclonal 
alloantibodies. Transplantation Proceedings. 14, 313-315.
Sunderland, C.A., McMaster, W.R. & Williams, A.F. (1979) Purif ica tion  
with monoclonal antibody of a predominant leucocyte common antigen and 
glycoprotein from ra t thymocytes. European Journal of Immunology. 9, 
155-159.
Superina, R.A., Wood, K.J. & Morris, P.J. (1985) Prolongation of
cardiac a l lo g ra f t  survival in the mouse using cloned donor class I 
antigens. Transplantation Proceedings. 17, 2423-2424.
Superina, R.A., Wood, K.J. & Morris, P.J. (1987) The e ffec t of
pretreatment with a single cloned donor class I gene product on
cardiac a l lo g ra f t  survival in mice. Transplantation. 44, 719-721.
Suthanthiran, M., Garovoy, M.R., Fagan, G., Gailunas, P. & 
Carpenter, C.B. (1977) Evidence fo r close association between B-cell
Fc receptor and la antigens, and independence from HLA-A,B locus 
determined antigens. Transplantation Proceedings. 9, 1705-1707.
Suthanthiran M., Gailiunas, P., St.Louis G., Fagan, G., Carpenter, 
C.B. Garavoy, M.R.(1977) Presensitisation to donor B cell ( la) 
antigens is associated with early a l log ra f t  fa i lu re  . Transplantation 
Proceedings. 9, 1807-1809
Suthanthiran, M., Gailunas, P., Fagan, G., Strom, T.B., Carpenter,
C.B. & Garavoy M.R. (1978) Detection of anti-donor la antibodies; a 
strong correlate of re jection. Transplantation Proceedings, 10, 
605-607
Suthanthiran, M., Catto, G.R.D., Kaldany, A., Geroge, K., Garavoy, 
M.R. Strom, T.B. & Carpenter, C.B. (1979) D if fe ren t ia l antibody 
responses to Ag-B (A region) and la (B region) antigens during 
enhancement of ra t renal a llog ra fts . Transpl antation., 28, 4-9.
Svejgaard, A., Nielsen, L.S., Ryder, L.P., Kissmeyer-Nielsen, F., 
Sandberg, L., Lindholm, A. & Thorsby, E. (1972) In H istocompatib ility  
Tpst.ina 1972. ed. Dausset, J, & Colombi, J. pp 465-473. Copenhagen: 
Munksgaard.
192
Swain, S.L. (1983) T cell subsets and the recognition of MHC class. 
Immunology Review. 74, 129-142.
Terasaki, P . I . ,  Mickey, M.R. & Kre is ler, M. (1971) Presensitisation 
and kidney transplant fa i lu res . Postgraduate Medical Journal. 47. 
89-100. --------------------------------------
Terasaki, P .I. (1984) The beneficial transfusion e ffec t on kidney 
g ra ft  survival attr ibuted to clonal deletion. Transplantation. 37,
Thorsby, E. & Piazza, A. (1975) Joint report from the Sixth 
International H istocompatibility Workshop Conference. Typing fo r 
HLA-D (LD-1 or MLC) determinants. In H istocompatib ility  Testing 1975. 
ed. Kissmeyer-Nielsen, F. pp414-422, Copenhagen: Munksgaard.
Tilney, N.L. & Bell, P.R.F. (1974) Studies on enhancement of cardiac 
and renal a llog ra fts  in the ra t.  Transplantation. 18, 31-37.
Tilney N.L., Strom, T.B., Macpherson S.G. & Carpenter, C.B. (1975) 
Surface properties and functional characteristics of in f i l t r a t in g  
ce l ls  harvested from acutely re jecting cardiac a llog ra fts  in inbred 
ra ts . Transplantation. 20, 323-330.
Tilney, N.L., Notis-McConarty, J. & Strom, T.B. (1978) S pec if ic ity  of 
c e l lu la r  migration into cardiac a llog ra fts  in ra ts. Transplantation. 
26, 181-186.
Tilney, N.L., Graves, M.J & Strom, T.B. (1978) Prolongation of organ
a l lo g ra f t  survival by syngeneic lymphoid ce l ls .  Journal of Immunology. 
121, 1480-1482.
Thomson, A.W., Stephen, M.E., Woo, J . ,  Hasan, N.U.& Whiting, P.H
(1989) Immunosuppressive a c t iv i ty ,  T cell subset analysis and acute 
to x ic i t y  of FK-506 in rats. Transplantation Proceedings. 21,
1048-1049.
Townsend, A.R.M., Rothbard, J . ,  Gotch, F.M., Bahadur, G., Wraith, D. 
& McMichael, A.J. (1986) The epitopes of influenza nucleoprotein 
recognised by cytotoxic T lymphocytes can be defined with short
synthetic peptides. Cell, 44, 959-968.
Tufveson, G., Forsum, U., Claesson, K., Klareskog, L., Larsson, E.,
Karlsson-Pavra, A. & Frodin, L. T-lymphocyte subsets and
HLA-DR-expressing ce lls  in rejected human kidney g ra fts . Scandinavian
Journal o f Immunology. 18, 37-40.
van Es, A., Meyer, C.J.L.M., Oljans, P.J., Tanke, H.J. & van Es, L.A.
(1984) Mononuclear ce lls  in renal a l log ra f ts . Transplantation, 37,
134-139.
van Rood, J .J . ,  Eernisse, J.G. & van Leeuwen, A. (1958) Leucocyte
antibodies in sera from pregnant women. Nature, 181, 1735-1736.
193
van Rood, J.J. & van Leeuwen, A. (1963) Leucocyte grouping. A method 
and i t s  application. Journal of C lin ical Investigation. 42, 1382-1390.
Voisin, G.A., Kinsky, R., Jansey, F. & Bernard, C. (1969) Biological 
properties of antibody classes in transplantation immune sera. 
Transplantation. 8, 618-632.
von Willebrand, E., Soots, A. & Hayry, P. (1979) In s itu  effector
mechanisms in ra t kidney a l log ra f t  re jection . I .  Characterisation of
the host c e l lu la r  in f i l t r a te  in re jecting a l lo g ra f t  parenchyma.
C e llu la r Immunology. 46, 309-326.
Wallis, A.E. & McMaster, W.R. (1984) Sequence of a cDNA coding fo r a
ra t class I I  chain: extensive DNA and protein sequence ide n t ity  to
H-2A and HLA-DC1 chains. Immunogenetics. 19, 53-62.
Watters, J.W.F., Locker, J.D., Kunz, H.W. & G i l l , T.J. I I I .  (1987a)
Polymorphism and mapping of the class I I  genes in the ra t:  RT1.B. 
RT1.D. and RT1.H, a new DP-like region. Immunogenetics. 26, 220-229.
Watters, J.W.F., Locker, J.D., Kunz, H.W. & G i l l ,  T.J. I I I .  (1987b)
Polymorphism and mapping of the complement gene C4 in the ra t.
Immunogenetics. 25, 204-206.
Weiss,A. & Fitch F.W. (1977) Macrophages suppress CTL generation in 
ra t mixed leucocyte cultures. Journal of Immunology. 119, 510-516.
Werner-Favre, C., Jeannet, M., Harder, F. & Montandon, A. (1979) 
Blood transfusion, cytotoxic antibodies and kidney g ra ft  survival. 
Preliminary results of a systematic transfusion protocol. 
Transplantation. 28, 343-346.
Widera, G. & F lave ll, R.A. (1985) The I region of the C57BL/10 mouse: 
characterisation and physical linkage to H-2K of a novel SB B-like 
class I I  pseudogene AB3. Proceedings of the National Academy of 
Sciences of the USA. 82, 5500-5504.
Williams, A.F., Galfre, G. & Mil stein, C. (1977) Analysis of cell 
surfaces by xenogeneic myeloma hybrid antibodies: d i f fe re n t ia t io n  
antigens of ra t lymphocytes. Cell, 12, 663-673.
Winnearls, C.G., Fabre, J.W., M illa rd , P.R. & Morris, P.J. (1979) A 
quantita tive  comparison of whole antibody and F(ab')2 in kidney 
a l lo g ra f t  enhancement. Transplantation, 28, 36-39.
Wong, G.H.W., Clark-Lewis, I . ,  Harris, A.W. & Schrader, J.W. (1984) 
E ffect o f cloned interferon-gamma on expression of H-2 and la 
antigens on ce ll lines of hemopoietic, lymphoid, e p i th e l ia l ,  
f ib ro b la s t ic  and neuronal o r ig in . European Journal of Immunology, 14, 
52-56.
Wood, K .J . , Evins, J. & Morris, P.J. (1985) Suppression of renal 
a l lo g ra f t  re jection in the ra t by class I antigens on purif ied  
erythrocytes. Transplantation, 39, 56-62.
194
Wood, K .J., Hopley, A., Dallman, M.J. & Morris, P.J. (1988) Lack of 
corre la tion between the induction of donor class I and class I I  
major h is tocom patib il ity  complex antigens and g ra ft re jection. 
Transplantation, 45, 759-767.
Wurst, W., Rothermel, E. & Gunther, E. (1988) Genetic mapping of C4 
and Bf complement genes in the ra t major h is tocom patib il ity  complex. 
Immunogenetics. 28, 57-60.
Yasumura, T. & Kahan, B.D. (1983) Prolongation of ra t kidney 
a l lo g ra f ts  by pretransplant administration of donor antigen extract or 
whole blood transfusion combined with a short course of cyclosporine. 
Transplantation. 36, 603-609.
Zinkernagel, R.M. & Doherty, P.C. (1979) MHC-restricted cytotoxic T 
c e l ls :  studies on the biological ro le of polymorhic major
transplantation antigens determining T ce ll re s tr ic t io n -  s p e c if ic ity ,  
function and responsiveness.Advances in Immunology. 27, 51-177.
Zukoski, C., Lee, H.M. & Hume, D.M. (1960) Prolongation of functional 
survival o f canine renal homografts by 6 mercaptopurine. Surgical 
Forum. I I ,  470-472.
195
[g la s g o w !
UNIVERSITY 
umSARY _ J 
